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During cardiac development and in cardiac disease changes in hemodynamic load 
initiate events leading to remodeling of the ECM. This study addresses the hypothesis that 
interactions between Integrins and Metalloprotienases function to modulate cell adhesion 
in the cultured cardiac fibroblast. The fibroblast is positioned to detect and respond to 
changes in the mechanical load on the heart. Functionally the cardiac fibroblast is the 
primary cell type responsible for the production, maintenance, and remodeling of the 
xi 
   
cardiac interstitium. Matrix Metalloproteinases, specifically the Gelatinases, are expressed 
in concert during development and in disease with changes in the hemodynamic loading of 
the heart.  
Our studies have identified by  a complex on the surface of the cardiac fibroblast 
composed of the a3b1 integrin, MMP-2, and TIMP-2. Putatively, this complex is involved 
in the maturation of adhesions. Inhibition of MMP-2 was associated with a decrease in the 
strength of adhesion of cell plated on collagen and fibronectin. Confocal imaging and 
analysis indicate that a predominate interaction occurs between MMP-2 and the a3 integrin 
chain.  
 Taken together biochemical, functional, and microscopic data have identified a complex 
on the surface of the cardiac fibroblast that represents elements of mechanotransduction 
and matrix metabolism in a single site that functions in the maturation of adhesion 
 
xii 
  
 
CHAPTER I 
 Introduction and Overview of Project 
 
Cell adhesion is the process by which cells become adherent to various surfaces 
and is a necessary requirement for the existence multicellular organisms. In the most 
general sense, cell adhesion may be cellular or non-cellular in nature. The adhesion of cells 
to one another is commonly referred to as intercellular adhesion or cell-to-cell adhesion. 
Cell adhesion to non-cellular constituents present in the extracellular environment is 
denoted as cell-matrix adhesion. Adhesion events may be non-specific or specific in 
nature. In non-specific adhesion, cells can undergo attachment to one another or other 
surfaces as a consequence of physical entanglements or electrostatic interactions. These 
non-specific events often represent a preamble to the formation of a specific adhesion site. 
Specific adhesion processes are mediated through the interactions of cell surface receptors 
that recognize specific binding sites on adjacent cells and/or in the surrounding 
extracellular environment. While all adhesion events may induce a cascade of intracellular 
responses, the binding of cells to a specific site(s) provides an increased measure of control 
over intercellular signals and downstream processes.  
The modulation of adhesion is central to the fundamental processes of cell 
migration during development, normal neonatal growth, the maintenance of normal 
homeostatic physiological states and at the onset of disease.  The loss of normal cell-to-cell 
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or cell-matrix interactions during the critical early stages of development can lead to a 
nearly endless variety of congenital defects; many of these defects are lethal. For example, 
changes in adhesion underlie stem cell differentiation and the formation of the blastocyst 1, 
embryonic cell sorting and migration 2, tissue patterning 3 and the generation of organ and 
tissue architecture 4.  
The pervasive role of cell adhesion is evident during many specific stages of 
development. Blocking the cell surface receptors that mediate the migration of epithelial 
cells in the apical ectodermal ridge disrupts the evolution of normal limb architecture 5. 
The loss of normal neuronal cell-matrix interactions is believed to cause the X-linked, 
Kallmann syndrome, a defect characterized by hypogonadotrophic hypogonadism and 
anosmia 6. Homozygous knockouts of the cell-matrix receptor α4 integrin, prevents 
placentation and is associated with defects in the epicardium and coronary vessels that 
result in cardiac hemorrhage and embryonic death 7. Cardiac looping and the subsequent 
stages of ventricular wall morphogenesis are mediated by homotypic and heterotypic cell-
to-cell interactions driven by members of the Connexon and Cadherin families of receptors 
8. Signals generated through members of the integrin and cadherin families are both 
necessary for the apposition and closure of palatal shelves 9.  Blocking signals normally 
passed through E-Cadherin during early embryonic development results in dysgenesis and 
embryonic death in the Zebrafish 10. This list of defects associated with the disruption of 
normal cell-to-matrix and cell-to-cell adhesion is by no means comprehensive.  
In adult life changes in cell adhesion continue to play a persistent and central role 
in such diverse processes as clot formation during hemostasis 11, the modulation of 
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immune response 12, cell migration and targeting during wound healing, and cell motility 
during routine remodeling throughout the tissue compartments and organ systems 13.  
Cell adhesion is a dynamic process. This dynamic aspect allows a cell to release 
from a specific site in response to various environmental conditions, undergo motility, and 
subsequently cease migration and establish stable long term, residency in a particular 
location. Non-specific and specific interactions may be disrupted by physical processes, 
electrostatic challenges, and or chemical insults. In addition to these general mechanisms 
of “control” (or perhaps lack there of), sites of specific cell-to-cell and cell-matrix adhesion 
are subject to more extensive regulation from the onset, by definition, this type of 
interaction is more “selective“ in nature. At one level of control specific adhesion events 
are mediated by the structural characteristics of the receptor in question and the chemical 
identity, availability and tertiary structure of the target ligand. A cell may express any 
number of cell surface receptors; if, however, the target ligand is absent or otherwise 
masked there can be no specific adhesion event. At the other end of the spectrum, once 
specific adhesion has been established it may be lost in response to the global 
physiologically processes that underlie motile activity (e.g. de-adhesion) and/or though 
more subtle molecular events associated with the routine turnover of cell adhesion 
molecules.  
The onset of specific cell adhesion is subject to regulation at several different sites. 
Beyond the notion that specific binding is regulated by receptor ligand interactions, 
specific adhesion can be subject to modulation by events initiated within the intracellular 
environment as well as through various external cofactors, including ions and/or other 
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peptides 14, 15, 16. This study defines a potential role for proteases of the MMP family in the 
regulation of specific cell adhesion by the α3β1 integrin to the ECM ligands, collagen and 
fibronectin. The present work developed from experiments designed to examine how 
adhesion to these ECM components and mechanical forces might regulate the expression 
of MMP-2 and MMP-9, extracellular proteases of the gelatinase family, in the cultured 
cardiac fibroblast 17, 18. This preliminary work indicated that the expression of protease 
activity mediated by these enzymes in response to stretch was different when this cell type 
was plated onto collagen, laminin or fibronectin. Preliminary experimentation leading to 
the present document was conducted to extend these observations. These experiments were 
designed to use various molecular interventions to alter the relative number of specific 
integrins expressed by the cultured neonatal cardiac fibroblast. The aim of this approach 
was to determine if changes in MMP expression in response to stretch where more closely 
associated with the absolute number of integrins or the specific identity of the integrins 
present on the cell surface (e.g. more receptors = more binding sites = tighter adhesion = 
more response to strain: or, changes in receptor identity = changes in cellular response to 
stretch). 
Technical and biological limitations limited interpretation of the data generated in 
these experiments; unfortunately, there was considerable noise in the experimental system 
ultimately used to test this hypothesis. However, in the course of these early experiments 
data was generated to suggest that MMPs may regulate integrin function to a greater extent 
than the opposite condition, notably, that integrins regulate MMP accumulation and 
activation in the cardiac fibroblast. The present study was developed as a consequence of 
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these observations. The overall objective of the present study is to test the hypothesis “that 
MMPs of the gelatinase family play an active role in modulating integrin mediated cell 
adhesion. To address this hypothesis four specific aims were developed: 
 
1. Define the structural relationships that exist between specific integrin sub-types and 
members of the MMP family of gelatinases.  
2. Optimize the binding conditions necessary to achieve maximal adhesion of 
neonatal rat cardiac fibroblasts to collagen, laminin and fibronectin using 
conventional adhesion assays.  
3. Define the strength of adhesion that develops as the cells attach to different ECM 
substrates using centrifugal adhesion assays.  
4.  Define the functional relationships that link extracellular protease activity with the 
integrin mediated adhesion of cardiac fibroblasts to collagen, laminin and 
fibronectin.   
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CHAPTER II  
 
Cell Adhesion Molecules 
 
There is a broad spectrum of cell surface molecules that mediate cell adhesion. This 
discussion will focus on the cell adhesion molecules (CAMs) that mediate specific binding 
events. Principle members of the CAM family include, the Cadherins 19, the 
Immunoglobulin superfamily-like molecules (Igsf-CAM, I-CAM) 20, the Selectins 21, and 
the Integrins 22. The CAMs can be further sub-divided into two main categories; those 
receptors that mediate intercellular (cell-to-cell) adhesion (ICAM) and those that mediate 
cell-ECM adhesion.  
The Cadherins mediate calcium dependent cell-to-cell adhesion, most often through 
homotypic (cadherin-cadherin) interactions 23.This diverse class is composed of at least 80 
different members that are differentially expressed during development and are present in a 
wide variety of different tissue types 24. These ICAM molecules span the plasma 
membrane and typically exhibit an intracellular domain, a transmembrane domain and an 
extracellular domain.  The intracellular domain can bind and signal though the catenin 
system 25, 26. During development, signals propagated by the cadherins play a well 
documented, and prominent role in cell sorting during early embryogenesis 27 and in the 
formation of the extremities 28 and the digits 29 and in myogenesis 30. In the central nervous 
system, N-Cadherin (neural cadherin) plays a role in growth cone mechanics and in the 
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interactions of neurites with glial cells and with glial cells interacting with each other 31. In 
adult tissues, cadherins are prominently localized within the epithelial tissues 32. These 
receptors are present in the adherens junctions of the keratinocytes. Adherens junctions 
form a nearly continuous band around the periphery of these cells and serve to anchor the 
lateral aspects of adjacent cells together. Within the intracellular space filaments of the 
actin-based cytoskeleton insert into the electron dense plaque that characterizes these 
junctions, providing a site for the distribution of mechanical forces across the cell 
population. Adhesion, at the molecular level, is mediated through homotypic bonds 
(cadherin-to-cadherin). Members of the cadherin family also are present within the 
desmosomes of the epithelium, these junctions, also called macula adherens junctions; 
appear as “spot-welds” between adjacent cells. Intermediate filaments insert into the 
cytoplasmic face of the desmosome.   
 Members of the Immunoglobulin superfamily-like CAM family comprise a second 
group of cell adhesion molecules. The transmembrane Ig-CAMs mediate cell-to-cell 
adhesion through homotypic and heterotypic interactions. These proteins are designated as 
part of the Immunoglobulin superfamily because they exhibit immunoglobulin like 
structural domain(s). Adhesion proteins of the Ig-CAM family have a wide tissue 
distribution. Representative of this Ig-CAM subfamily are Vascular Cell Adhesion 
Molecules (V-CAM), Intercellular Adhesion Molecules (I-CAM), and Neural Cell 
Adhesion Molecules (N-CAM) 33 and L1, a subset of the Ig-CAM family that functions in 
neuronal outgrowth, fasciculation and interneuronal adhesion 34. Ig-like CAM heterotypic 
interactions often partner with a receptor of the integrin family of cell-matrix receptors.  
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For example, the heterotypic binding of VLA-4 (α4β1 integrin) with VCAM-1 provides 
leukocytes with firm adhesion to the vascular wall in the process of diapedisis 35. 
Heterotypic interactions between the Nectin class of Ig-like CAM and the cadherins also 
have been described 36. 
Members of the Selectin family are concentrated in the endothelium and the 
leukocyte cohort of blood 37, 38. These CAMs mediate adhesion to carbohydrate moieties 
through specific binding events; however, these cell-to-cell adhesions represent relatively 
low avidity (strength) contacts 39. Selectins are type-1 transmembrane glycoproteins that 
display calcium dependant binding and, as the name implies, bind to selected 
polysaccharide residues. This group of CAMs is part of the C-type lectin family and 
subtypes are based on distribution and include; the L-(Leukocyte), the E-(Endothelial), and 
the P-(Platelet) selectins. Selectins function in the trafficking and accumulation of 
inflammatory cells in the vicinity of a wound 40. In response to injury both selectins and 
selectin ligands are rapidly expressed, from intracellular granules, onto the surface of the 
endothelium. These molecules can then interact with the selectins and selectin ligands 
present on the surface of circulating leukocytes. Selectin-to-selectin interactions mediate 
the initial aspects of adhesion that allow leukocytes to roll along the luminal surface of 
blood vessels. This low affinity adhesion process, which is reversible, represents a 
preamble to the subsequent formation of more “mature”, stable adhesions that are mediated 
by integrins.  
Integrins comprise the last major family of CAMs. These receptors are widely 
expressed and are present in nearly all cell types. These transmembrane heterodimeric 
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glycoproteins bind to a broad spectrum of ECM components 41. Integrin dependent events 
take place throughout life from the earliest stages of embryogenesis. The receptors of this 
family represent integral components of the cellular machinery that mediates motility 42 . 
Loss of integrin mediated adhesion frequently results in apoptosis or more specifically 
anikosis 43. The binding properties of the Integrins are subject to considerable regulation 
from intrinsic and extrinsic factors, this study describes results suggesting that these 
proteins interact in a unique fashion of members of the MMP family of proteases. This 
interaction has potential consequences in the regulation of integrin biology during cardiac 
development and at the onset of disease in this organ. The biology of the integrin family 
will be considered in more detail in the subsequent chapters.  
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CHAPTER III  
Integrin Biology 
 
Integrin fine structure.  
The functional integrin receptor is composed of an α and a β chain, the specific 
complement of subunits that are present within a given integrin receptor define its binding 
specificity. At least 18 α and 8 β subunits have been described and in all at least 26 
different functional heterodimers have been identified. Splice variants of the β chain inflate 
the actual number of functional receptors to a small degree. Each transmembrane 
glycoprotein chain that makes up the integrin complex is expressed from a unique gene 
sequence; the subunits are linked in a non-covalent fashion with one another and arrive on 
the cell surface as an intact receptor 44.   
The integrins can be grouped into a series of subcategories based on the identity of 
the β chain. For example, the β1 family of integrins is composed of all the α chains that can 
combine with this subunit to form a functional receptor (α1-α11). The β2 family combines 
with the αL, αM, αX, and the αD subunits. Integrin families based on the β3, β4, β5, β6, β7, 
and β8 chains have been described.  
Each integrin chain displays an intracellular, a transmembrane and an extracellular 
domain. The intracellular domain, or cytoplasmic tail, of the prototypic β chain is 
composed of 20-50 amino acid residues, this domain represents a target for intracellular 
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regulatory factors and ultimately, as a docking site for cytoskeletal proteins and signal 
molecules. Integrin binding events are believed to be initiated by the interaction of Talin, a 
cytoskeletal associated protein, with the cytoplasmic tail of the β chain. This intracellular 
binding event, called integrin activation, promotes a conformational change in the receptor 
that leads to increased adhesion avidity for target substrates in the extracellular 
environment 45. In cells of hematopoietic origin talin function can be replaced by kindlin-3 
46.  The cytoplasmic tail of the β chain also is a target for tyrosine phosphorylation.  The 
addition of phosphates to this domain may be a component element of the signal 
transduction pathway that destabilizes the association of the integrin complex with the 
actin based cytoskeleton, thereby facilitating the onset of motility 47. The α chain 
cytoplasmic domain is variable, but typically very limited in length. This domain 
participates in the interactions that ultimately generate the functional integrin complex 48.  
The helical transmembrane domains of the α and β chains function to localize, and 
anchor, the receptor in the plasma membrane 49. Interactions of these domains orchestrate 
the assembly of the non-covalently linked  α  and  β  heterodimer and participate in the 
formation of higher order interactions between other integrin complexes (clustering).  
In the extracellular space the integrin chains extend from the surface of the cell 
through a series of domains that exhibit structural, regulatory, cation binding, or ECM 
binding activity. The extracellular domains of the β chain exhibit several epidermal growth 
factor-like (EGF) repeats, a plexin, a semphorin, and integrin (PSI) domain, a hybrid 
domain, and a terminal β-A domain 44. The prototypical α integrin extends from the cell 
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surface and contains a “calf” domain, a “thigh” domain, a β propeller, and a variable α-A 
domain inserted in the β propeller. Integrin α chains can be further subclassified based on 
the presence of the A-α domain, this sequence helps to define ligand binding 50. 
The structural/functional properties of the A-α domain are dependent upon the 
binding of metal ions to adjacent domains in the α chain. The αvβ3 integrin binds to 
fibronectin in an RGD dependent fashion. For this binding event to take place metal ions 
must be present in three adjacent domains; the MIDAS (Metal Ion Dependant Adhesion 
Site) domain, the adjacent MIDAS (ADMIDAS) domain, and in the neighboring LIMBS 
(Ligand associated metal binding site) domain of A-α sequence 51. The occupation of these 
metal ion binding sites stabilizes the tertiary structure and architecture of the ligand 
binding pocket. Crystallographic analysis of the αvβ3 integrin demonstrates that ligand 
binding occurs within the groove that is present between the α and β chains, providing a 
structural correlate to explain how the complement of integrin subunits present in a given 
receptor can define binding specificity.  
 
Integrin activation.  
There is evidence that the functional integrin complex exists in 3 distinct structural 
states 52. Each of these states, the folded closed state, the folded open state and the 
extended open state, exhibits unique binding properties against the target substrate. In the 
folded closed state, or non-activated state, the integrin resides on the cell surface in a 
somewhat folded conformation that exhibits low binding affinity. In this folded 
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conformation the calf and thigh of the α chain exist in a “knees” bent state and the PSI 
domain of the β chain is folded in a fashion thought to sequester the binding domains from 
ECM ligation 53.  During activation the entire integrin complex is believed to undergo a 
conformational change that is initiated by the binding of talin to the cytoplasmic tail of the 
β chain 45. This binding event leads to the extension of the entire molecule; a 
transformation that is marked by a marked increase in the binding affinity of the receptor 
for the target ligand. The conformation that is intermediate to the folded state and the 
extended fully activated state is transitory in nature; however, it does appear to exhibit 
intermediate binding properties.  
Integrin activation can occur through “outside-in” and “inside-out” mediated 
events. Outside-in activation occurs in response to cues, such as structural motifs, that exist 
in the surrounding ECM 54. However, the final pathway to integrin activation ultimately 
involves the binding of talin (or the analog kindlin) to the intracellular domain of the β 
chain. Talin, itself, exists in at least 2 states, a masked, auto-inhibited and an unmasked, 
active state 55. In the masked state talin exists in a cytoplasmic compartment and does not 
interact with the integrin. At unmasking, talin binds to the integrin and initiates the 
conformational change associated with activation. It is not known how the binding of talin 
to the cytoplasmic tail of the β chain might induce structural changes in the extracellular 
domain of the integrin.  
Talin represents a pivotal regulator protein for integrin activation. This small 
peptide is directed to the plasma membrane by Rap1-GTP-interacting adaptor molecule, 
(RIAM) mediated linking of Rap 1, a ras GTPase that serves as a targeting sequence 56. 
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This complex places RIAM as an intermediary for the docking of Talin between the 
plasma membrane and integrins. Typically RIAM is distributed throughout the cytosol and 
is focused to the plasma membrane by Rap1. The physiological basis for the unmasking of 
talin remains unclear; however, this process can be driven by increased 
phosphatidylinositol 4,5-bisphosphate 55. In vitro, the proteolytic processing of the 
extended talin molecule with the enzyme calpain II dissociates the head from the tail of 
talin, allowing it to bind to the β integrin chain. Phosphorylation also appears to regulate 
the stability of the association of the talin head domain with β chain and the overall 
stability of focal adhesions 57. Beyond the effects on integrin activation, the tail section of 
talin serves as a mechanically sensitive site for the incremental accumulation of the actin 
binding protein vinculin 58. 
 
Integrin binding properties.  
As a family, Integrin binding activity can be unique towards a specific moiety in 
the ECM; however, different integrins may exhibit considerable overlap in binding 
specificity. Multiple integrins exhibit binding activity against the same ECM protein and a 
given ECM target may be recognized by more than one integrin subtype. In addition, 
selected integrin subtypes are highly promiscuous and may bind to a variety of different 
ECM substrates. Integrin binding to a target may be mediated by specific amino acid 
sequences or by the presentation of a defined tertiary structure in the target molecule. See 
table 1 for representative binding properties of specific integrins 
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Integrin chains and Classic Binding Partners 
Table 1    
 Integrin β chain Integrin α chain Classic binding partner 
 β1  Family 
(VLA) 
α1, α2 Collagen, laminin 
  α3 Collagen, laminin and fibronectin 
  α4 VCAM-1 
  α5 Fibronectin, RGD sequence 
  α6, α7 Laminin 
  α8 RGD sequence  
  α9 Tenascin 
  α10, α11 Collagen 
    
 β2  Family (LFA) αL,αM,αX,αD Leukocyte specific receptors 
    
 β3  Family αΙΙb RGD sequence, highly promiscuous 
    
 β4  Family α4 Plaque proteins and plectin 
  α6 Laminin 
    
 β7  Family αE  Leukocyte specific receptor 
  α4 Lymphocyte trafficking, VCAM-1 
    
 Other   
 β1,  β3,  β5, β6,  β8   αV RGD Sequence 
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This discussion will focus on the binding properties of the α1β1, α2β1, α3β1, and the 
α5β1. These receptors represent the principle integrins expressed in the neonatal rat 
myocardium 59. The α1β1 and α2β1 integrins both bind to collagen and laminin. The α3β1 is 
highly promiscuous and exhibits binding activity against collagen, laminin and fibronectin. 
The α5β1 integrin is highly specific to fibronectin. These receptors of the β1 family are 
expressed in a developmental pattern and the profile of integrins present in the adult rat 
heart undergoes a shift during ventricular wall hypertrophy 60. The expression of the α1β1 
and the α3β1 integrins are low in fetal life and increase with age, both are prominently 
expressed in neonatal life. The α2β1 is not detectable by immunoprecipitation in fetal life 
and is expressed at relatively modest levels later in development. The α5β1 is expressed at 
substantial levels throughout life. In sedentary adults and during the onset of pressure 
overload hypertrophy α1β1 expression is depressed, α3β1 expression is regulated in a nearly 
opposite fashion under these conditions.  
The α1β1 and α2β1 integrin both exhibit binding activity against Type I collagen 61 
and EHS laminin 62, 63. However, these integrins recognize distinctly different binding sites 
within these ECM molecules 64. The α1β1 integrin exhibits a lower affinity to collagen  
than the α2β1 integrin 65. This integrin (α1β1) binds to type I collagen in an RGD 
independent manner sites that is dependant upon the topography of the triple-helical 
conformation of the collagen molecule 66,67. In contrast, α2β1 integrin binds to a specific 
peptide sequence (GFOGER) that is present in the α1(I) chain of type I collagen 68. 
Laminin is comprised of an alpha, beta, and gamma chain arranged in a cruciform shape. 
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Proteolytic dissection of the laminin molecule indicates that α1β1 and α2β1 bind to 
different domains within this basement membrane protein 69.  Further, the binding of the 
α2β1 integrin to laminin-1 is dependent on the extended open conformation and the 
activation state of the integrin 70.  
The α3β1 integrin exhibits binding properties that are described as promiscuous 
because it participates in the adhesion of cells to collagen, laminin, and fibronectin. The 
binding of the α3β1 integrin to each of these ECM substrates exhibits varying sensitivity to 
cations and challenge with RGD antagonists 71. Binding appears to be mediated by RGD 
dependent and RGD independent events. While this integrin is described as promiscuous in 
its binding properties with respect to collagen, laminin and fibronectin the α3β1 integrin 
certainly does not exhibit pan ECM adhesion properties. Over expression of the α3β1 
integrin enhances cell adhesion to the RGD motif present in entactin but does enhance the 
RGD dependent adhesion of cells to fibronectin 72. One possible explanation for the unique 
binding properties of this integrin, the α3β1 molecule may not mediate the initial events of 
adhesion to ECM target substrates. Rather, this integrin may become secondarily localized 
to developing focal adhesion sites in association with other integrins 73.  Intracellular 
signals induced by this integrin complex play a role in regulating the expression of 
pericellular matrix constituents, a reasonably common theme in integrin biology 72.  
The α5β1 integrin is an example of an integrin that exhibits unique binding activity 
against a target ligand. This receptor mediates specific and high affinity binding to the 
glycoprotein fibronectin 74; this binding event enhances fibronectin expression and the 
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assembly of this protein into fibers in the vicinity of the cell surface 75,76. The specificity of 
the α5β1 integrin for fibronectin is derived from a target RGD sequence as well as the 
conformation of this ECM molecule. Fibronectin is a dimeric protein that contains three 
distinct, and repeating, structural modules, type I, type II and type III. All three modules 
contain anti-parallel β sheets, the type I and type II domains are stabilized by disulfide 
bonds 77. The integrin RGD target sequence resides within the ninth fibronectin type III 
repeat (FNIII9). The FNIII10 repeat site contains a sequence called the synergy site 
(PSHRN). The initial binding of the α5β1 integrin to the fibronectin molecule is driven 
primarily by an interaction between the β1 chain and the RGD sequence; full engagement 
of the integrin can only occur if the synergy site is present in an accessible conformation. 
This synergy site can be exposed by strain induced changes in fibronectin conformation 78. 
Proteolytic processing of fibronectin increases the number of available RGD sites 79. 
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Chapter IV.  
   
 
Cell Adhesion 
 
Cell adhesion is an umbrella term that encompasses a variety of concepts and in 
reality the term has a number of working definitions. Typically, the term cell adhesion 
refers to the attachment of a cell to a surface, usually one that is coated with an ECM 
protein, a carbohydrate moiety and/or other candidate molecule, under controlled 
conditions in the tissue culture environment. However, cell adhesion routinely takes place 
in vivo. Regardless, cell adhesion is a process that is subject to a variety of checkpoints. 
These checkpoints “allow” cells that are “designed” to be mobile to remain mobile. At the 
same time the regulation of cell adhesion enables a cell that is resident to a particular place 
to form stable, long term adhesions (both cell-cell and cell-matrix),  allowing that cell to 
remain in place for extended periods of time.  
As a working definition of adhesion for this discussion, cell adhesion represents the 
specific adhesion of neonatal rat cardiac fibroblasts to a 2D surface coated with collagen, 
laminin, or fibronectin in tissue culture at 370C. This working definition requires yet more 
refinement as cell adhesion is a dynamic process that takes place in time, the nature of the 
interaction between cells and the surrounding environment changes rather dramatically 
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over a 1-2 hour interval 80, the time frame used in this study. When applied to a surface, 
cells initially interact with the surrounding micro-environment through physical 
entanglements and/or charge-based interactions. These non-specific interactions represent 
a prelude to adhesion events driven by CAMs. Once specific adhesion events have taken 
place many cell types spread out over a 2D surface and assume a highly flattened and 
spread morphology. Subsequently, cells typically undergo some degree of motility once 
they have reached “a spread equilibrium” with their surroundings.  
For integrin-mediated events that take place in tissue culture the process of specific 
cell adhesion is initially marked by the formation of the focal contact (complex). This 
structure represents the transition from non-specific adhesion interactions to an event 
associated with the talin-initiated activation and ligation of an integrin with a target ligand 
81. During the initial phases of contact with a surface in 2D culture these structures are 
scattered over the basal surface of the cells in a punctate pattern. Over time, and given the 
appropriate circumstances, this structure evolves into the much more elaborate focal 
adhesion site. The classical focal adhesion exhibits a much larger surface area than the 
focal contact and generally has a triangular-like shape. This structure is composed of a 
population of integrins packed into a defined area on the cell surface. It is essential to 
recognize the equally important role of de-adhesion in the regulation of cell adhesion. 
Without this aspect of the process cells could not change shape and/or undergo motile 
activity. 
The transition from the focal contact to the focal adhesion begins with the 
accumulation and clustering of integrin receptors with one another into a higher order 
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structure 82. A pool of integrins that is freely mobile within the plane of the plasma 
membrane (lateral diffusion) is recruited to the developing focal adhesion 83. This 
recruitment process requires a minimal threshold of mechanical loading in the guise of 
strain (stretch), this loading may originate from intracellular or extracellular sources 84. The 
disruption of the actin based cytoskeleton with drugs such as cytochalasin b 81 or 
latrunculin 85 suppresses the maturation process. This occurs, presumably, because the 
actin based cytoskeletal network generates the internal tension necessary to promote focal 
adhesion assembly. Similar effects are observed when actin mediated contraction is 
suppressed 86. Models of assembly predict that strain literally pulls the integrins into 
clusters, leading to the formation of the focal adhesion site. Early models were based on 
the assumption that actin was polymerized into cables from the forming focal adhesion; 
however, with the advent of more sophisticated imaging techniques it has become clear 
that the actin fibers exist prior to the adhesion site 87. 
In parallel with integrin clustering there is a marked up-regulation of intracellular 
signal cascades and a continuing reorganization of the cytoskeleton, these events result in 
assembly of the multi-molecular complex that typifies the focal adhesion site. In the fully 
mature adhesion site, large scale actin bundles approach and terminate into an electron-
dense, sub-plasmalemma plaque. This plaque contains structural proteins, including, talin, 
vinculin, and α-actinin 88, 89 as well as signal molecules including FAK, Paxillin and ILK 
(integrin linked kinase) 90, 91. The strength of the focal contact is weak in the prototypic 
cell-substrate interaction and increases in strength as cells develop mature focal adhesions 
92. 
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The maturation of initial contacts into the mature focal adhesion is intertwined with 
the process of cell spreading. In turn, cell spreading encompasses many of the events that 
take place during cell motility. During cell spreading, nascent focal contacts present at the 
cell periphery provide traction for the protrusion of lamellapodia. The formation of these 
membrane processes is driven by the polymerization of actin fibers in the core of the 
lamellapodia 94. The focal contacts present at the protruding margin of the cell are “pulled” 
centripetally under the motive force of actin “tread milling”, an action that generates the 
internal strain necessary to induce integrin clustering and the elaboration of the 
prototypical triangular focal adhesion site 85. The assembly and contraction of the actin 
based cytoskeleton is regulated through the Rac/Rho signal transduction pathway 94. RAC, 
a small GTPase, induces actin polymerization. Subsequently, RHO drives the 
accumulation of smaller actin-based fibers into stress fibers through ROCK, a downstream 
kinase that promotes actin contractility 95.  
Cell migration can be viewed as an extension of the cell spreading phenomena. In 
the case of motility, adhesion sites, spreading and the release of adhesions must be 
sequentially regulated to enable the cell to undergo movement. The rates at which adhesion 
sites are lost are believed to represent the rate limiting step in cell motility 96. The 
disassembly of integrin mediated adhesions is a distinct process and it is not a simple 
reversal of the assembly process. Determining the events, and signal molecules that 
regulate the disassembly of adhesion sites has proved difficult, these factors are in 
continual flux between the cytosolic compartment and the existing adhesion sites. 
However, experimental evidence points to a microtubule-based process. Blocking the 
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formation of microtubules with Nocodazole promotes the formation of extensive focal 
adhesions under the direction of Rho. Upon subsequent washout of this agent, focal 
adhesions are disassembled in concert, and in parallel, with the formation and growth of 
microtubules 97. The disassembly of the existing focal adhesions is not affected by changes 
in Rho GTPases activity, rather, the disassembly process is sensitive to the formation of a 
FAK: dynamin: Grb2 complex. Based on these findings and morphological data, it appears 
that focal adhesion disassembly is dependant upon endocytosis 97, 98, 99. Consistent with this 
model of regulation there is an increased concentration of integrins within endocytic 
compartments when dynamin becomes associated with FAK 100. 
Grossly, the nature of the adhesions that cells make in tissue culture and the 
strength of these adhesions are dependent upon several variables. First, if the adhesion 
process is to transition beyond the initial contact stages that are non-specific in nature, the 
cells under consideration must express the appropriate complement of receptors to the 
candidate substrate. The target ligand must be present, and accessible, in sufficient density 
to support cell spreading. Next, metabolic activity (i.e. viable, living cells) must be utilized 
to re-organize the cytoskeleton and enable cell spreading to take place. Lastly, mechanical 
signals, originating from the cytoskeleton or from the external environment, are needed to 
drive the elaboration of the fully mature adhesion site 101. A variety of different techniques 
and model systems have been used to define the processes and events that lead to cell 
adhesion and the assembly of the focal adhesion. Each of these paradigms has its own 
attendant strengths and weaknesses. Some assays are designed to look at population 
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dynamics while others are more subtle and are designed to examine specific events at the 
level of the single cell.  
 
Conventional adhesion assays 
In a classical approach, often denoted as the conventional adhesion assay, a tissue 
culture dish is coated with a substrate of interest 102. In this study these assays were 
conducted to define the baseline kinetics and binding characteristics of the cultured 
neonatal cardiac fibroblast to different ECM substrates. For these experiments a 
suspension of cells is applied to a surface of interest for a defined interval of time, usually 
30 to 60 minutes. This time interval, for many cell types, encompasses the critical time 
period where cell adhesion is transitioning from non-specific processes to events that are 
mediated by specific, receptor-driven interactions. At the conclusion of the plating interval 
the culture plate is inverted and the cells are “dumped”, adherent cells are retained, stained 
and quantified in some fashion. One aspect of this assay that remains an art form is the 
dumping phase. The amount of force that is used to invert and displace non-adherent cells 
can vary considerably from one investigator to another and as a result this phase of the 
experiment can be subject to variability from one lab to the next. However, in practice, and 
with experience, individual investigators can conduct this type of assay with remarkable 
consistency. By varying the plating interval used, the rate at which cells become adherent 
to the candidate substrates can be evaluated on a population wide basis.  
The conventional adhesion assay is a very effective approach to study population 
dynamics and characterize the basic rate at which cells undergo adhesion to different types 
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of surfaces. However, given that integrin binding can be redundant and overlapping (with 
other integrins and even other CAMs) it can be difficult to ascribe a result to a specific 
receptor subtype. This limitation can be circumvented to some degree by using a cell line 
that is engineered to express a limited repertoire of receptors 103 or by examining how 
adhesion is effected when specific receptors are blocked. This later condition can be 
achieved through the use of antagonistic peptides like cyclic RGD peptides 104and/or 
through the use of function blocking antibodies 105. By eliminating one class of receptors 
and then evaluating the rate of cell adhesion, it is possible to extrapolate the contributions 
that the inhibited receptor might have in the outcome of the experiment. Alternatively, 
cells also can be transfected to express increased (or decreased) levels of receptors or other 
components of the cell adhesion machinery. From a functional prospective, the relatively 
brief interval between the initial adhesion events and the elaboration of the fully mature 
focal adhesion site results in a highly synchronized population of cells. This characteristic 
can be exploited to examine the biochemical correlates of the various events of adhesion.  
 
ECIS assays 
Conventional adhesion assays essentially take a snap shot of information at defined 
intervals of time, however, attachment and spreading can be continually monitored in a cell 
population with an ECIS (Electric Cell-Impedance Sensing) device106. This platform is 
fabricated on a microscope slide and consists of a series of miniature tissue culture wells 
(the volume of each well in this device is on the order of the volume found in an individual 
well in 96 well plate). At the floor of these miniature tissue culture wells is a conductive 
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grid that is linked through a circuit to a detector. This grid surface can be coated with ECM 
proteins, or other materials, prior to cell plating. When cells are applied to the wells they 
settle out onto the grids and there is a change in the electrical impedance that is present 
across the circuit 107. Over time, the impedance decreases as the cells spread out over the 
surface of the grid, essentially insulating the surface and changing the conductive 
properties of the circuit as a consequence. By adding various reagents, for example drugs 
that inhibit components of the cytoskeleton and/or specific signal molecules, the ECIS 
assay makes it possible to evaluate the dynamics of cell attachment and subsequent cell 
spreading. 
 
Centrifugal adhesion assays 
Conventional adhesion assays have limited utility at defining the absolute strength 
of adhesion that takes place between the cell and the target substrate. As noted there is too 
much variability in the “dump phase” in this type of assay. This limitation can be 
circumvented through the use of the centrifugal adhesion assay. In this application, cells 
are usually labeled with a vital dye (often a fluorescent metabolic reagent that is taken up 
and retained by live cells) and plated out onto a substrate of interest for a defined interval 
of time. At some point in the assay after the metabolic labeling has been completed an 
initial reading is taken of the plate to generate an estimate of cell number. The plates are 
then sealed and placed in an inverted position within a centrifuge equipped with a 
swinging arm rotor and an appropriate carrier for the culture plate and spun for a specific 
time and rotation per minute (RPM.) By knowing the radius of the rotor arm the actual 
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force experienced by the cultures can be estimated. At the completion of the centrifugation 
interval the plates are gently rinsed and a final determination of adherent cells is 
determined. A comparison of the initial cell number before and after centrifugation 
provides a measure of adhesion. 
 
Molecular adhesion 
“Adhesion” has been examined at the “molecular level” using atomic force 
microscopy and magnetic twisting. These experiments for the most part are designed to 
examine the forces that are present at the interface of the integrin and ECM (atomic force) 
or at the interface of the integrin and the cytoskeleton (magnetic twisting). In atomic force 
microscopy beads coated with various peptides are linked to the cantilever arm of the 
microscope.  As the cantilever arm is brought into contact with the cell surface binding 
events are initiated, the physical nature of this interaction is then characterized by 
determining the amount of force that is necessary to deflect the cantilever 108 . A similar 
approach has been used to characterize the association of specific integrins with the actin 
based cytoskeleton. In these experiments a magnetic bead can be coated with various 
peptides that will bind to a given class of integrins and allowed to interact with the cell 
surface. When these experiments are conducted in the presence of drugs that alter actin 
stability the amount of force necessary to twist the bead is substantially decreased with 
respect to untreated samples 109 (Wang 1999); a result that demonstrates the physical 
association of actin fibrils and the cytoplasmic domain of the integrin receptor. 
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Morphological Assessment of Cell Adhesion. 
The principal strength of the conventional adhesion assay is in its simplicity and 
utility at generating adhesion data for a large population of cells to a defined surface over a 
defined interval of time. This assay and the related centrifugal adhesion assay are not 
particularly effective at examining the dynamics of adhesion, the processes that underlie 
cell spreading, or the relative distribution of different proteins with respect to one another. 
High resolution light or fluorescence microscopy designed to examine these events in 
single cells are more appropriate for this type of analysis. In early experimentation, this 
work was conducted on fixed samples, cells were plated for varying lengths of time and 
processed for microscopic examination 110. Occasionally, transmission and scanning 
electron microscopy techniques have been applied to study cytoskeletal organization 111,112. 
Considerable insight has been provided by this strategy concerning how cell structure 
changes over time during cell adhesion and spreading. These experiments essentially 
generated a static map of cytoskeletal changes (and signal cascades) associated with the 
different steps in the adhesion process.  
The actual site of cell-substratum interaction can be unambiguously defined by the 
technique of interference reflection microscopy. This form of light microscopy uses a high 
numerical aperture lens constructed with strain free optics. When light is passed through a 
cell and focused on a cover glass the light is reflected off the surface of the substratum, a 
fraction of this light passes back along the original light path. When the optics are focused 
on the cover glass the maximal amount of light is passed back to the detector (eye, camera, 
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photo-detector etc.). At sites where a cell is in contact with the cover glass the amount of 
light that is reflected back into the detector is decreased, the extent to which the light 
reflection is decreased is proportional to the distance the intervening structure is from the 
glass reflecting surface 113. In practice a cover glass produces a bright reflection, focal 
contacts will appear as punctate spots that are somewhat gray. A fully mature focal 
adhesion site appears as a much darker structure. Within a given cell the darker the area 
associated with the contact the more intimately applied that structure is to the underlying 
surface. This technique can be used in living or fixed samples. However, for live cell 
imaging the heating effects of the illuminating light must be minimized, fixation tends to 
collapse the cell to a degree.  
Real-time observations of living cells with high resolution optics make it possible 
to study the dynamics of adhesion and cell spreading. This method can be coupled with the 
micro-injection of mutant or fluorescently labeled proteins that target different elements of 
the cytoskeleton or the focal adhesion complex 114. The true dynamics of protein turnover 
in these structures has been evaluated with the technique of fluorescence recovery after 
photobleaching (FRAP). Once an injected fluorescently labeled protein has been allowed 
to come to equilibrium within the cell, the fluorescent tag present in a specific domain of 
the cell is bleached with a pulse of light 115. The site of bleaching is then monitored over 
time as the bleached proteins are replaced with tagged proteins. This turnover is a 
reflection of the stability of the structure under investigation, the bleached and unbleached 
proteins exchange with one another from the structural compartment and the cytosol.  
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Chapter V.  
  
The Matrix Metalloprotienases  
 
 
While there are clear homologies, the binding events and processes that underlie 
cell motility in vivo are different than the binding events that take place in the simplified 
2D microenvironment of tissue culture. In vivo the cell is enmeshed within a 3D 
microenvironment consisting of cells and the ECM. This complex matrix is composed of a 
heterogeneous array of interconnected fibrous proteins and other macromolecules that 
define tissue architecture. This heterogeneous mixture of proteins and proteoglycans 
provide the cellular compartment with a diverse variety of potential binding sites. Unique 
cell-matrix interactions between a single cell surface receptor subtype and a single unique 
moiety are rarely, if ever, encountered within intact tissues.  
Like the cell:ECM interaction in vitro, the cell:ECM interaction in vivo is highly 
dynamic. In both environments there is evidence of two-way regulation across the plasma 
membrane (i.e. inside-out as well as outside-in signaling) on a local, as well as a global 
scale. The chemical identity, and physical arrangement, of the ECM interact to regulate the 
function of the resident cellular population. In turn changes in the steady state physiology 
of the cellular compartment can lead to changes in the composition and organization of the 
ECM.  
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Under steady state conditions an external signal or other change in the status quo 
must ordinarily alter the balance of information passing between from the cellular and 
extracellular compartments. Signals that initiate or modulate this two-way pattern of 
signaling often originate from soluble factors present in the local microenvironment.  
These signals can have direct consequences on the expression and/or deposition of specific 
ECM constituents 116. Sustained changes in mechanical load can also impact the cell:ECM 
interaction and thereby alter the steady state conditions. These forces can be detected 
directly in the cellular compartment and transduced into intracellular signal cascades that 
modulate cell phenotype and/or ECM metabolism 117, 118.  
In native tissues many cell types express a variety of integrin subtypes (and other 
CAMs). Within this complex 3D environment any given cell can be linked to a variety of 
different binding moieties, providing several different potential conduits for the 
transmission of information across the plasma membrane. For integrin-based binding 
events it is unclear how or if a cell discriminates between these different signals. The 
observation that different integrin:ECM interactions exhibit different binding constants 
(e.g. strength of adhesion), suggests that information concerning the local mechanical 
environment might be detected in a biased fashion 64. For example, an integrin with a high 
avidity interaction with a target molecule can be expected to transduce mechanical 
information in a different pattern than an integrin that is weakly linked to the surrounding 
environment. Ultimately, the physiological status of the cell must be the sum of the 
individual binding events; cell adhesion does not take place in a vacuum. Preliminary 
experimentation conducted for this study was designed to determine if the absolute number 
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of a specific integrin subtype or the identity of integrins present on the cell surface dictated 
cellular response to strain and the expression of the gelatinases, MMP-2 and MMP-9. As 
noted in the introductory remarks of this study the results of these experiments suggested 
that MMP-mediated protease activity modulated cell adhesion to a greater extent than the 
converse circumstance (cell adhesion modulating MMP expression). 
The characteristic specificity of MMP-2 and MMP-9 for ECM proteins suggests 
that these proteases might impact cell adhesion by altering the structure and/or availability 
of cell binding sites in the surrounding matrix.  Native proteins can contain adhesion sites 
that are sequestered and not presented to the cellular compartment in an orientation that is 
available for binding activity. These sites, called cryptic sites, can be unmasked by changes 
in mechanical loading and/or through the proteolytic processing of ECM components. For 
example, increased mechanical loading can act to uncoil or otherwise alter the tertiary 
structure of the protein(s) under consideration, thereby exposing these hidden binding sites 
78. While changes in strain are often associated with an increase in mechanical load, the 
converse circumstance, a decrease in mechanical load, can also induce changes in protein 
structure that result in the exposure of previously unavailable binding sites. This 
unmasking process is undoubtedly facilitated by the highly interconnected nature of the 
ECM and cellular compartments. 
Proteolytic processing of ECM components or the denaturation of proteins through 
physical, chemical or through radiation can directly alter protein structure and unmask 
cryptic sites contained within individual proteins. Such degradative events also can 
unmask hidden sites indirectly by altering the degree of strain that is present across an 
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individual protein119 or even across a relatively large volume of tissue 120. In dermal burn 
injuries, native collagen fibrils are physically damaged, this serves to unmask specific 
integrin binding sites that are not ordinarily available 121, 122. Once these sites become 
available the keratinocyte population begins to shift in phenotype to mediate the re-
epithelialization of the wound bed. A variety of proteolytic enzymes can mediate the 
processing of ECM proteins, not surprisingly; these degradative events are subject to a 
considerable degree of regulation. Relevant to this study are the extracellular enzymes of 
the Matrix Metalloprotienase Family. 
 
The Matrix Metalloprotienases 
 The Matrix Metalloprotienases (MMP) is a family of zinc dependant enzymes that 
collectively degrade most ECM proteins. These extracellular proteases are expressed 
broadly in the animal kingdom. First identified in the tail of the metamorphosing frog these 
enzymes play a central role in regulating the turnover and remodeling of the ECM in 
development 123, normal homeostasis and in disease 124. Subsequent to this initial 
identification 28 different MMP have been identified. A defining feature of this class of 
endopeptidases is the Zn+2 ion that is an integral component of the active enzyme. 
Members of this family are classified into subfamilies based on functional and structural 
criteria. Substrate specificity serves as a functional criteria; the primary and tertiary 
structure of the peptide define the structural characteristics. The MMP subfamilies include; 
(i) the Collagenases, (ii) the Stromelysins, (iii) the Gelatinases, (iv) other MMP, and (v) 
the Membrane-type MMPs. 
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Structural domains present in MMPs underlie the functional differences used to 
define the subfamilies. Common to all MMP is the Zn+2 cation that is necessary for the 
function of the catalytic domain. Other divalent cations such as Ca+2 serve to stabilize the 
tertiary structure of the enzymes. The molecular weight of these proteases can vary 
considerably; the actual mass of each MMP is determined by the number of functional 
domains that are present in the enzyme 17 For example, the smallest protease of the family, 
MMP-7 or Matrilysin (28 kD, classified as an “other MMP”), is a soluble enzyme that is 
composed a signal domain, a pro-domain, and a catalytic domain. In contrast, MMP-9, also 
a soluble protease, is considerably larger (92kDa). In addition to a signal domain, a pro-
domain and the catalytic domain this protease contains a fibronectin type II repeat that is 
typical, and diagnostic, of the gelatinase family of MMPs. MT1-MMP (54-64 kDa-
depending upon activation state) is a Membrane-type protease that contains a 
transmembrane domain that functions in part to anchor the enzyme to the plasma 
membrane.  
Typically the prototypic, soluble MMP is expressed in a latent, zymogenic state 
(non-active) into the extracellular compartment. Intracellular processing by furin represents 
an alternate site for enzyme activation.  These enzymes may be stored in the extracellular 
environment in this state for variable intervals of time and then activated in response to an 
environmental signal. Activation is regulated through the pro-domain, this portion of the 
molecule acts as a physical constraint on the structure of the enzymatic domain. Within the 
80 amino acid sequence of the pro-domain there is a conserved region, PRCG(V/N)PD, 
that contains a cysteine residue that forms a coordination complex with the Zn+2 cation that 
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resides within the catalytic domain. This bond confers latency to the enzyme and has given 
rise to the concept of a “cysteine switch” 125.  The nature of this bond makes these enzymes 
susceptible to a host of chemical, mechanical, and physiologic events that can lead to 
activation. A family of peptides, the Tissue Inhibitor(s) of Metalloprotienase (TIMP), 
modulate the activation cascades that ultimately regulates the enzymatic activity of these 
proteases. There are 4 described TIMPs, these small (~24 kDa MW) peptides bind to 
various sites on the enzymes and act to suppress activation and/or localize specific MMPs 
to different extracellular compartments.  
 
The Gelatinases: MMP-2 and MMP-9 
Representative of the Gelatinase family of MMPs are MMP-2 and MMP-9.  These 
proteases are of particular interest to this study as these enzymes are active in the 
myocardium during embryonic growth and during episodes of ventricular wall remodeling 
in adult life 126, 127. These enzymes represent the primary MMPs expressed by the cardiac 
fibroblast in the rodent 128. Historically the nomenclature designating these enzymes has 
been based on substrate specificity, molecular weight and/or the order of discovery. MMP-
2 has been variously identified as Gelatinase A and/or the 72 kDa type IV collagenase (and 
MMP-2). MMP-9 has been known as Gelatinase B and/or the 92 kDa type IV collagenase 
(and MMP-9). The designations of MMP-2 and MMP-9 for these gelatinases reflect a 
naming convention that is based on the order of discovery and these terms are widely used 
to describe these two proteases.  
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For most MMPs,   non-catalytic interactions with ECM proteins occur through the 
C-terminal, hemopexin domain. However, unique to MMP-2 and MMP-9 are the 
fibronectin Type II-like domain repeats that are present within the N-terminal catalytic 
domain of these enzymes. These domains mediate the unique N-terminal binding 
interactions of these proteases with collagenous components of the ECM 129. Note, MMP-2 
and MMP-9 are both expressed and deposited into the ECM as inactive enzymes that are 
subsequently activated in response to environmental signals. Essentially, the fibronectin 
Type-II repeats function to tether these inactive enzymes to components of the 3D 
scaffolding that surrounds the fibroblasts of the heart (and most other tissues).  
Substrate specificity of the gelatinases is fairly broad. MMP-2 and MMP-9 both 
have demonstrated activity against such diverse proteins as elastin, vitronectin, laminin, 
SPARC, aggrecan, decorin, Link Protein and MBP 18.  MMP-2 can cleave collagen Type I, 
III, IV, VII, X and XI. MMP-2 also has unique activity against the non-collagenous 
proteins, fibronectin and various laminins. MMP-9 has activity against the collagen Types 
IV, V, XI, and XIV. Enzymatic activity of MMP-2 and MMP-9 against the target substrate 
proteins has largely been defined in vitro, resulting in some degree of controversy, and 
uncertainty, as to the targets that might be degraded in vivo by these proteases (defining 
this type of activity in the complex in vivo environment is not a trivial task). Nevertheless, 
MMP-2 binds and can cleave native type I collagen into fragments in a fashion typically 
assigned to the interstitial collagenases 130, 131. In contrast, MMP-9 exhibits only binding 
activity against this ECM protein and does not appear to cleave Type I collagen 132.  
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The activation of MMP-2 and MMP-9 is regulated at a number of different sites; 
the uncontrolled activation of these proteases would clearly have deleterious consequences 
on the structural integrity of the ECM 133. Under most circumstances MMP-2 is expressed 
constitutively into the extracellular environment in the inactive, pro-form and stored as a 
zymogen within the ECM. MMP-9 is more often expressed into the extracellular 
environment in response to specific environmental signals. As with MMP-2, MMP-9 is 
typically deposited into the ECM in the inactive, pro-form.  The conversion of these pro-
forms of these enzymes into the active state is subject to a multi-tiered pattern of 
regulation.  
The regulatory schemes controlling the activation state of MMP-2 and MMP-9 vary 
to some degree. As noted, MMP-2 is usually expressed in a constitutive manner; however, 
this does not mean that the enzyme is expressed in a haphazard, unregulated manner. The 
over-expression (and dysregulation) of this protease occurs in some cancers and is 
associated with enhanced cell migration and the spread of metastatic disease 134, 135. The 
principle pathway for the activation of pro-MMP-2 involves the cell surface bound MT1-
MMP and the regulatory peptide, TIMP-2 136, 137. When MMP-2 and TIMP-2 are present at 
equimolar concentrations in the extracellular environment, the conversion of pro-MMP-2 
to the active MMP-2 isoform is inhibited. As the concentration of TIMP-2 is increased, the 
TIMP-2 molecule binds to MT1-MMP. When a critical concentration of TIMP-2 is 
reached, TIMP-2 can be bound simultaneously to a pro-MMP-2 and to a MT1-MMP, 
forming a ternary complex at the cell surface. This complex positions the pro-MMP-2 in 
proximity to an adjacent “free” MT1-MMP leading to the proteolytic processing of the 
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pro-MMP-2 molecule to the active MMP-2 state. If very high concentrations of TIMP-2 
are present with respect to pro-MMP-2 and MT1-MMP these “enzymatic” compartments 
become saturated; effectively blocking the formation of the ternary complex and 
quenching the activation cascade. Alternate pathways leading to the formation of the MT1-
MMP:TIMP-2:MMP-2 complex and/or the activation of pro-MMP-2 are limited. The pro-
MMP-2 enzyme is highly resistant to many endoproteases, which limits the activation 
process through spurious cleavage events 138. However, pro-MMP-2 can undergo a process 
of self cleavage and subsequent autoactivation under conditions in which the enzyme is 
present in very high concentrations 139. 
The regulation of MMP-9 is perhaps in some ways more elaborate as it is not 
expressed constitutively 140.  MMP-9 expression is regulated by growth factors, cytokines, 
cell-cell interactions, and cell-ECM interactions and events that alter cell shape 141. In a 
model of cyclic stretch MMP-9 was detected only at moderate degrees of stretch whereas 
MMP-2 was detected at baseline, moderate and high degrees of stretch 142. The proteolytic 
activation cascade that regulates the processing of pro-MMP-9 to active MMP-9 is subject 
to TIMP-dependant regulation in a pattern similar to MMP-2. TIMP-1 (a peptide related to 
TIMP-2) and TIMP-2 can both bind and suppress the conversion of pro-MMP-9 to the 
active state. The relative contributions of TIMP-1 and TIMP-2 in the regulatory cascade 
remain ill-defined 143, although TIMP-1 dependant regulation of MMP-9 appears to be the 
predominate regulatory pathway in the control of pro-MMP-9 144. Adding additional 
support to this conclusion, TIMP-1 and pro-MMP-9 are expressed in a highly coordinated 
fashion.  In an analogous axis of control that regulates the activation of pro-MMP-2, the 
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activation of pro-MMP-9 is mediated by the disruption of the cysteine/ Zn+2 coordination 
bond. TIMP-1: pro-MMP-9: MMP-3 (Stromelysin-1) form a ternary complex that results 
in the formation of active MMP-9 145. MMP-3 and a plasmin dependant pathway 
effectively process the pro-peptide yielding the active MMP-9 146,147. Plasmin has two fold 
effects on the activation cascade, first, this protease can directly active MMP-9, second 
plasmin can increase MMP-3 mediated processing of MMP-9 148. 
 
Functional Consequences of MMP-2 and MMP-9  
Changes in MMP-2 and MMP-9 activity are closely associated with disease states 
and developmental processes (events in which the balance of signals between the 
intracellular and extracellular environments have been perturbed, leading to a change in the 
steady state condition) and that lead to alterations in ECM architecture and function. The 
role of these gelatinases in matrix remodeling is particularly striking in arthritis and in a 
variety of cancers.  For example, increased gelatinase activity parallels the onset of the 
osteoid and rheumatoid types of arthritis 149,150. Increased levels of Activated Protein C 
process and cleave PAR-2 (protease activated receptor-2) in osteoarthritic cartilage; this 
enzymatic activity leads to increased activation of MMP-2 and MMP-9 151. This pathway 
is not observed to be active in normal cartilage. Symptomatic of osteoarthritis is the 
accumulation of high levels of collagen breakdown products, this diagnostic feature of the 
disease can be blocked by treatment with broad spectrum MMP inhibitors 152.  In 
rheumatoid arthritis, the invasion of the cartilage matrix by migrating synovial fibroblast 
occurs in a MT1-MMP dependent process that is susceptible to the application of TIMP-2 
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(to block activation processes) and other pharmacologic agents that disrupt MMP-2 
activation. The invasive process also can be blocked by the over expression of a dominant 
negative MT1-MMP that is inactive and cannot activate MMP-2 153.  
The dysregulation of gelatinases (and other MMPs) has devastating effects in the 
progression of cancers. The breakdown of the basement membrane and the loss of 
compartment integrity is often a prelude to the dissemination of cancer cells in tumor 
invasion and metastases 134. For example, the loss of basement membrane type IV collagen 
paralleled elevation in MMP-2 and MMP-9 activity in the progression of colorectal tumors 
in human 154. For migration and direct invasion of cancer cells, the native ECM forms a 
barrier that is overcome by the proteolytic events that compromise its structural (and 
functional) integrity. MMP-2 specific protease activity mediates the processing of ECM 
proteins during the attachment and migration of ovarian tumor cells within the peritoneum 
155.  Critical to the growth of solid tumors is the process of angiogenesis, an event that can 
be initiated by the migration, in the absence of proliferation, of the existing of endothelial 
cells 156. The gelatinases can drive the process of vessel formation by inducing the release 
of VEGF 157.  Alteration in the  levels of MMP activity  are associated with a poor outcome 
in many cancer types. A representative but by no means comprehensive list highlights the 
many cancer types that involve deregulated MMP.   
- The expression of MMP-2, MMP-9 and MT1-MMP was associated with 
disseminated, advanced disease and correlated with shorter disease 
specific survival in ovarian carcinoma 158.   
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- In prostate cancer a major problem diagnostically is the lack of markers 
that delineate clearly the disease state. Traditionally PSA levels along 
with clinical impression were the mainstay in this determination. In a 
comparison of men with normal, benign hypertrophic, organ confined and 
metastatic prostate adenocarcinoma the levels of plasma activity of 
MMP-2 and-9 were highest in men with disseminated disease 159.  
- In a range of severity of astrocytic tumors MMP-2 and MMP-9 
expression levels were not correlated with survival rates 160. The lack of 
difference in the survival rates is likely a reflection of the high degree of 
infiltration of astrocyomas which is correlated with the level of MMP-2 
activity 161. 
- Levels of gelatinases and TIMP were correlated with established 
prognostic criteria in breast cancer it was seen that alteration on the 
MMP-2/ TIMP-2 ratio was indicative disease that had spread and was 
positive for nodal involvement.  
- MMP involvement is also a determinant in the growth of more “cellular” 
tumors as Hodgkin’s lymphoma162. In CLL (chronic lymphocytic 
leukemia) MMP-9 is involved in the invasion and migration of this B-cell 
cancer 163.  
 
The changes in MMP mediated proteolytic activity observed in parallel with the 
growth of so many different types of transformed cells has lead to the increased interest 
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and use of inhibitor based therapies that are designed to limit cell migration 164. The 
recurrent theme in the interplay between cancer and MMP is that MMP degrade ECM 
components, which serve as a barrier to constrain cells. Additionally, MMP are responsible 
for the release of cryptic site and for the processing and release of growth factors from the 
ECM.  In this context the ECM can be though of as 1) the substrate that provides structure 
to tissue and 2) the series of tissue interfaces created by basement membranes that define 
compartments. The breakdown of both of these components is evidenced in disseminated 
diseases.  In cancer invasion within the local tissue environment requires migration that is 
dependant on the action of MMP. Differences in levels of TIMP-2 regulate the activation 
of MMP-2 by MT1-MMP and underlie the invasive potential of melanoma 165. Basement 
membrane demarcates tissue compartments and is enriched in type IV collagen. 
Gelatinases are relevant as type IV collagenases.  
 
MMPs in the Heart in Development  
 During embryonic and fetal development in mammals the forming body and 
individual organ systems undergo dramatic changes in topology (shape) and size. These 
processes are mediated by events that take place on a local cellular scale that transpire in a 
coordinated fashion, ultimately resulting in the formation of the adult body plan. Organs of 
the gut, the lungs, the central nervous system, urogenital system are initially expressed in 
one form during embyrogeneis and then during subsequent development are completely 
remodeled to achieve the final adult form (and function). Synthetic and degradative 
processes must be precisely regulated to achieve normal development.  
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The changes in tissue architecture that mark normal development are clearly 
apparent in cardiac development and growth. At the onset of organogenesis mesenchymal  
stem cells emerge from the primitive streak, congregate, undergo differentiation and 
establish the cardiogenic zones 166.  As development precedes this cell population is 
recruited to form the solid, paired cylindrical heart tubes parallel to the midline of the body 
axis. The tubes condense to form a single hollow heart tube and that will undergo erosion 
to form the internal lumen that will become portions of the ventricular and atrial chambers. 
Initially the heart tube is nearly straight, as growth continues it elongates and this 
primordial structure begins to loop to form the basis for the four chambered architecture of 
the mammalian heart. At this point the developing heart is structurally simple with an outer 
layer of differentiating myocytes, a proteoglycan rich connective tissue, cardiac jelly, and 
the innermost layer of endocardium 167. 
The biological events that drive formation of the four chambered mammalian heart 
take place in a complex regulatory environment. Signals from multiple sources modulate 
the looping process, although, hemodynamic signals do appear to play an absolutely 
central role in the formation of the four chambered myocardium 168. In the rat, changes in 
load alter the differentiation patterns of myocytes and selectively promote the maturation 
of myofibrillar arrays in a regional pattern 169. These changes in cytoskeletal organization 
may serve to limit the extensibility of the ventricular wall and thereby direct the looping 
process by stiffening (strengthening) aspects of the muscle wall. In this model of 
development, the less stiff domains undergo the looping process. Protease mediated events 
also are critical to normal development. In the context of these events, the suppression of 
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MMP-2 mediated proteolytic activity results in gross defects in cardiac looping and 
varying degrees of cardia bifida 170. Presumably, proteolytic events facilitate cardiac 
looping by reducing the structural integrity of the ventricular ECM, thereby allowing the 
gross movements in the ventricular wall that must take place during looping. The 
embryonic period from E-12 to E-21 is dominated by MMP-2 mediated proteolytic 
activity, with a peak of activity around E-16. In contrast, MMP-9 has much lower level of 
activity during this window of development with a peak around E-16 126. This interval of 
development is associated with the formation of valvular structures.  
A recurring theme in cardiac physiology is the notion that changes in hemodynamic 
load promote the elaboration and accumulation of the ECM throughout the heart proper as 
well as in the outflow tracks and valve structures 128. Changes in MMP expression 
typically track with the events that promote the accumulation of nascent ECM proteins 
during these developmental processes. For example, MMP-2 activity is contemporaneous 
with migration of mesenchymal cells and the expression of this enzyme parallels the 
differentiation of cardiac valves 171. The migration of non-resident, neural crest cells into 
the developing heart during septation is spatially and functionally associated with changes 
in MMP-2 expression; suppressing MMP mediated migration of neural crest cell results in 
severe cardiac defects as persistent truncus arteriosus, double outlet right ventricle and the 
tetrology of Fallot 172.  
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MMPs in the Heart in Adult Life  
Sustained changes in mechanical loading in the adult heart initiate well documented 
remodeling events 173. Within the myocardial compartment elevated peripheral vascular 
resistance results in increased mechanical load and the onset of hypertrophic cardiac 
growth. During the compensatory stage of the disease the heart exhibits increased 
contractility and improved performance (output). Overtime the heart begins to 
decompensate as remodeling events alter the ECM composition and the myocardial 
compartment begins to fail 174,175. In long standing hypertension the progression into 
congestive heart failure is hallmarked by left ventricular dilation. This transition involves a 
thinning of the myocardial wall and a dilatation of the ventricular lumen. In rodent models 
of hypertrophy expression of MMP-2 and MMP-9 are markedly elevated during when 
compensation or decompensation 127. Moreover, inhibition of MMP activity can directly 
attenuate this process 176. Experimentally induced expression of MMP-2 in the heart can, 
independently of hemodynamic load, induce marked ventricular wall remodeling and the 
onset of systolic dysfunction 177.   
In experimental myocardial infarction the suppression of MMP mediated processes 
acts to preserve ventricular architecture. Notably, Ramipril, an Angiotensin Converting 
Enzyme (ACE) inhibitor, prevents left ventricular dilation following a coronary artery 
occlusion induced infarct in the spontaneously hypertensive rat. This treatment is 
associated with a depression in MMP-2 activity 178. The positive effects of ACE inhibitor 
treatment in lowering MMP-2 activity, in the A-V shunt (High output failure) model, were 
detected with a reduction of the intendant cardiac hypertrophy that develops in untreated 
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control animals 179. Lower levels of MMP-2 activity decrease the remodeling of the 
existing cardiac interstitium that is a prelude to the development of hypertrophy. Of 
patients with controlled hypertension, only patients with left ventricular hypertrophy and 
congestive heart failure had high serum levels of TIMP-1180. The high level of TIMP-1 was 
related to the extent of left ventricular remodeling. These data are mentioned to reiterate 
the importance of balance in the turnover of ECM components in the heart as being 
effected by the not only the activity(amounts) of MMP, but also the regulatory peptides 
that control activation of these proteases.  
 
 
MMP Interactions with Integrins 
In the classic view of MMP-2 and MMP-9 these proteases are found bound to 
constituents of the extracellular matrix. The enzymes are then processed into an active state 
and function to degrade elements of the surrounding environment. It is unclear how 
enzymes that are bound to the ECM are transitioned into a more or less soluble state for 
processing into the active protease. These processes are clearly regulated as enzyme 
activity increases and decreases in response to various environmental signals.  
Another factor in the biology of these systems concerns the extent to which the 
positioning and the degree to which the actual enzymatic processing of target substrates is 
regulated. Developing evidence has pointed to binding interactions between specific 
integrin subtypes and selected MMP molecules. This type of interaction results in a 
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complex on the cell surface that theoretically can target small, and highly relevant domains 
(to the cell) for processing.  
The association of pro-MMP-1 collagenase with the α2β1 integrin in keratinocytes 
represents a profound, and elegant, example of the functional consequences of the 
formation of this type of complex. In dermal burns (and other forms of full thickness 
injuries to the dermis) the keratinocytes at the periphery of the wound site undergo a 
phenotypic shift. At least 4 distinct sub-populations, based on various molecular markers, 
can be described, including the differentiated, proliferative, motile and differentiating 
phenotypes 181.  Each cell type appears to “evolve” from cells that existed in a previous 
phenotypic state. Differentiated basal keratinocytes represent the cell population that 
resides at the base of the epithelial layer in normal skin. Within hours of injury rates of cell 
division increase, marking the appearance of proliferative keratinocytes. During this phase 
of wound healing there increased expression of MMP-3182. The motile phenotype is 
composed of the keratinocytes that migrate out over the provisional wound matrix to form 
the epithelial tongue 183. Differentiating keratinocytes appear as contiguous sheets of cells 
form on the wound.  
The migration process for the motile phenotype of keritinocytes on native collagen 
is absolutely dependent upon the expression of functional α2β1 integrins and the MMP-1 
protease 122, 184. Demonstrating this association were a series of experiments that blocked 
the function of MMP-1 with either pharmacological, physiological (TIMP-1), 
immunological, also blocked the migration of keritinocytes on native collagen. Moreover, 
keritinocyte migration was inhibited by collagenase resistant collagen. Specific blocking of 
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α2β1 blocked migration on type 1 collagen and the expression of MMP-1. These functional 
(observations) of keritinocyte migration suggests a physical association of proMMP-1 and 
α2β1 integrin. This association was vetted by microscopic demonstration of the 
colocalization of these proteins on the surface of migratory keritinocytes and the 
coimmunoprecipitation these antigens. Disrupting the association by the exogenous 
application of active MMP-1 or antibodies directed against the I-domain of the α2 chain 
demonstrate the interaction to be  constrained to the linker and hemopexin domain of 
MMP-1 with the I- domain of the α2 chain. The specific interaction of the I-domain and 
MMP-1 was delineated with a series of binding assays of purified α2 I-domain to native 
and chimeric MMP-1 185.  This complex appears to direct proteolytic activity to domains 
that must be remodeled in the ECM in order for migration to take place 184.  
Several other examples of integrins linked to MMPs also exist. In angiogenic 
blood vessels MMP-2 colocalizes with the αvβ3 integrin on the endothelium. This 
interaction is mediated through the C-terminal domain of the MMP-2 molecule with the 
αvβ3 integrin. It is thought that this interaction is based on homology of the C-domain with 
the established αvβ3 integrin ligand vitronectin.  In this topological arrangement the N-
terminal catalytic domain of the MMP is free to mediate proteolysis 186.  The fibronectin 
Type II like repeats of the MMP-2 molecule have also been implicated in linking this 
protease to the cell surface. In this instance, a pericellular collagen peptide acts as a bridge 
between the β1 integrin subunit and the MMP-2 protease 187. One aspect of this particular 
relationship that remains to be more fully explored concerns the observation that the 
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MMP-2 recovered from this complex is resistant to cellular activation. It has been 
theorized that this resistance may be a reflection of this pool of MMP-2 being positioned as 
“reserve” of readily available latent gelatinase that can be secreted in the inactive pro-form 
without intersecting the MT1-MMP activation pathway.  
Several lines of evidence indicate that specific interactions between selected MMPs 
and other cell surface molecules exist in a variety of systems. MMP proteases have been 
detected in association with CD44, ICAM-1, and Caveolin-1 188. The formation of these 
complexes appears to allow the cell to specifically direct and control proteolytic activity 
within its immediate vicinity. In the heart, changes in MMP expression and activation 
occur during periods of active ventricular wall remodeling. Given this observation and the 
emerging literature that MMPs are specifically tethered to the cell surface in many tissue 
types this study was undertaken to test the hypothesis that MMP mediated proteolytic 
activity is spatially regulated in the rat cardiac fibroblast by members of the integrin 
family. The specific aims of this study were to:  
 
1. Define the structural relationships that exist between specific integrin sub-types and 
members of the MMP family of gelatinases.  
2. Optimize the binding conditions necessary to achieve maximal adhesion of 
neonatal rat cardiac fibroblasts to collagen, laminin and fibronectin using 
conventional adhesion assays.  
3. Define the strength of adhesion that develops as the cells attach to different ECM 
substrates using centrifugal adhesion assays.  
4.  Define the functional relationships that link extracellular protease activity with the 
integrin mediated adhesion of cardiac fibroblasts to collagen, laminin and 
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fibronectin.   
 
The results of this study demonstrate that MMP-2, and not MMP-9, is linked 
specifically to the α3β1 integrin in a complex that also contains TIMP-2. Evidence in 
support of this conclusion is derived from co-immuno-precipitation experiments designed 
to alternately pull down the α3, the β1, or the MMP-2 molecule from a cell extract isolated 
from 3-5 day old neonatal rat cardiac fibroblasts. The recovered material was then assayed 
for the presence of α3, the β1, MMP-2, MMP-9, TIMP-1 and TIMP-2.  MMP-2 immuno-
reactivity was present in material recovered from immuno-precipitations against α3 and β1. 
Assays of material recovered by immuno-precipitations directed against MMP-2 indicated 
that these integrin subunits represented the predominate site of attachment. There was no 
immuno-reactivity against α1 α2 or α5 integrin when MMP-2 was targeted for immuno-
precipitation.  Quantitative scanning confocal microscopic observations were used to 
confirm these results. Functionally, adhesion assays suggest that MMP mediated protease 
activity promotes the attachment and or maturation of adhesion sites in cells plated onto 
collagen and fibronectin, but not laminin or poly-l-lysine.  
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CHAPTER VI.   
 
 
Methods 
 
Cell Culture 
Cell Isolation. Cardiac fibroblasts were isolated from postnatal, three to five day 
old (P3 to P5) Sprague-Dawley rat pups. (IUCAC 0204-3058) Pups were decapitated and 
subjected to a mid-line thoracotomy. Skin was folded back from the thorax and the 
pressure applied to the dorsum of the pup during this procedure causes the heart to move to 
the anterior surface of the thorax and through the thoracotomy where it was clipped from 
the attached vasculature. Hearts were collected and placed into PBS in a 50 ml centrifuge 
tube. Any floating or suspended debris was decanted and discarded. Hearts were rinsed 
with PBS until clear of blood. Hearts were transferred to a sterile 30 ml beaker (Pyrex No. 
1000) and minced with iris scissors into 1 mm2 pieces. This preparation was rinsed in fresh 
PBS until clear of blood.  
 Using a 30 ml syringe (BD Falcon) fitted with a #14 gauge x 6 in stainless steel 
cannula (Popper),  the minced heart tissue was transferred to a sterile 50 ml Erlenmeyer 
flask (Pyrex No. 4980) for enzymatic dissociation. Liquid contents were aspirated and 
discarded using the syringe and cannula. A 10 ml aliquot of collagenase solution was 
introduced into the vessel. Collagenase was prepared fresh in PBS (Collagenase type I, 250 
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u/mg, Worthington Biochemical Corporation; Lakewood, NJ), diluted to 120 units of 
enzymatic activity/ml and filtered through a 0.2 µm syringe filter. The flask containing the 
heart tissue and collagenase solution was placed into a shaking water bath set to agitate at 
100 cycles/min at 37˚C (Precision; Winchester, VA) for 10 min. The supernatant was 
aspirated and discarded. A fresh 10 ml aliquot of collagenase solution was added to the 
tissue, followed by gentle cannulation (4x) to mechanically disrupt the tissue. The flask 
was returned to the water bath for a 10-15 min digestion cycle. Supernatant was collected 
and strained (100 µm cell strainer, BD Falcon) to remove large debris into a 50 ml 
centrifuge tube. The addition of collagenase, the digestion incubation, and collection 
procedure was repeated, without additional mechanical cannulation, until the tissue was 
fully digested.  
 The pooled cell supernatant was pelleted by centrifugation at 800 x G for 8 min 
(ALC International, Milano, Italy). The recovered cell pellet was suspended in 5 ml of 
Complete Media (DMEM/F-12 supplemented with 5% Horse Serum, Sigma H1138, 2.5% 
Fetal Bovine Serum, Heat Inactivated, Invitrogen 10437-028, 1.2% Sodium Bicarbonate, 
Invitrogen 25080, and 1.2% Antibiotic/Antimycotic, Invitrogen 15240).  
 Differential adhesion was used to partially purify viable cardiac fibroblasts from 
the crude digest.  The suspended cell pellet was divided into three 150 mm2 tissue culture 
flasks (Corning), each having a total final volume of 20 ml, for each litter of pups 
(assuming 8-10 animals per litter). Flasks were incubated in a 5% CO2 incubator at 37˚C 
for 5 hours. At the conclusion of this interval the media was decanted and the flask was 
rinsed briefly with PBS. Complete Media was added to a final volume of 25 ml. At best, a 
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nominal number of cardiac myocytes will adhere to tissue culture dishes under these 
conditions. Any surviving myocytes are lost during subsequent cell passages. 
 
Culture Maintenance.  Cultures of neonatal rat cardiac fibroblasts were routinely 
maintained in 150 mm2 culture flasks supplemented with 25 ml of Complete Media in a 
5% CO2 incubator at 37˚C. Media was changed every 3-5 days. Cultures were assessed by 
microscopic examination. When cultures were 90% confluent, the cells were split 1:2 into 
fresh culture vessels. For cell passage, media was decanted, plates were rinsed with PBS 
and supplemented with 10 ml of 0.25% Trypsin/EDTA (Invitrogen, 25200) prepared in 
DMEM and incubated for 10 min at room temperature. The release of cells was visually 
confirmed. Cells were collected in 50 ml centrifuge tubes, flasks were rinsed with 10 ml of 
complete media which was collected and added to the 50 ml tube containing the released 
cells. The number of 50 ml tubes needed for each passage was determined by the number 
of culture flasks that were to be split; typically 3 flasks can be accommodated by one 50 
centrifuge ml tube. Cells were brought to pellet by centrifugation (800 x G for 8 min). The 
cell pellet was suspended in a small volume of complete media (~ 5-10 ml per flask) mixed 
and then distributed into twice the number of starting flasks. Complete media was added as 
needed to bring the total volume of media to 25 ml per flask. Fibroblasts were used for 
experimentation after 3 and no more than 8 passages. 
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Culture Media Formulation.  Media formulations that were used during these 
experiments are as listed. All reagents from Gibco/Invitrogen unless noted. Formulations 
included:   
1) “Complete Media” as already described-used for routine culture 
maintenance: DMEM F-12 supplemented with 5% Horse Serum (Heat 
Inactivated: Sigma), 2.5% Fetal Bovine Serum (Heat Inactivated; 
Sigma), 1.0% Sodium Bicarbonate, and 1.0% Anti-biotic/anti-mycotic 
(penicillin G, streptomycin, and amphotericin). 
2) “ITS Media”- DMEM F-12 supplemented with; 1.0% Insulin 
Transferrin, Selenium (ITS+1; Sigma), 1.0% Sodium Bicarbonate, 1.0% 
Anti-biotic/anti-mycotic (penicillin G, streptomycin, and amphotericin).  
3) “Depleted Media”- used for selected experimentation: DMEM F-12 
supplemented with 0.1% Gelatinase depleted FBS, 1.0% Insulin 
Transferrin Selenium (ITS+1; Sigma), 1.0% Sodium Bicarbonate, 1.0% 
Anti-biotic/anti-mycotic (penicillin G, streptomycin, and amphotericin). 
Gelatinase depleted media was prepared by incubating FBS overnight at 
4º C against a 1% Gelatin/ PBS slab polymerized in a 150 cm2 culture 
flask (proteases of the MMP family that reside in serum adhere to the 
gelatin slab). Following recovery, the depleted FBS was passed through 
a 0.2 µm syringe filter.  Depletion of endogenous gelatinase activity in 
this media formulation was verified by 10% gelatin zymography. This 
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media formulation was selected for use to minimize the effects of serum 
proteases in the experimental paradigms. 
 
Adhesion Assays  
Conventional Adhesion assays. Conventional adhesion assays were conducted on 
surfaces coated with different extracellular proteins. These experiments are designed to 
examine the initial stages of cell adhesion. Conventional adhesion assays were 
subsequently used in conjunction with various MMP inhibitors to investigate how this 
family of enzymes might modulate initial adhesion. 
In preliminary conventional adhesion experiments, 96 well flat bottom culture 
plates (Immunolon HB2, ThermoForma) were coated with various concentrations (0, 1, 5, 
10, 25, or 100 µg protein/ml of PBS in 250µl) of Type I collagen (Vitrogen 100, Palo Alto, 
CA), laminin (EHS, Sigma), or fibronectin (Human Plasma, Sigma) or poly-l-lysine 
(0.01% 70k-150k in 250µl, Sigma) overnight at 4˚C. The protein concentrations translate 
into surface densities of 0.007 µg protein/mm2, 0.035µg/mm2, 0.07 µg/mm2, 0.21µg/mm2, 
and 0.7µg/mm2, respectively. This range of extracellular protein concentrations (ECM) 
was selected to produce 2D surfaces that exhibit an incremental increase in the number of 
available ECM sites for specific adhesion. After coating all wells were blocked with 2% 
BSA (1 hour) and rinsed with PBS prior to experimentation.  
Trypsin released cells were counted and plated onto the different surfaces in 100µl 
of depleted media or ITS media for varying time points from 30 min to 4 hours. Non-
adhering or floating cells were removed by blotting the plate upside down on lint-free 
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towels and a single gentle rinse with PBS. This rinse was done by tilting the dishes to 
approximately 450 angle and allowing the rinse solution to flow slowly across the bottom 
of the dishes. Adherent cells were stained and fixed with 100 µl of 0.5% (w/v) Methylene 
Blue (Fisher Scientific) prepared in 50/50 ethanol/ water for 30 min at room temperature. 
Excess stain was removed by 3x flooding with ddH2O and aspiration. The retained dye was 
solubilized with 100 µl of 1% Sodium Dodecyl Sulphate prepared in ddH2O. Absorbance 
at 620 nm was read after 1 hour in a Molecular Devices SpectramaxPlus 
spectrophotometer 189. 
In 30 minute adhesion assays the absolute cell number present on the dishes at the 
conclusion of the experimental interval was determined by extrapolation against a standard 
curve of cells seeded onto plates coated with 100 µg/ml Type I collagen. Data sets were 
screened by one-way ANOVA, absolute cell numbers that were adherent to the different 
surfaces were compared by pairwise multiple comparison using the Holm-Sidak method. 
In 60 minute adhesion assays the numbers of cells present on each ECM substrate was 
expressed as a percentage of cells present on poly-l-lysine. Once again these data sets were 
screened by one-way ANOVA, the Holm-Sidak method was used for multiple pairwise 
multiple comparisons. 
 
Centrifugal adhesion assays. The strength of adhesion of CF to different surfaces 
was tested using a centrifugal adhesion assay. In this assay cells are allowed to adhere to a 
given surface for a defined interval of time and then subjected to a controlled centrifugal 
force that is oriented perpendicular to the plating surface (i.e. the plates are centrifuged 
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upside down).  See 189 for additional discussion. These assays were conducted in 
Immunolon HB2 96 well plates (ThermoForma) that had been coated overnight at 4˚C with 
10 µg/ml of Collagen type I (Vitrogen 100), Fibronectin (Human Plasma) (Sigma Aldrich), 
EHS Laminin (Sigma Aldrich) or Poly-L-Lysine (Sigma Aldrich, 100 µl 0.01% 70k-150k) 
prepared in PBS. The plates were rinsed with PBS and blocked for 1 hour at room 
temperature with 1% BSA in PBS.  
 Cells were trypsinized with 0.25% Trypsin/EDTA (Invitrogen) from 150 mm2 
tissue culture flasks. Complete Media was used to quench any residual trypsin activity. 
Cells were recovered by centrifugation (800 x G for 8 min) for cell plating and suspended 
in ITS media. The cells were counted and diluted to the target stock concentration desired 
for a particular experimental protocol (1.0 x 106 or 5 x 104 cells/ml) using ITS media. 
These stock concentrations were used to deliver 2,000 to 40,000 cells per tissue culture 
well, depending upon the nature of the specific experiment or the concentration of cells 
needed in the assay (e.g. sparse vs. dense cell cultures).  
Statistical evaluation of the centrifugal adhesion assays was conducted in 2 steps. 
At the conclusion of the initial 1 hour plating interval the number of cells present on each 
surface was expressed as a percent present on poly-l-lysine. At this stage of the experiment 
the data sets are equivalent to the data sets generated by a conventional 1 hour adhesion 
assay. These data sets were screened by one-way ANOVA, the Holm-Sidak method was 
used for multiple pairwise comparisons. The objective of the centrifugation paradigm is to 
examine how the controlled force applied by centrifugation impacts cell adhesion as a 
function of ECM substrate. Cell number at this juncture of the experiment was expressed 
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as a percent of cells present on each matched substrate at the conclusion of the 1 hour 
initial adhesion interval. For example, at the conclusion of the experiment the number of 
cells present on collagen after centrifugation was expressed as a percentage of the number 
of cells present on collagen after 1 hour of adhesion. Data sets were screened by one-way 
ANOVA, the Holm-Sidak method of pairwise multiple comparison was used for multiple 
pairwise comparisons. 
 
Enzyme Inhibition. 
The use of pharmacological inhibitors was employed to inhibit the activity of 
extracellular proteases to test the hypothesis that enzymes of the MMP family play a role 
in the processes that control the adhesion of CF to specific substrates. The broad spectrum 
collagenase inhibitor GM6001 (Ilomastat; Chemicon, CC1010) 191,192,193 and the gelatinase 
MMP specific inhibitor, SB-3CT (Chemicon, CC1500) were used in these experiments 
194,195,196. In cultured cells the typical working dosage of GM6001 is 10-25µM with 
inhibition coverage for MMP-1 (Ki = 4 nM), MMP-2 (0.5 nM), MMP-3 (27 nM), MMP-8 
(0.1nM) and MMP-9 (0.2nM) 197. SB-3CT is more selective and inhibits the activity of 
MMP-2 (Ki = 0.0139 +/- 0.0004 µM) and MMP-9 (Ki = 0.6 +/- 0.2 µM) 198.  Cells were 
diluted for experimentation from a starting stock concentration of 5 x 104cells/ml. 
 
GM-6001. For experiments using GM-6001, the stock concentration (2.5 mM) was 
prepared to a working stock (100µM) in PBS and diluted as necessary to achieve the 
desired working concentrations.  Dilutions that were used during experimentation include; 
58 
   
5, 10, 25 µM. Vehicle control (DMSO) was prepared following this same dilution format.  
The preparation of sample groups is depicted in the table below.  
  
GM-6001 (µM) Cell Volume Inhibitor/Vehicle Media Total Volume 
0  µM 1600 µl 0 2.4 ml 4 ml 
5  µM 1600 µl 200 µl 2.2 ml 4 ml 
10 µM 1600 µl 400 µl 2.0 ml 4 ml 
25 µM 1600 µl 1000 µl 1.4 ml 4 ml 
 SB-3CT. A stock solution of 20 mM was prepared and diluted 1:20 in Buffer R (50 
mM HEPES pH 7.5, 150 mM NaCl, 5 mM CaCl2, 0.01% Brij-35, and 50% DMSO) to a 
final concentration of 1 mM. This stock solution was then diluted to 200 µM in ITS media. 
Vehicle control dilution was made based on this dilution. Final doses used in 
experimentation included; 1, 5, 10, 25 µM.  In table format, experiments conducted with 
2000 cells per well on a 96 well plate in a well volume of 100 µl would have the following 
culture tubes prepared for plating. 
 
 
SB-3CT (µM) Cell Volume  Inhibitor/Vehicle Media Total  Volume 
0  µM 1200 µl 0    µl 1.800 ml 3 ml 
1  µM 1200 µl 15   µl 1.785 ml 3 ml 
5  µM 1200 µl 75   µl 1.725 ml 3 ml 
10 µM 1200 µl 150 µl 1.650 ml 3 ml 
25 µM 1200 µl 375 µl 1.425 ml 3 ml 
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Adhesion experimentation with protease inhibitors.  The proper volume of cell 
solution was added to the media/ inhibitor solution to generate the desired plating number. 
This mixture was gently swirled to ensure an even distribution of cells with inhibitor and 
was incubated with intermittent swirling for 30 min prior to plating onto different ECM 
coated surfaces. During the protease inhibitor incubation, a standard curve of CF that had 
been serially diluted over a five point range (A=4000 cells/well, B=2000 cells/well, 
C=1500 cells/well, D=1000 cells/well, E=500 cells/well) were plated onto tissue culture 
wells coated with 10 µg/ml type I collagen (Type I acid soluble collagen, Vitrogen). 
Following the 30 min protease inhibitor incubation interval, 100 µl of cell 
suspension was plated in triplicate on each of the substrates Collagen type I (0.07 µg 
protein/mm2), Fibronectin (0.07 µg protein/mm2), Laminin (0.07 µg protein/mm2), and 
Poly-l-Lysine (100 µl 0.01% 70k-150k) to be examined and incubated for 1-4 hour at 
37˚C.  At the conclusion of the adhesion interval media was carefully aspirated and 
replaced with 100 µl of media supplemented with of Calcein AM solution (2 µM in PBS-
D) and allowed to incubate for 15 min at room temperature. Following this interval, non-
adhering cells were removed by blotting the plate upside down on lint-free towels. The 
wells were filled with 200 µl of PBS-D (1x PBS, 1% Sodium Bicarbonate, 200 mM 
Dextrose) and an initial fluorescence measurement was conducted at 485 nm 
excitation/520 nm emission using a BMG Labtechnologies FLUOstar. This measurement 
provides a baseline for comparison and standardization and represents the relative number 
of cells that are retained on each substrate at the onset of centrifugation. The wells were 
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then filled completely with PBS-D and sealed. The plate was placed upside down in a 
custom plate carrier (ThermoForma, 5785) and centrifuged for 1 min at 51rcf in a 
(ThermoForma 5682 GP8R) centrifuge. With the plate remaining upside down, the sealing 
tape was removed and the contents blotted to remove any non-adhering cells. Wells were 
filled with 200 µl of PBS-D and a final absorbance measurement was taken to determine 
the relative number of cells remaining on the plates after centrifugation. 
In preliminary experiments the timing of the Calcein AM labeling was varied to 
test for possible global metabolic effects that protease inhibitors or carrier solvents might 
induce on the cultures. If one or another of these agents were to adversely and or 
selectively effect the uptake of the Calcein AM the relative number of cells present in a 
culture may be under (or over) estimated due to a metabolic effect (poor uptake or 
stimulated uptake of the Calcein AM). For these experiments freshly suspended cells were 
allowed to recover from trypsin digest for 10-15 min and exposed to Calcein AM labeling. 
Cells were rinsed by centrifugation (800 x G, 8 min) and processed with inhibitors as 
described in the centrifugation adhesion experiments. This approach makes it possible to 
ensure that all cells are exposed to the same pool of Calcein AM. However, this strategy 
increases the length of time that a particular cell population is maintained in suspension, a 
condition that appears to non-specifically reduce the absolute number of cells that will 
adhere to the ECM substrates. In summary, the results of these experiments, in conjunction 
with cell viability assays, indicate that there is no measurable impact of the enzyme 
inhibitors or carrier solvents on the accumulation of the Calcein AM indicator. As a result 
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of these preliminary observations, the experiments documented in this study were 
conducted by labeling plated cells with Calcein AM. 
Statistical analysis of the adhesion data generated from the centrifugal assays was 
conducted in two separate steps. In the first analysis the number of cells present at the 
conclusion of the initial plating interval (as estimated from Calcein AM labeling) was 
expressed as a percent of the cells present on poly-l-lysine. A 2-way ANOVA was used to 
screen data sets for the impact of substrate composition (Factor 1: collagen, laminin, 
fibronectin or poly-l-lysine) and the impact of drug dose (Factor 2: drug dose) on cell 
adhesion (Data). The Holm-Sidek method was used in multiple pairwise comparisons. 
Second, after the centrifugation interval the number of cells present on each substrate was 
expressed as a percent of the number of cells present on each specific substrate at the onset 
of centrifugation. These data also screened by two-way ANOVA, where, once again Factor 
1=substrate (collagen, laminin, fibronectin or poly-l-lysine) and Factor 2= (drug dose) and 
the data was the percentage of cells present on each surface. The Holm-Sidek method was 
used for multiple pairwise comparisons.  
Viability assays. The use of viability assays occurred in parallel with the design and 
in defining the parameters used in our adhesion assays. Assays were conducted to verify 
that cell viability remains constant under the conditions used to define cell adhesion. The 
selective loss of cells (for any reason) from this type of an assay manifests itself as a 
reduction in total cell adhesion.  As such, many of these assays were conducted on CF that 
had been plated and allowed to adhere for a defined time interval prior to the cultures being 
supplemented with drug or vehicle. These assays were designed to parallel the cell number 
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used for plating in adhesion assays (2k and 40k/ per well/ 96 well plate.) Viability was 
assessed by routine microscopy, and with two metabolic based measures; the WST-1 assay 
and with Calcein AM. The WST-1 assay is typically used as an assay to measure cell 
proliferation; in this study we utilize this assay to determine the potential toxicity of the 
inhibitors (GM-6001 and SB-3CT) used in conventional and centrifugal adhesion assays.  
This colorimetric assay relies on the conversion by mitochondrial dehydrogenases of the 
WST-1 tetrazolium salt to formazan. The accumulated formazan can be measured at an 
absorbance at ~450nm. Calcein AM is metabolically dependant as well; however, it is the 
metabolic cleavage of this dye that 1) converts Calcein AM to  Calcein, the  fluorescently  
active species of the  dye, and 2) decreases the membrane permeability of the dye thereby 
“trapping” the dye in the cell and providing a “direct” measure of cell number. 
Accumulated Calcein was measured at 480ex/520em. As stated, theses assays were 
conducted in concert with the process of determining the parameters; the type of inhibitor 
(GM 6001 / SB-3CT), the concentration of that inhibitor, and the density at which CF were 
plated. These assays function to validate the adhesion data and suggest a cell 
number/density dependant response to treatment with MMP inhibitors. As the scope of 
adhesion assays narrowed, viability testing became more focused and was tailored to 
encompass the relevant inhibitor concentrations and cell density.  
 Viability was assessed on collagen, laminin, and fibronectin under the following 
sets of conditions;  
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Inhibitor Assay Cells 
Per well 
Dose/ Vehicle Timing of 
dose 
Incubation 
time 
GM-6001 WST-1 40k 0, 10, 25µM After 30min 4hr 
SB-3CT WST-1 40k 0,1,5,10,25µM At plating 4hr 
SB-3CT WST-1 40k 0,1,5,10,25µM At plating 24hr 
SB-3CT WST-1 2k 0,1,5,10,25µM At plating 24hrs 
SB-3CT CalceinAM 2k 0,1,5,10,25µM At plating 24hrs 
SB-3CT WST-2 2k 0,1,5,10,25µM At 24, 26, 
28hr post 
plating 
6hr,4hr,2hr 
 
Data from viability assays on SB-3CT was expressed as the percent of activity 
detected in the untreated, substrate matched control. Data from each plating substrate was 
treated with one-way ANOVA (P=<0.001) and followed with pairwise multiple 
comparison using the Holm-Sidak method with an overall significance level of 0.05.  
  
Microscopy 
Hoffmann Modulation Contrast. The morphology of live cardiac fibroblasts was 
examined using a Nikon Eclipse TE 300 microscope equipped with Hoffman modulation 
optics and Nikon DXM 1200 digital camera. Culture plates were coated with various ECM 
substrates or poly-l-lysine as described at a rate of 0.07 µg protein/mm2 (optimized ECM 
density that supports maximal adhesion for each of the surfaces assayed).  Cells were 
plated at a rate of approximately 55 cells per mm2, a density equivalent to that used in 
adhesion assays. Cells were plated in depleted media and cultured for 4 hours. Non-
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adherent cells were rinsed from the wells by PBS rinsing, and the cultures were re-fed with 
depleted media. Imaging was conducted with a 40x objective at the 4 hour time point and 
again at 24 hours post plating.  
 A similar approach was used to examine the effects of GM 6001 on cell 
morphology. These experiments were run in parallel with the adhesion assays. Cells were 
incubated with inhibitor (10 and 25 µM) and plated onto plates coated with 0.07 µg 
protein/mm2 with collagen, laminin, fibronectin, or Poly-l-lysine (100 µl 0.01% 70k-150k). 
Cells were imaged at the time of plating or following a 30 min and a 4 hour interval of 
culture.  
Given observations concerning the effects of gelatinase inhibition on cell adhesion, 
the morphological impact of SB-3CT was documented by time lapse microphotography in 
cultures plated onto different ECM substrates. CF were plated onto collagen, laminin, 
fibronectin (all at 0.07 µg protein/mm2) or poly-l-lysine in the presence or absence of 10 
µM SB-3CT or vehicle control (Buffer R) in ITS Media . Over the next 60 min images 
were captured at 2 min intervals; data files (.TIFF) were compiled and converted to a 
Windows Media File format. For presentation in this document selected time points (0, 10, 
30, 40, 50, 60min) for each data set are presented in graphical format for side-by side 
comparisons. In a similar set of experiments, CF were plated onto laminin in the presence 
or absence of 25 µM SB-3CT. Times series were taken for the one hour interval following 
plating, and  for one hour following the addition of inhibitor to cells that had been plated 
for 24 hours. This dose was abandoned due to overt toxicity issues.  
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Colocalization experiments: Quantitative scanning confocal microscopy. To 
document the spatial relationships between specific integrins, MMP-2 and MT-MMP1 co-
localization experiments were conducted. Coverglass slides, #1.5  were acid etched (100% 
Nitric acid) and rinsed extensively in PBS and distilled water and autoclaved. The glass 
coverslips were allowed to air dry and coated at a rate of 0.07 µg protein/mm2 with 
collagen, laminin, fibronectin or poly-l-lysine (100 µl 0.01% 70k-150k) overnight at 40C. 
Surfaces were blocked for 1 hour with 1% BSA prepared in PBS; CF were then plated onto 
each surface for 1 hour at 370C.  At the conclusion of the plating interval cultures were 
rinsed in PBS, fixed in 4% para-formaldehyde for 5 min rinsed 3x with fresh PBS and 
blocked for 2 hours with 500 µl normal serum at 40C. 
Members of the integrin family that were imaged in these experiments include the 
β1 integrin (AB1952, Chemicon), the α1 chain (AB1934, Chemicon), the α2 chain 
(AB1936, Chemicon), the α3 chain (AB1920, Chemicon) and the α5 chain (AB1952, 
Chemicon) all in rabbit polyclonal format. Based on previous work these represent the 
principle integrins expressed by the rat neonatal cardiac fibroblast (Kanekar, 1998). A 
monoclonal mouse anti-MMP-2 was used to image this protease (IM51, Calbiochem).  A 
monoclonal rabbit isolate was used to detect MMP-MT1 (Ab51074, Abcam).  DAPI was 
routinely used to image the nuclei of the cells. Secondary antibodies used for detection 
included goat anti-rabbit 488 (A11034, Invitrogen), and goat anti-mouse Texas Red (T862, 
Invitrogen.) 
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Images for co-localization analysis were captured on a Leica DMIRE2 confocal 
microscope using a 63x oil immersion lens with a N.A. of 1.4, x-y resolution of 0.1394 
µm, x-z resolution of 0.2358 µm. Images were captured at 400Hz with a line average 
setting of 4 and formatted at 1024 x 1024 pixel dimensions. With this optical setup and 
pixel dimensions a minimum zoom of 3.37X is necessary to achieve Nyquist sampling 
parameters and a voxel size of 69.03nm x 69.03nm. PMT settings were set within the 
dynamic range of the collectors and maintained constant during the capture of images from 
different slides. Sequential scanning was used to collect all data in the “between lines” 
mode for image capture. Three separate PMTs were used; the first PMT was set up for 
interference reflection to direct and verify the plane of focus was at the cell-coverslip 
interface, the second PMT was set to capture a narrow bandwidth in the vicinity of 520 
nm, and the third PMT was set to capture wavelengths in the vicinity of 615 nm. During 
the initial set up for each experiment all instrumentation settings were optimized to 
eliminate chromophore bleed through between PMTs 1-3. 
JACoP (Just Another Colocalization Plugin) in the NIH Image J software package 
(http://rsb.info.nih.gov/ij/) was used for image analysis. Data generated from this software 
include; 1) Pearson’s Correlation Coefficient, 2) the Overlap coefficient and, 3) Mander’s 
coefficient.    
Pearson’s Correlation Coefficient looks at the overall relationship between two 
channels. This analysis effectively determines the “strength” of the relationship that might 
exist between images. This method determines the correlation of fluorochrome association 
given by linear regression. For example, the position of each antigen site in 1 channel is 
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plotted against the position of each antigen site in channel 2 in a scatterplot. When these 
values are most coincident, a single straight line with positive slope is generated. If this 
line is positive in slope there is (+1) perfect colocalization; however, if this line is negative 
in slope (-1) there is perfect inverse correlation. A slope of (0) represents that the channels 
are not correlated.  The tighter the distribution of points in channel 1 are with the points in 
channel 2, the closer to (1) is the correlation between these channels. Partial correlation 
occurs when not all of the molecules imaged in channel 1 are coincident with the 
molecules imaged in channel 2. The plotting of the point to point position of channel 1 
with channel 2 then deviates from perfect correlation and a single straight line, and 
graphically has a wider distribution.    
In Overlap analysis, the correlation coefficient ranges in value from 0 to 1 and 
provides an indication of the overlap that exists between two channels of interest without 
sensitivity to variations in signal intensity. The relative insensitivity to variations in signal 
intensity originates in the calculation of the Overlap coefficient. In the equation for 
calculating the overlap coefficient, the mean pixel intensities for each channel are not 
subtracted from the original pixel intensities. This is the primary difference between 
Overlap and Pearson’s Coefficient an analysis where the mean channel intensity is 
subtracted. By not subtracting the mean channel intensity the result is a correlation 
coefficient that reflects the “raw” overlap between channel 1 and channel 2. Addressing the 
issue of differences in intensity of the channels are the component coefficients, k(1) and 
k(2). Briefly, k(1) is dependant on the values of intensity of Channel 2 whereas k(2) is 
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dependant on the values of intensity in Channel 1, and the product of these component 
coefficients is equal to the square of the Overlap. When there is greater variation in the 
intensity of Channel 1 as compared to Channel 2, the value of k(2) will be higher than the 
value of k(1).   
Mander’s coefficients indicate the percentage of each antigen that is present in one 
channel that is co-incident with another molecule present in the second channel. For 
example, given M1, this data represents the percentage of the molecules present in channel 
1 that are participating in overlap with a molecule imaged in channel 2. The data might 
look at 100 sites of M1 and ask how many of these sites are coincident with M2. Then the 
analysis takes the converse circumstances and asks the question “for 100 M2 molecules 
present in channel 2 how many of these are coincident with M1 in channel 1?” It follows 
from this discussion that it is possible for 100% of the molecules in channel 1 to be 
coincident with molecules present in channel 2. However, if the molecules present in 
channel 2 far out number the molecules present in channel 1 the converse circumstances 
will not be true. Substantially less than 100 of the molecules in channel 2 may be 
associated with molecules in channel 1 under these circumstances. This condition was 
detected in the analysis of Mander’s coefficient for the association of MMP-2 (“channel 1 
in this example”) with the α2 integrin (“channel 2”). 
 
Interference Reflection Microscopy.(IRM) In this imaging mode the focal plane at  
the cell/ substratum interface produces a maximal amount of reflection off the sample (i.e. 
the image background is dark when the imaged focal plane is not at the cell-substratum 
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interface and becomes progressively brighter as the interface is approached). At the cell 
substratum interface the sites where cell processes are most tightly linked (closest) to the 
underlying substratum appear dark, sites of contact just distal to the actual contact sites 
appear grayer in the final image 113. IRM approach unambiguously identifies the sites 
where cells and the surface of the coverslip are in contact with one another.  
Interference reflection microscopy was used to characterize focal adhesion 
structure with respect to protein markers of these structures. Number 1.5, 22 mm x 60 mm 
cover slips (Fisher) were etched with nitric acid for 15 min, neutralized with PBS, rinsed 
with ddH2O and autoclaved prior to substrate coating. Coverslips were coated with 
collagen, laminin, fibronectin (0.07 µg protein/mm2), or poly-l-lysine (100 µl 0.01% 70k-
150k) overnight at 40C, rinsed with PBS, and blocked with 1% BSA for 1 hour. Cells were 
plated for varying lengths of time depending upon the nature of experimentation. All 
cultures were rinsed gently with PBS and fixed in 3% paraformaldhyde for 10 minutes. 
Cultures were permeabilized with 0.1% Triton X-100 prepared in PBS, rinsed in PBS and 
blocked (3% BSA, 10% Normal Goat Serum, 0.1% Tween 20 in PBS or as otherwise 
noted in specific experiments using interference reflection microscopy as a method to 
identify the cell substratum interface) for 30 min at room temperature.  
Mouse monoclonal anti-talin (T3287, Sigma) antibodies were applied at 1:40 
overnight at 4ºC. Samples were counter stained with Texas Red goat anti-mouse (1:200, 
Invitrogen) and with 2 units fluorescein phallodin for 1 hour at room temperature. Selected 
cultures were stained with DAPI to detect nuclei. Coverslips were mounted with anti-fade 
mounting media (Vector) and sealed with nail polish. Confocal images were taken with a 
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63x objective using a 6x zoom setting with a Leica DRE2 scanning laser scanning confocal 
microscope.  
 
 
Gelatinase Labeling  
To conduct localization and competition experiments in live cells MMP-2/ MMP-9 
gelatinase zymography standards (Chemicon, gelatinase standard, CC073) were labeled 
with rhodamine. Briefly, the EZ-Label Rhodamine Protein labeling kit (Pierce 53002) was 
used according to the manufactures protocol for the labeling of gelatinase standard. In this 
reaction, 50 µl of stock gelatinase standard (Chemicon) was labeled with 1 µl of NHS-
Rhodamine. Labeled MMP was dialyzed against PBS to remove un-incorporated 
rhodamine. The rhodamine labeled gelatinase (RLG) standard was frozen at -70˚C in 5 µl 
aliquots. RLP was run separated by SDS gel electrophoresis and processed for gelatin 
zymography to verify that the labeling procedure did not overtly alter protein structure or 
cause the formation of multimeric complexes.  
 
 
Titration of Gelatinase label. Experiments utilizing confocal microscopy were 
conducted to determine the localization of exogenously applied RLG protein as well as to 
optimize the amount of labeled gelatinase needed for use in future experimentation. CF 
were incubated in suspension (20k cells/ml) in ITS media supplemented with a 1000 fold 
range of RLG. Serial dilutions were made as follows: 
71 
   
 
A) 5 µl of RLG stock solution to 20 ml ITS media (solution A) 
B) 1 ml of solution A added to 9 ml ITS media (Solution B=10X dilution of A) 
C) 1 ml of solution B added to 9 ml ITS media (Solution C= 100X dilution of A) 
D) 1 ml of solution C added to 9 ml ITS media (Solution D=1000X dilution of A) 
 
Cardiac Fibroblast  were incubated in RLG formulations for 30 minutes and centrifuged 
for 8 min at 800 x G, media was decanted and cells were suspended in 10 ml of fresh ITS 
media. Cells were pipetted into 4-well Lab-Tek II Chambered slides that were coated at a 
rate of 0.07 µg Type I collagen/mm2 and allowed to adhere for 1 hour at 370C.  Chamber 
wells were rinsed with PBS and then fixed with 3% paraformaldhyde for 15 min. Cultures 
were rinsed 3x with PBS and permeablizied with the addition of 500 µl of  0.01% Triton 
X-100 prepared in PBS for 5 min. Cultures were rinsed 3x with PBS. In the final rinse, 2 
units of fluorescein phallodin were added to each well for the visualization of F-actin. 
After 15 min, the samples were rinsed with PBS, and mounted in anti-fade media (Vector 
Laboratories). Samples were imaged by laser scanning confocal microscopy as described.  
Results from preliminary dilution experiments using various concentrations of the 
RLG indicated that dilution “D” described in the previous discussion provides more than 
adequate signal for the detection of surface associated gelatinase. Next, unlabelled “cold” 
gelatinase (ULG) was added to the experimental paradigm over the 1000 fold range used in 
the initial RLG experiments. The objective of this approach was to determine if it is 
possible to chase off the labeled gelatinase in manner analogous to a radio immune assay. 
In these experiments varying concentrations of ULG were added to a constant 
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concentration of RLG and mixed. Control (ITS supplemented with 10 µg/ml BSA) and ITS 
media containing no additional gelatinase were used to determine the non-specific effects 
of adding protein or fresh media to the cultured cells. Each media formulation was added 
to an equal density of cells and gently mixed. Replicate cultures were incubated at 40C 
(cold) or at 370C (warm) for 1 hour in solution. At the conclusion of this incubation 
interval the suspended cells were pelleted by centrifugation (800 x G for 10 min), re-
suspended in 200 µl of PBS and plated by centrifugation (51rcf x 5 min) onto coverslips 
coated with collagen (0.07 µg/mm2). This plating procedure was used to minimize the 
potential impact that adhesion processes might have on the distribution of surface 
associated MMPs. Cultures were fixed with 3% paraformaldhyde for 15 min, rinsed with 
PBS 3x, and stained with fluorescein phallodin.  
 
Evaluation of SB-3CT effects on cell surface associated MMPs. Experiments were 
conducted to determine if the distribution of cell surface associated MMP-2 gelatinase in 
the living state is effected by the SB-3CT inhibitor. These experiments, while largely 
unsuccessful (in the sense that the inhibitor did not displace the MMP-2 molecule), 
provided indirect evidence that the integrin MMP-2 complex is structurally stable in the 
face of challenge by protease inhibition. A series of 4-well Lab-Tek II Chambered (#1.5 
Borosilicate Coverglass; NalgeNunc) were coated at a rate of 0.07 µg protein/mm2 with 
collagen type I (adhesion is sensitive to MMP inhibition) or with EHS Laminin (adhesion 
to this surface is not sensitive to MMP inhibition) overnight at 40C and then blocked for 1 
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hr with 1% BSA prepared in PBS.  Cells in suspension were treated to one of the following 
interventions: 
 
1) Exogenous RLG (5 ul/20ml ITS media) 
2) Exogenous RLG (5 ul/20ml ITS media) + SB-3CT  
3) Exogenous RLG and vehicle (DMSO) 
4) Baseline controls, no treatment. 
 
Cells were incubated for 30 min in each of the conditions as described. Cells were 
then plated at 55 cell mm2 as per conventional adhesion experiments for 1 hour and then 
rinsed 3x with 500 µl of PBS. Cultures were fixed in 3% para-formaldehyde for 10 min, 
rinsed 3x with fresh PBS and blocked for 2 hours with 500 µl Normal Goat serum at 40C. 
Primary monoclonal mouse-anti MMP-2 antibody (Ab-4, Oncogene) was applied at a rate 
of 5 µl per well in 200 µl of blocking buffer for 1 hour at room temperature. In this 
application, blocking buffer is formulated in PBS supplemented with 3% BSA, 10% 
Normal Goat Serum, and 0.1% Tween 20. Chambers were rinsed 3x for 15 min with 
blocking buffer on a rotating table at room temperature. Primary antibodies were imaged 
with a Texas Red conjugated goat anti-mouse antibody (Molecular Probes, Eugene OR, 
1:200) diluted into blocking buffer for 1 hour at room temperature. The chambers were 
then rinsed 3x with PBS + 0.1% Tween 20 for 15 min intervals. These antibody complexes 
were then fixed with 3% paraformaldhyde and rinsed 3x for 15 min with PBS + Tween 20. 
The chambers were then incubated overnight at 40C with 500 µl of blocking buffer.   
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 For β1 integrin staining, 250 µl of Rabbit anti-β1 (1:500, Chemicon, AB1952) was 
prepared in blocking buffer and added to each well for 1 hour at room temperature. 
Cultures were incubated with blocking buffer 3x for 15 min. Alexa 488 conjugated goat 
anti-rabbit antibody (Molecular Probes) was used for detection at a dilution of 1:200 in 
blocking buffer. The secondary antibody solutions were supplemented with 2 µl of DAPI 
for the detection of DNA. Chambers were rinsed 3x with PBS + 0.01% Tween 20. A final 
brief rinse with ddH20 was used to reduce salt contamination. One drop of medium set 
anti-fade mounting media (Vector Laboratories) was delivered to each well. Images were 
captured using a Leica DMIRE2 scanning laser confocal microscope. 
 
 
Immunoprecipitation  
A variety of different immunoprecipitation (IP) strategies were used to characterize 
the structural relationships that exist between members of the integrin family and MMP-2. 
This section will describe the methods used to immunoprecipitate antigens from cell 
lysates. Experiments in which immunoprecipitation was used to evaluate specific events 
will be described in sub-sections that are experiment specific.   
 
Routine immunoprecipitation. Cells were plated on 100 mm x 15 mm Falcon Petri 
dishes for 1 hour at 370C, media was decanted and the plates were rinsed 3 X with 10 ml 
sterile PBS. Cultures extracted in 1 ml ice-cold, modified RIPA buffer (50 mM Tris-HCl, 
150 mM NaCl, 1% Triton X-100, pH 7.4). In selected experiments this buffer was 
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supplemented with protease inhibitors (Roche, 11 836 145 001). On ice, cells were 
removed from the plate with a cell scraper (Falcon), the lysate was quantitatively recovered 
and transferred to a 1.5 ml microcentrifuge tube. Cell lysates were placed on ice for 30 min 
with occasional mixing and centrifuged at 10 G for 15 min at 40C (Eppendorf, 5804 R). 
Supernatant was decanted, without disturbing the pellet, and transferred to a clean 1.5 ml 
centrifuge tube.  
 Cell lysates were pre-cleared using normal serum appropriate to the primary 
antibody used in the IP. A 20 µl aliquot of normal serum (2 mg/ml normal serum; Rabbit 
or Mouse, Pierce Immunopure) was added to each lysate sample and allowed to incubate at 
40C for 30 min on a shaker. Next, 50 µl of protein A/G agarose beads (Santa Cruz, SC-
2003) was added to each solution, samples were incubated for 60 min on ice and 
centrifuged at 10 x G for 10 min at 40C. Supernatant was decanted, without disturbing 
beads and transferred into a clean centrifuge tube (if beads were disturbed, samples were 
spun again and transferred to a new tube).  Each pre-cleared cell lysate was supplemented 
with 5 µl of the primary (precipitating) antibody and incubated on ice for 2-8 hour at 40C 
on a shaker. Following this interval, 50 µl of protein A/G agarose beads was added and 
incubated at 40C on a shaker for 60 min. Tubes were then spun at 10 x G for 1 min at 40C. 
Without disturbing the pellet, the supernatant was decanted, and the beads were washed 
with 500 µl of ice-cold, modified RIPA buffer. The wash, centrifugation cycle, and 
aspiration cycle was repeated 3-5 times. Following the final wash, 80 µl of 1x Laemmli 
buffer (Bio-Rad, Cat # 161-0737) was added to the bead pellet. Samples were placed in a 
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pre-heated (950C) dri-bath for 3-5 min (Thermolyne, Type 16500 Dri-Bath). Samples were 
once again centrifuged at 10G for 5 min and the supernatant was recovered for analysis.  
 Antibodies used in these experiments include: 
• Anti β1 integrin, Chemicon 
• Anti MMP-2, IM51 Calbiochem 
• Anti MMP-9, IM73 Oncogene 
 
Samples were immediately separated by SDS-PAGE (25 µl per sample) or gelatin 
zymography. Selected material recovered by IP was frozen until needed at -20˚C.  
  
 Crosslinking of cell surface Except were noted, the bulk of the experimentation 
presented in this document was conducted with cells with a “native” plasma membrane. 
However, during early experimentation cell surface associated proteins were crosslinked to 
stabilize protein-protein interactions using DTSSP (21578, Pierce). This reagent has an 
effective cross linking distance of 12 Å.  In these experiments CF were plated out onto 
poly-l-lysine coated 6 well dishes in ITS media. Following one hour of plating, cultures 
were rinsed 2x with PBS, cultures were then supplemented to a final concentration of 
crosslinker at 1 mM in PBS and allowed to incubate for 30 min at room temperature. The 
reaction was quenched with the addition of sufficient Tris (stock solution 1 M, pH 7.5) to 
bring the final Tris concentration to 15 mM for 15 minute incubation. At this point cultures 
were treated with cell lysis buffer in preparation for SDS-PAGE. Parallel cultures without 
the use of crosslinker were processed for SDS-PAGE.  
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 Seize IP. By definition conventional IP experimentation recovers the primary 
antibodies used to identify (capture) an antigen of interest. When this type of material is 
processed for Western blot analysis the primary antibodies can be dislodged from the 
protein A/G agarose beads used to initially recover the antigen complex. Subsequently, 
these primary antibodies can and clearly do appear as a component element in the analysis 
of the antigen complex. This condition can introduce artifacts into the analysis of the 
recovered material; this is especially a consideration when Western blot analysis is 
conducted. The primary or secondary antibodies used to probe the recovered antigens may 
react with the contaminating precipitating antibodies that have been dislodged from the 
agarose beads.  The presence of this contaminating antibody restricts the species of 
antibodies that can be used to probe the blot, can cause interference and ambiguity if the 
molecular weight of the antigen of interest overlaps with the contaminating antibody, and 
or limits the selection of antibodies that can be used in the Western blot analysis (due to 
cross-reactivity and or poor specificity of the secondary detection antibodies).  
To validate the conventional IP experiments, IPs were also routinely conducted 
with primary antibodies cross-linked to the surface of agarose beads using a Seize primary 
IP kit (Pierce, 45335). Cross-linking the primary antibody of interest to the agarose beads 
negates the need for the protein A/G interaction for the capture of the antibody/antigen 
complex and eliminates the risk of antibody contamination in the eluted antigen fraction. 
This method is identical in the preparation of cell lysate as described above under “routine 
immunoprecipitation.” The seize IP method was used in experiments designed to test the 
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the interaction of β1 integrin and MMP-2, to identify the α integrin chain(s) involved, and 
to determine the interaction of TIMP-1 and TIMP-2 with the α3β1: mmp-2 complex. 
Primary antibodies of interest were coupled to agarose beads supplied by the 
manufacturer as per AminoLink Plus Coupling Gel recommendations. The process of 
coupling the antibody to the beads involved “activation” (using the buffers supplied by the 
kit) of the beads, over-night incubation at 4˚C with mixing, and a series of rinsing and 
washing steps to remove any uncoupled antibody present on the beads. The reactions using 
this kit take place in a spin cup placed in the top of a 2 ml centrifuge tube which allows for 
ease of rinsing and elimination of possible bead contamination during the elution of 
antigen.  In brief, approximately 2 million cells were prepared as cell lysate either from 
suspension or following one hour of plating in ITS media  in 1 ml of modified RIPA buffer 
by a 30 minute 4˚C extraction with agitation. Lysate was then centrifuged for 30 minutes 
4˚C at 14 K rpm to remove debris. Prepared lysate (333uL) was added to the antibody 
conjugated beads or frozen at -20˚C for future analysis. Conjugated beads and lysate were 
incubated with end-over-end mixing overnight at 4˚C. Column was then spun to remove 
flow through and washed (3X) to clear any nonspecifically bound material on the beads. 
Antigen complexes were eluted in a series of three repetitive elution steps by lowering the 
pH with the supplied elution buffer. The fractions were kept separate for analysis by 
Western blot. For Western blotting, eluted material was mixed at a ratio of 20ul:5 ul of 5X 
sample buffer, heated to 65˚C for 5 min, allowed to cool, and loaded at a rate of 25 ul per 
gel well for 10% SDS-PAGE. When reduction of sample was necessary, samples were 
prepared to a final concentration of 5% 2-mercaptoethanol, and heated to 95˚C for 5 
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minutes. The Seize IP format was used for the pull down of antigen complexes recognized 
by the following antibodies (coupled to beads) and these antibodies were used in antigen 
detection as primary antibodies in Western blotting. 
 
Primary antibodies used in these assays include: 
   
• Anti- α1 integrin, Rbt polyclonal (AB1934, Chemicon) 
• Anti- α2 integrin, Rbt polyclonal (AB1936, Chemicon) 
• Anti- α3 integrin, Rbt polyclonal (AB1920, Chemicon) 
• Anti- α5 integrin , Rbt polyclonal (AB1946, Chemicon) 
• Anti- β1 integrin, Rbt polyclonal (AB1952, Chemicon) 
• Anti- TIMP-2, Rbt polyclonal (ab38973, Abcam) 
• Anti-TIMP-1, Rbt polyclonal (AB800), Chemicon) 
• Anti- MMP-2, Ms Monoclonal (IM51, Calbiochem) 
• Normal Mouse IgG, (12-371, Upstate) 
 
Secondary Antibodies;  
• HRP labeled Anti- Rabbit, Goat (H+L)(PI-1000, Vector) 
• HRP labeled Anti- Mouse, Horse (H+L)(PI-2000, Vector) 
 
Immunoprecipitation and gelatin zymography. Gelatin zymography was conducted on 
samples recovered by IP against β1 Integrin. Material recovered by IP was first separated 
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by conventional SDS gel electrophoresis on a 10% slab gel and transferred to PVDF for 
Western blot analysis against β1 and/or MMP-2 (AB1952, Chemicon; IM51, Calbiochem, 
respectively.) Representative fractions of the IPs were then subjected to gelatin 
zymography.  
 
Zymography. Equal volumes of whole cell lysate or protein fractions purified by IP 
were mixed with Laemmli buffer and separated on a SDS 10% polyacrylamide gel 
supplemented with 1.0% gelatin. Gelatinase standards (Chemicon) were loaded (20 µl of 
stock solutions that had been diluted 1:200) were used as positive controls to identify 
MMP-9 and MMP-2 enzymatic activity. In experiments that focused on MMP-2, pro-
MMP-2 (Calbiochem, PF037) was used as the positive control (20 µl of a 1:200 dilution of 
the stock solution). Following electrophoretic separation at 120V (constant voltage), gels 
were incubated in renaturation buffer (BioRad) for 1 hour and then transferred into 
development buffer (Bio-Rad) for 18 hour at 37ºC. Gels were fixed (20% Methanol, 10% 
Glacial Acetic Acid, 70% distilled de-ionized H2O) and stained with Coomassie Blue, G-
250 (Bio-Rad). De-stained gels were imaged (Gel Doc 2000, BioRad) and analyzed by 
densitometry (Quantity One, BioRad) to characterize gelatinolytic activity.  
Following development and documentation, the gelatin zymograms were 
transferred to PVDF for Western Blot analysis against MMP-2. The preparation of these 
samples was done in the absence of exogenous protease inhibitors (to allow protease 
activity associated with IP material to function and degrade the gelatin present in the 
zymograms).  Lanes were loaded with a whole cell lysate prepared from a CF cell 
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suspension, an IP to β1 (AB1952, Chemicon), or recombinant human MMP-2 pro-enzyme 
standard (PF037, Calbiochem). The anti-MMP-2 antibody used in these experiments 
recognizes the 72 kDa latent and 66 kDa active species of MMP-2.   
 
Western Blotting.  Following protein separation by SDS-PAGE, gels were 
incubated in Towbin buffer (Tris-Glycine, 20% MeOH) for 30 min to equilibrate and 
remove residual SDS. Simultaneously, PVDF Membranes (BioRad) was activated by a 
brief incubation in 100% methanol and then equilibrated in Towbin Buffer. Transfer 
cassettes were loaded and placed into a Criterion Blotting chamber (Biorad) for the transfer 
of proteins from gels to PVDF membranes, transfer was effected at 125 mA for a total of 
1250 mA/hour at 40C. Following the transfer interval, the appearance of the molecular 
weight standard on the PVDF was used to visually verify the transfer process.  PVDF was 
blocked in 5% Non-Fat Dry Milk prepared in PBS/0.01% Tween-20 for a minimum of 30 
min. To reduce “spotting” artifacts blocking buffer was made at least 1-2 hour prior to use 
to ensure the milk was fully dissolved when applied to the PVDF membranes. Primary 
antibodies were applied overnight at 40C or for 1 hour at room temperature with constant 
agitation. Antibodies were applied to the blots in 10 ml of Blocking buffer per 7 cm x 8.4 
cm sheet of PVDF. Specific dilutions included: 
• Rb anti-α1 1:1000 (Chemicon, AB1934),  
• Rb anti-α2   1:1000 (Chemicon, AB1936),  
• Rb anti-α5 1:500 (Chemicon, AB1949),  
• Rb anti-β1 1:1000 (Chemicon, AB1952),  
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• Rb anti-TIMP-2 1:1000 (Abcam, ab38973) 
• Ms anti-MMP2 1:5000 (EMD, IM51),  
• Ms anti-MMP-9 1:5000 (EMD, IM73).  
 
Following incubation with primary antibodies the PVDF membranes were rinsed 
extensively with PBS-0.1% Tween 20 (5 rinses for 15 min/ rinse) under constant agitation. 
Prior to the application of secondary horse radish peroxidase labeled antibodies, blots were 
placed in blocking buffer for additional 30 min incubation. This step was found to further 
reduce non-specific background staining. Again, 10 ml of antibody solution was used per 
sheet with secondary antibody concentrations of 1:20,000, in blocking buffer, of either 
Goat anti-Rabbit (Vector, PI-1000) or Horse anti-Mouse (Vector, PI-2000) as appropriate 
for a 1 hour incubation at room temp. PVDF was rinsed, as previously described, and then 
treated for 5 min with ECL Plus Western Blot detection reagent (GE Healthcare, RPN 
2132). Excess chemiluminescence solution was wicked from the PVDF, the PVDF 
membranes were wrapped in plastic and then secured in an 8 x 10 inch Spectroline 
radiographic cassette (Spectronics Corporation, Westbury, New York.). In the dark, 
radiographic film (Kodak BioMax MR, Rochester, New York) was placed for detection of 
Chemiluminescence signal. Film was developed on an automatic processor (Futura 2000K, 
Fischer Industries Inc, Geneva, IL).  Exposure time was adjusted to optimize the signal 
intensity over a linear range. Developed film was then returned to the cassette and 
molecular weight ladder indication and blot orientation was made with indelible ink.  
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To verify the specificity of primary and secondary antibodies used in conventional 
IP and seize IP based experiments, sera were separated by SDS and transferred to PVDF as 
described. To test the specificity of secondary rabbit antibodies blots were stained with 
Goat anti-rabbit or Horse anti-mouse antibodies. If these blots remained devoid of staining 
the samples were stripped (100mM 2-mercaptoethanol, 2% SDS, 62.5mM Tris-HCL pH 
6.7) and restained with Horse anti-mouse or  Goat anti-rabbit to verify the presence of the 
primary antibodies on the blot and verify the specificity of the matched primary and 
secondary antibody interaction.   
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CHAPTER VII.   
 
Identification of a MMP-2/Integrin/TIMP-2 Complex in the Cultured 
Neonatal Cardiac Fibroblast.  
 
INTRODUCTION 
In this chapter the structural association of MMP-2 and the α3β1 integrin is 
documented in pull down assays. These experiments were conducted with freshly prepared 
suspensions of neonatal cardiac fibroblasts isolated from 3-5 day old pups and cultured for 
2-3 passages.  In several sites in the following chapters supportive evidence for various 
observations or experimental techniques are referenced to Appended materials. This 
approach was used to provide the reader with additional information with minimal 
interruption to the primary data presented in this chapter (which has been designed to be 
submitted as a manuscript in support of this thesis).   
RESULTS 
Immunoprecipitation from cell suspensions. The gelatinases MMP-2 and MMP-9 
are expressed at elevated levels during ventricular wall remodeling in development 128 and 
at the onset of cardiac hypertrophy in the adult 127. Given the association of selected 
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integrins with selected members of the broader MMP family, pull down assays were 
conducted to evaluate the possible structural relationships that might exist between these 
receptors and MMP-2 and MMP-9 in the rat neonatal cardiac fibroblast. Beginning with a 
suspension of cells in ITS Media, β1 integrin or MMP-2 was first recovered by 
immunoprecipitation (IP) using Seize IP kits (ThermoScientific). The enriched material 
recovered by IP was eluted in 3 separate fractions from the antibody columns; each 
fraction was then separated by SDS gel electrophoresis under non-reducing conditions and 
probed by Western blot for β1 integrin, MMP-2, or MMP-9. The Seize IP kits were used in 
these experiments to avoid cross-contamination/cross-reactivity of the primary antibodies 
with antibodies used in the Western Blot analysis (see also Appendix 1, for examples).  
Western blot analysis of an IP against β1 integrin for β1 integrin reveals 3-5 
prominent bands, depending upon the elution fraction, running at 210-220 kDa, 180 kDa, 
110-120 kDa, 60 kDa and 40 kDa (Figure 1A, lanes 1-3). The lower molecular weight β1 
immunoreactivity represents intracellular domain containing fragments 113. Blotting this 
same isolate for MMP-2 revealed a single band in each of the 3 fractions recovered from 
the antibody columns running at 210-220 kDa (1A, lanes 4-6). Immuno-reactive MMP-9 
was not detectable in this same assay or in a raw cell pellet fraction of cardiac fibroblasts 
plated for 1 hour in ITS Media. However, MMP-9 was detectable by zymography in the 
soluble media fraction recovered from CF plated for 1hour (see also Appendix 2 for this 
data).  
In the converse series of experiments, Western blot analysis of an IP against MMP-
2 for MMP-2 detected 2-3 bands (again, depending on the elution fraction examined). 
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Elution fraction 1 exhibited a single prominent band running at 210 kDa. Elution fractions 
2 and 3 exhibited 3 bands, running at 220 kDa, 210 kDa and 180 kDa (Figure 1B, lanes 1-
3). Blotting material recovered by an IP against MMP-2 for β1 integrin revealed a single 
distinct band running at 210-220 kDa (Figure 1B, lanes 4-6).  
Given these results, zymographic analysis was conducted to confirm the presence 
of gelatinolytic activity in material recovered by an IP against the β1 integrin subunit. In 
these experiments, protease activity was only detected in IPs directed against β1 that were 
recovered in the presence of the gelatinase specific inhibitor SB-3CT (Figure 1C). This 
protease activity was present on the gels in association with a 200+kDa protein that 
appears to correspond to the complex detected by the initial IP experiments. This result is 
somewhat counterintuitive; however, it is possible that MMP-2 protease activity is at such 
a high concentration in material recovered by IP that the enzyme is subject to some degree 
of auto-proteolytic degradation during processing under baseline conditions 139. Consistent 
with this conclusion gelatinase activity was present near the base of each gel lane; this low 
molecular weight material was present even in samples treated with SB-3CT gelatinase 
inhibitor. The gelatinolytic activity present in lanes treated with SB-3CT is probably a 
reflection of the method used to assay gelatinase activity; this drug does not completely 
suppress all MMP-2 proteolytic activity in this type of analysis (see Appendix 3, Figure 1). 
As judged by zymography, SB-3CT suppresses approximately 50% of the MMP-2 
associated gelatinase activity present in this type of analysis.  
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FIGURE 1 
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Figure 1. Immunoprecipitation (IP) experiments; Identification of a complex of β1 
integrin and MMP-2. Panel (A) represents various fractions recovered from cardiac 
fibroblasts subjected to immunoblotting (IB). IP against β1 integrin blotted for β1 reveals 
proteins running at 210-220 kDa, 180 kDa, 110-120 kDa, 60 kDa and 40 kDa (A, lanes 1-
3).  MMP-2 immunoreactivity is present in association with the 210-220 kDa protein band 
(A, lanes 4-6). Panel (B) represents the analysis of an IP against MMP-2. Western blot 
analysis of this IP against MMP-2 reveals 3 bands running at 220, 210 and 180 kDa (B, 
lanes 1-3).  β1 integrin immunoreactivity is present in association with the 210 kDa band 
(B, lanes 4-6). Panel (C) represents zymographic analysis of IP to β1 integrin with 
Gelatinase inhibition.  Lanes 1 and 2 represent raw lysate from cells in suspension treated 
with 10µM SB-3CT or vehicle. Eluted fractions (Lanes 3-5) from IP to β1 with 10µM SB-
3CT or fractions (Lanes 6-8) from IP to β1 with vehicle were processed for zymography.  
Zymographic analysis of an IP against β1 integrin in the presence of SB-3CT revealed 
distinct bands of gelatinolytic activity (Panel C, Lane 3) at 210-220 kDa, 148 kDa and 94 
kDa, representative of  the intact complex, dimeric MMP-2, and pro-MMP-2 with TIMP-2, 
respectively.  To verify the identity of the material recovered by IP selected samples were 
processed for zymography and then transferred for Western blot analysis and the detection 
of MMP-2 (see Appendix 4).( See also Appendix 2 , Figure 1 for documentation of SB-
3CT inhibitory effects on MMP-2 activity).  
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To determine if MMP-2 is associated with a specific integrin complex an IP against 
MMP-2 was conducted and then probed by Western blot for β1, or α1, α2, α3, or α5, the 
principle α integrin chains present in the neonatal rat cardiac fibroblast 59. In this pull 
down assay, only the α3 integrin chain was detectable in the recovered material (Figure 2). 
From these experiments it is clear that α3β1 integrin and MMP-2 are present in a complex 
that runs at 210-220 kDa.  
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FIGURE 2  
 
91 
   
 
Figure 2. Alpha integrin subunit analysis, composite image (all data from non-reduced 
gels). MMP-2 was recovered by IP from 2 X 106 cells; this material was then subjected to 
Western blot analysis for specific integrin subtypes. Panel (A): Lanes 1 and 2 Western blot 
of β1, Lanes 3 and 4=α1, Lanes 5 and 6=α2, Lanes 7 and 8=α5 integrin. In this series of 
experiments we were able to detect the β1, α1, and α5 integrin in the whole cell lysate 
(lanes 1, 3, 5, and 7). The β1 chain was the only integrin subunit present in the fractions 
recovered by IP to MMP-2 (Lane 2).  Panel (B) represents a detailed analysis of the α3 
subunit. Lane 1= Western blot against α3 in a whole cell lysate. Lanes 2 and 3 represent the 
detection of the α3 subunit in enriched material recovered by IP to MMP-2, Lanes 4 and 5 
represent the detection of the MMP-2 molecule in a pull down assay against the α3 
integrin.  
 
 
 
 
 
 
 
 
 
 
 
92 
   
In vivo, MMP-2 and MMP-9 present in the ECM are bound to a TIMP molecule; 
these small inhibitory peptides play a role in regulating the activation state of these 
enzymes 199,143. To determine if TIMP-1 or TIMP-2 are component elements of the 
integrin:MMP-2 complex an IP against β1 or α3 integrin was recovered from a suspension 
of cells. This material was then run under non-reducing or reducing conditions and probed 
for TIMP-1 and TIMP-2. Immunoreactive TIMP-1 was not detected in this assay (See 
Appendix 5, for representative Western blot of TIMP-1 analysis). Immunoreactive TIMP-2 
was present in the recovered material. In an IP against β1 integrin that was separated for 
Western blot analysis under non-reducing conditions, 2 bands of TIMP-2 positive staining 
were present, one prominent band at 220 kDa and a minor band at 56 kDa (Figure 3, A). 
When these same samples were run under reducing conditions the 220 kDa band was lost 
and bands running at 65, 50, 45 and 41 kDa were observed (Figure 3B). TIMP-2 has a 
molecular weight of 24kDa; we assume that these higher molecular weight bands detected 
under reducing conditions might represent complexes or multimers.  In the analysis of an 
IP to α3 integrin no reactivity was detected against TIMP-2 in the non-reduced format 
(Figure 3, C). However, when these samples were run under reducing conditions, TIMP-2 
was detected in the IP from α3 (Figure 3, D). Non-reduced samples of IPs directed against 
α3 (Figure 3, E) and β1 integrin (Figure 3, F) from these experiments were blotted against 
MMP-2 to confirm the existence of the putative complex. MMP-2 immunoreactivity was 
present in both samples at a MW of 220 kDa.    
Using a starting IP against the α3 integrin and then probing for TIMP molecules 
produced similar, albeit not identical results when an IP against β1 integrin was used as the 
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starting material. Under non-reducing conditions no TIMP-2 was detectable in the 
recovered material. However, when this same sample was separated under reducing 
conditions, protein bands running at 86, 55 and 50 kDa were detected. These data would 
suggest that the antigenic site for the TIMP-2 peptide is sequestered when the complex is 
isolated by an IP against α3 integrin and separated under non-reducing conditions. This 
sequestration may occur because this aspect of the peptide represents the linkage site to the 
α3 integrin 200.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
94 
   
FIGURE 3 
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Figure 3. Identification of TIMP-2 as a component of theα3β1 integrin / MMP-2 
complex. Cells (2 X 106) were suspended and then incubated in the presence or absence of 
10 µM SB-3CT or Vehicle for 30 minutes, immunoprecipitated and separated under non-
reducing or reducing conditions. Panel (A) represents the detection of TIMP-2 from a β1 
directed IP under non-reducing conditions: lane 1 with SB-3CT, lane 2 without SB-3CT. 
Panel (B) represents the detection of TIMP-2 from a β1 directed IP under reducing 
conditions: lane 1 with SB-3CT, lane 2 without SB-3CT. Panel (C) represents the detection 
of TIMP-2 from an α3  directed IP under non-reducing conditions: lane 1 with SB-3CT, 
lane 2 without SB-3CT. Note the absence of staining. Panel (D) represents the detection of 
TIMP-2 from an α3 directed IP under reducing conditions: lane 1 with SB-3CT, lane 2 
without SB-3CT. Panel (E) and Panel (F) represent blotting against MMP-2 as non-
reduced samples from IP to α3 or to β1, respectively;  lane 1 with SB-3CT, lane 2 without 
SB-3CT. 
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To address the possibility that MMP-2 might become secondarily associated with 
the α3β1 integrin complex when the cell lysates are prepared for IP pull down analysis, live 
cardiac fibroblasts were treated with the cross-linking agent DTSSP (Pierce). In these 
experiments the cross-linking reagent links peptides that are within 12 Angstrom of one 
another. Live, surface cross-linked cells were then processed for Western blot analysis. In 
these experiments MMP-2 was present in association with a 200-210 kDa complex. These 
results indirectly suggest that MMP-2 is bound to the α3β1 integrin prior to the IP process 
and is not secondarily associated with this receptor as a consequence of the extraction 
procedures (for documentation of these results see Appendix 6). 
 
Summary. These experiments indicate that MMP-2 and TIMP-2 exist in a complex 
with the α3β1 integrin of the neonatal cardiac fibroblast. This complex is stable enough to 
withstand the processes used to recover IP isolated material for Western blot analysis 
under non-reducing conditions. One aspect of these results that is difficult to fully 
reconcile concerns the total MW of the isolated complex.  
If the β1 represents the predominate binding site for MMP-2, it would be expected 
that the α3 subunit would run at a substantially lower MW (120-130 kDa vs. 210-220 kDa). 
The converse argument also holds true. If the α3 subunit was the exclusive binding partner 
for MMP-2, the β1 subunit should run at approximately (110-120 kDa vs. 210-220 kDa). 
However, regardless of the starting material used to recover MMP-2 in these pull down 
assays, immunoreactive β1 and α3 are present in association with MMP-2 in a complex that 
97 
   
has an estimated MW of 200-2120 kDa. There are several possibilities to explain these 
results. For example, it is possible that under non-reducing conditions that the complex 
runs at an aberrant MW due to its overall topography. However, it is also possible that the 
MMP-2 molecule is linked to both integrin subunits. 
When the MMP-2:TIMP-2:α3β1 complex is separated by SDS gel electrophoresis 
the 2 integrin chains may separate from one another but the linkages that the anchor MMP-
2 to β1 and MMP-2 to α3 may be more stable, resulting in the appearance of the “common” 
210-220 kDa complex that is observed. One may be composed of MMP-2, β1 and TIMP-2 
and one may be composed of MMP-2, α3 and TIMP-2. In one case, the MMP-2 may be 
bound to the β1 through the hemopexin domain 201or the collagen binding domain 187 and to 
the α3 through TIMP-2 200. Additional molecular experimentation will be necessary to 
define the exact nature of the complex. 
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CHAPTER VIII   
 
Functional Implications of MMP-mediated Protease Activity  
In Cell Adhesion Processes in the Cultured Neonatal Cardiac Fibroblast.  
 
INTRODUCTION 
 
The association of MMP-2 with the α3β1 integrin suggests this protease plays a role 
in the process of cell adhesion and/or migration. To explore this putative aspect of MMPs 
function in the neonatal cardiac fibroblast conventional 30 minute adhesion assays were 
conducted with plates coated with various amounts of collagen, laminin, or fibronectin. 
From these experiments, the optimized density of each ECM substrate that was necessary 
to support maximal cell adhesion was determined. Centrifugal adhesion assays were then 
used to characterize the relative strength of adhesion to each surface. These experiments 
were all conducted in the presence and absence of protease inhibitors designed to block 
MMP associated enzymatic activity. To limit the potential of untoward of serum elements 
these assays were conducted in ITS supplemented media. These experiments suggest a role 
for MMP in the maturation of adhesion in the Cardiac Fibroblast. 
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RESULTS 
 
Conventional Adhesion Assays. In 30 min conventional adhesion assays maximal 
cell adhesion occurred at surface coating densities of 0.07 µg collagen/mm2, 0.035 µg 
laminin/mm2 and 0.07 µg fibronectin /mm2 (Figure 4A). On plates coated with 0.07 µg 
ECM/mm2, the minimal amount of each protein necessary to support maximal cell 
adhesion for each type of surface, collagen, laminin and fibronectin all supported more 
adhesion than tissue culture plastic or BSA (P<0.001). Further, at this same coating 
density, collagen and laminin supported more adhesion than fibronectin (P<0.001). When 
the plating interval was extended to 60 minutes under these same coating conditions, 
collagen, laminin and fibronectin supported similar rates of adhesion (Figure 4B).  Based 
on these results all other experiments were conducted at an optimized surface coating 
density of 0.07 µg ECM protein /mm2. 
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FIGURE 4 
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Figure 4.  Optimization of conventional adhesion assays: Panel (A) 30 minute incubation 
and Panel (B) 60 minute incubation. The adhesion of cardiac fibroblasts to different ECM 
substrates increases as a function of the coating density used to prepare the plates (A). 
When equal numbers of cells were applied to collagen, laminin or fibronectin for 30 min 
maximal adhesion occurred when the plating surfaces were coated with at least 0.07 
µg/mm2 ECM protein (P<0.001).  Each of these ECM substrates supported similar rates of 
adhesion at this threshold value of coating density when the plating interval was extended 
to 60 min (B). Each data point +/- S.E. N=3 of 3 replicates.  
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Pharmacological inhibition of MMP function with the inhibitor SB-3CT did not 
alter cell adhesion in conventional adhesion assays conducted over a 60 min incubation 
interval (see Appendix 3 for characterization of SB-3CT effects on MMP function). SB-
3CT is a potent and highly specific inhibitor of gelatinases198 Rates of adhesion to 
collagen, laminin, fibronectin, and poly-l-lysine were similar in the presence and absence 
of this inhibitor (Figure 5). Experiments conducted with the more general and broader 
spectrum, and less potent197 MMP proteinase inhibitor, GM6001, yielded similar results 
(Figure 6).  
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FIGURE 5 
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Figure 5. SB-3CT does not alter initial adhesion. Cells were plated for 60 min onto 
collagen, laminin or fibronectin (plates coated at 0.07 µg ECM protein/mm2) in presence or 
absence of SB-3CT or vehicle. MMP inhibition with this reagent had little effect in this 
assay. Cultures plated onto fibronectin in the presence of this inhibitor exhibited a modest 
increase in adhesion with respect to vehicle treated cultures (P<0.006), but not to the naïve 
controls. Each data point +/- S.E. N=3 of 3 replicates.  
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FIGURE 6 
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Figure 6. GM6001 does not alter initial adhesion. Cells were plated for 60 min onto 
collagen, laminin or fibronectin (plates coated at 0.07 µg ECM protein/mm2) in presence or 
absence of GM6001 or vehicle. MMP inhibition with this reagent had little effect in this 
assay. An increase in the number of adherent cells was detected in cultures plated onto 
fibronectin in the presence of 25µm GM6001 as compared to vehicle treated cultures( 
P=0.005) but not to the naïve controls.  Each data point +/- S.E. N=3 of 3 replicates.  
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Centrifugal Adhesion Assays. To characterize the strength of adhesion that was 
achieved over a 1 hour plating interval centrifugal adhesion assays were conducted. For 
these experiments, culture plates were coated with collagen, laminin or fibronectin using 
the optimized conditions established in the conventional adhesion assays. After the initial 1 
hour plating interval the plates were inverted and decanted as if they were to be processed 
for a conventional adhesion assay. The plates were rinsed and a determination of the total 
cell number that was present was made, the plates were then centrifuged upside down to 
subject the cells to a calibrated force. In the centrifugal assays neonatal cardiac fibroblasts 
plated onto collagen and fibronectin were more strongly adherent (i.e. resistant to 
detachment by centrifugation) than cells plated on laminin or poly-l-lysine (P<0.001, 
Figure 7).   
Incubating cultures with SB-3CT selectively reduced adhesion strength in cultures 
plated onto collagen and fibronectin with respect to non-treated controls and vehicle 
controls (P<0.003, Figure 8). This inhibitor had no effect on adhesion in cultures plated 
onto laminin or poly-l-lysine. Treatment with GM6001 did not impact adhesion strength in 
this assay (Figure 9). 
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FIGURE 7 
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Figure 7. Baseline Centrifugal adhesion assays. Panel (A) illustrates the relative number 
of cells adherent to culture dishes coated with 0.07 µg/mm2 ECM protein after a 60 min 
plating interval. Rates of adhesion to collagen, laminin and fibronectin were similar and all 
3 supported more adhesion than poly-l-lysine (P<0.001). These cultures were then turned 
upside down and centrifuged at a calibrated force. Adhesion data in this panel is expressed 
as a percent cells adherent to poly-l-lysine. Panel (B) illustrates the relative number of cells 
adherent at the conclusion of centrifugation. Data is expressed as the per cent cells 
remaining adherent with respect to the number of cells present at the onset of 
centrifugation. Each data point +/- S.E. N=3 of 3 replicates.  
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FIGURE 8 
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Figure 8.  SB-3CT impacts the strength of cell adhesion. Cells were plated for 60 min onto 
collagen, laminin or fibronectin (plates coated at 0.07 µg ECM protein/mm2) in presence or 
absence of SB-3CT or vehicle and subjected to a calibrated centrifugal force. Cells plated 
onto collagen and fibronectin (P<0.003) were preferentially displaced from these ECM 
substrates when treated with SB-3CT (A,C). Adhesion to laminin and poly-l-lysine was 
un-effected by this drug treatment. Each data point +/- S.E. N=3 of 3 replicates.  
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FIGURE 9 
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Figure 9. GM6001 does not impact the strength of cell adhesion. Cells were plated Cells 
were plated for 60 min onto collagen, laminin or fibronectin (plates coated at 0.07 µg ECM 
protein/mm2) in presence or absence of GM6001 or vehicle and subjected to a calibrated 
centrifugal force. No significant change in the adhesion of CF was attributable to the 
application of this inhibitor. The reason for the differences in the effects of SB-3CT and 
GM6001 in the adhesion of CF may be a reflection of the differences in specificity of these 
inhibitors. N=3 of 3 replicates.  
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Cell Viability in the face of protease inhibition. There is a technical limitation to 
the adhesion based viability assays used in this study. These assays assume that any 
intervention that reduces the number of cells present at the conclusion of the assay will be 
reported as a reduction in cell adhesion. Unfortunately, any intervention that reduces cell 
viability also will be reported by these assays as a reduction in cell number. A 10% loss of 
cells due to cell death will be reported as a 10% loss of cells from the assay. A further 
complication arises when a particular intervention is used to study the process of cell 
adhesion, a variety of cell types will undergo apoptosis when adhesion is blocked or lost 
202. 
 
To verify that protease inhibition reduces cell number in the adhesion assays used 
in this study occurs as a consequence of impacting the adhesion process, cell viability 
assays were conducted under a variety of conditions (See also Appendix 7). These 
experiments indicate that SB-3CT has nominal effects on cell viability over the time 
intervals used in the assays described in this chapter (Figure 10). As per the discussion in 
the preceding paragraph, conducting an assay for cell viability in which the agents to be 
tested have an effect on cell adhesion implies inherent limitations in the design of these 
assays (interventions that kill cells reduce cells in the adhesion assay, interventions that 
reduce adhesion reduce cells in the viability assays).  To address the major concern that 
cells will not attach if plated in the presence of inhibitors, viability was first assessed on 
cells that had been plated for 24 hours. In these assays there was no detectable change in 
metabolic activity in cultures treated with 1µM, 5µM SB3-CT or vehicle with 2, 4, and 6 
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hours of treatment. However, within 2 hours of treatment at the 10µM dose of SB3-CT the 
cultures plated on collagen and laminin exhibited approximately a 20% decrease in 
metabolic activity as compared to naïve and vehicle controls (P=<0.001).  Under these 
same conditions CF plated on fibronectin were similar to naïve and vehicle controls.  
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FIGURE 10 
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 Figure 10. Time component of cell viability. Cultures were plated out onto collagen (A), 
laminin (B), and fibronectin (C) for a total of 30hours. At time points 2, 4, and 6 hours 
prior to assessing metabolic activity, media was aspirated and replaced with media 
supplemented with 1, 5, and 10um or vehicle control. No change in metabolic activity was 
detected at the 1 and 5uM doses in CF plated on these surfaces. At 10uM the inhibitor 
appeared to impact the metabolic activity of CF in a time dependant manner. In cultures 
plated on collagen (A) and laminin(B) there was a decrease in metabolic activity following 
2hours of exposure to 10uM SB-3CT as compared to vehicle and untreated, naïve controls 
(P=<0.001)( with overall significance level of 0.05 for multiple comparisons). We note that 
initial cell adhesion was similar when CF were plated in the presence of inhibitors as 
compared to vehicle and naïve controls in 1hr adhesion assays. N=3 
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Summary. Overall the results of the conventional adhesion assays and the 
centrifugal adhesion assays demonstrate that cardiac fibroblasts adhere relatively slowly to 
fibronectin (this surface supported the least adhesion in conventional adhesion assays 
conducted over a 30 minute interval).  However, the cells that do attach to this ECM 
protein are more strongly anchored than cells plated onto laminin or poly-l-lysine (more 
cells are retained on this surface in the centrifugal adhesion assays). The strength of 
adhesion of cells to collagen and fibronectin was similar in the centrifugal assays.  
Treatment with SB-3CT selectively reduced cell adhesion when cells were plated 
onto collagen and fibronectin. GM6001 did not impact cell adhesion in these assays. 
Together, the cell adhesion assays and cell viability assays suggest that SB3-CT alters the 
total number of cells present in the adhesion assays by perturbing the processes that lead to 
the maturation of adhesion sites. Perhaps the most compelling series of experiments that 
support this conclusion are the results of the centrifugal adhesion assays. First, at the initial 
1 hour time point SB3-CT does not alter the total number of cells present in the assay on 
any of the surfaces examined. Second, in the centrifugal portion of this same assay (which 
is conducted and concluded within 10 minutes of taking the initial cell number reading)  
SB3-CT selectively reduced cell number on collagen and fibronectin but not laminin or 
poly-l-lysine.  
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CHAPTER IX  
 
In Situ Structural Relationships between MMP-2, Specific Integrin Subunits 
and MT-1 MMP in the Cultured Neonatal Cardiac Fibroblast. 
  
INTRODUCTION 
Pull down assays have detected a complex composed of the α3β1 Integrin, MMP-2 
and TIMP-2. Adhesion assays have implicated MMP mediated activity in the regulation of 
cell adhesion to collagen and fibronectin, but not laminin or poly-l-lysine. In this series of 
experiments the spatial relationships of specific integrin sub-units with respect to MMP-2 
is examined using high resolution scanning confocal microscopy. The spatial relationship 
of MMP-2 and MT1-MMP is also evaluated with this approach. Observations made in this 
study were constrained to the ventral surfaces of the cells as defined by Interference 
Reflection Microscopy.   
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RESULTS 
 
Qualitative Scanning Confocal Microscopy. To investigate the spatial 
relationships that exist in situ between β1 integrin, specific integrin α chains, and MMP-2 
qualitative and quantitative, scanning confocal microscopy was used to examine cultures of 
fibroblasts plated onto collagen, laminin, fibronectin or poly-l-lysine for 1 hour. These 
experiments suggest that the distribution and relative overlap of the integrins and MMP-2 
with respect to one another is subject to regulation by the identity of the surrounding ECM. 
At the light microscopic level a gross examination of the cultures revealed that fibroblasts 
plated for 1 hour onto each of these surfaces exhibited, on average, a rounded-cell shape. 
Cell processes extended from the central rounded domain of the cells out over the coated 
surfaces in a concentric pattern. Other cells within the cultures appeared less symmetrical 
in shape; however, the general staining pattern described for the rounded cells was still 
present in cells that displayed this phenotype. 
A qualitative survey of cells plated onto collagen revealed that staining for β1 
integrin was scattered over the basal surface of the cells in a punctate pattern (Figure 11A). 
Staining for MMP-2 was present in a prominent band that was localized along the distal 
boarders of the spreading fibroblasts (Figure 11Ab). β1 integrin and MMP-2 were co-
incident with one another at low density and in small clusters along these distal domains 
(Figure 11Ae). The central regions of the rounded cells exhibited punctate staining for β1 
integrin but were largely devoid of MMP-2.  
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On laminin, staining for β1 integrin appeared in two distinct patterns (Figure 11B). 
First, this receptor subunit was present in the punctate pattern along the basal surfaces that 
was reminiscent of cells plated onto collagen (Figure 11Bb). Second, staining for β1 
integrin was concentrated in a prominent, concentric band along the edges of the forming 
cell processes. MMP-2 was concentrated in these distal domains and was co-incident with 
the larger aggregates of β1 (Figure 11Be). On fibronectin, staining for both β1 integrin and 
MMP-2 appeared in a population of small scattered spots (Figure 11C).  These antigens 
were co-incident with one another in restricted domains, many cells exhibited a poorly 
defined band of β1 integrin and MMP-2 staining that appeared just proximal to the distal 
boarders of the cells (Figure 11Ce). Finally, on poly-l-lysine β1 integrin and MMP-2 were 
scattered over the basal surfaces of the cells, as with cells plated onto fibronectin there was 
a degree of overlap in specific sub-domains (Figure 11D).  
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FIGURE 11- Qualitative imaging of MMP-2 and β1 
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Figure 11. Scanning confocal images of cells plated for 1 hour on various ECM substrates. 
Panel (a) in each set of images represents a typical survey image taken at low 
magnification (63X) of cells plated onto collagen, laminin, fibronectin or poly-l-lysine 
stained for β1 integrin (green) and MMP-2 (red).  Panel (b) for each image represents data 
sets captured in zoomed section of the cell periphery. Note in Ab (collagen) the MMP-2 
associated signal nearly overwhelms any β1 integrin staining. Panel (c) (green: β1 integrin) 
and (d) (red: MMP-2) for each data set represent projection of the individual channels. 
Panel (c) in each image set represents a subtraction analysis; the green projection depicts 
the sites of β1 integrin and MMP-2 that are co-localized. The grey pixels in this image 
represent the population of β1 integrin that exists independent of MMP-2 staining. 
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Quantitative Scanning Confocal Microscopy. Next, the distribution of α1, α2, α3, 
α5, and β1 with respect to MMP-2 and the overlap of MMP-2 with respect to MT1-MMP 
were evaluated by quantitative methods. For these experiments data was captured at the 
interface of the ventral surfaces of the cultured cells and the substratum as defined by 
interference reflection microscopy. This approach makes it possible to concentrate on 
domains within the cell that are actively undergoing remodeling during cell spreading 
(example, domains similar to those depicted in Figure 11 panel e).  As with the adhesion 
assays the cells were plated for 1 hour onto each of the different substrates and then 
processed for microscopic analysis. Representative images depicting the interference 
reflection, the distribution of each antigen that was assayed, an overlay of the IRM with the 
antigens, and an overlap image of the antigens are provided in Figures 12-16.  
The overlap image (panel 5) in this type of analysis represents the distribution of 
the relevant integrin chain (in grey) with regions of overlap with MMP-2 (in green). In 
Figures 12-15, MMP-2 is represented in red and the integrin chains are represented in 
green. In Figure 16, staining for MMP-2 was captured in the red channel (panel 2), staining 
for MT1-MMP was captured in green channel (panel 3). In the overlap image (panel 5) the 
green represents domains where staining for MMP-2 is co-incident with MT1-MMP (in 
grey). For quantitative analysis the following parameters were maintained during image 
collection; 1) Channels were scanned sequentially with a line average setting of 4, 2) 
Images (1024 X 1024) were collected at the same voxel dimension of 69 nm x 69 nm to 
obtain Nyquist limits, 3) PMT settings were set and maintained at levels that reflect the 
125 
   
dynamic range, 4) PMT settings were adjusted for image capture to insure no bleed 
through from one channel to the other could occur. A similar treatment of images was used 
during post imaging analysis with JaCoP (Just another Colocalization Plugin) within Image 
J.  Overlap images presented within figures 11-17 were generated with Colocalization 
Finder within Image J. 
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Representative Image Panels Used in Overlap Analysis: Integrin α chains/MMP-2 
 
The following series of confocal images depict the distribution of integrin chains of the 
cardiac fibroblast with MMP-2. Figure legends are not provided as this information is 
integrated within the results section preceding these images. In each image series, Panel 1 
represents the Interference Reflection, Panel 2 represents MMP-2 (red), Panel 3 represents 
the specific integrin alpha chain, Panel 4 is the overlay of these images, and Panel 5 is an 
overlap image with the integrin chain distribution shown in grey and the areas coincident 
with MMP-2 in green.  
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Figure 12: Distribution of α1 integrin subunit with respect to MMP-2. 
Interference reflection images of cells plated onto collagen reveals a series of contact sites 
along the distal boarders of the spreading membrane processes that are arranged into a 
series of concentric rings (Figure 12A, Collagen Panel 1).  MMP-2 (Collagen Panel 2) is 
scattered over this domain and appears as a broad band of staining that is distributed into a 
concentric pattern that appears like a hollow ring encircling the middle of the cell. A subset 
of this staining appears to lie within domains in contact with the underlying substratum as 
defined by interference reflection microscopy (see Collagen Panel 4). Staining for the α1 
subunit on these ventral cell surfaces is generally distributed as punctate spots. Examining 
the images depicted in Collagen figure 12, panels 2 and 3 reveals that staining for MMP-2 
occurs more prominently along the outer edges of the cells while staining for α1 is mainly 
concentrated in the more central domains of the rounded cells. This central concentration 
of α1 staining is approximately encircled by the concentric rings of focal adhesions as 
defined by interference reflection microscopy. It is along the edges of this central area that 
the most overlap between MMP-2 appears to occur (green, Collagen Panel 5). A similar 
staining and overlap pattern was observed in cells plated onto laminin (Figure 12B, 
Laminin).  
No attempt has been made to conduct overlap analysis for the relative distribution 
of α1 (or other integrin subunits or MMP-2) with respect to the focal adhesions as defined 
by interference reflection. While technically possible, processing samples for immuno- 
fluorescence microscopy will cause the cells to collapse to an uncertain degree. This does 
not obviate the usefulness of this technique for defining the focal plane at which the cell is 
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in contact with the substratum. However, this can increase the total surface contact area to 
some degree, thereby reducing the accuracy of the technique with respect to defining 
individual contact sites. 
Cells plated onto fibronectin did not display the pronounced concentric distribution 
of contact sites defined by interference reflection microscopy that cells plated onto 
collagen and laminin exhibited (Figure 12C, Fibronectin Panel 1). Instead, these cells 
developed a series of small triangular adhesion sites along the distal boarders of the 
spreading membranes (Fibronectin Panels 1 and 3). The concentric ring-like staining 
pattern for MMP-2 that was observed in cells plated onto collagen and laminin was some 
what less pronounced in cells that were plated onto fibronectin (Fibronectin Panel 2). This 
pattern was present, just not as clearly delineated. The α1 chain was distributed as fine 
punctate dots over the entire basal surface, but there was evidence that this integrin subunit 
was present in somewhat higher abundance in the central domains (Fibronectin Panel 3). 
Overlap analysis indicates that most of the co-localization appears to be of low level across 
the surface of the cells (Fibronectin Panel 5). 
Cells plated onto poly-l-lysine were not in full contact with the substratum. Focal 
contacts were scattered over the basal surfaces that were in contact with the underlying 
surface. Staining for MMP-2 and α1 integrin appeared to be scattered over the ventral 
surfaces, the concentric (MMP-2) and circular patterns (α1) observed in the other cells 
were largely absent in these cultures (Figure 12, Poly-l-Lysine).  
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FIGURE 12- Distribution of a1 integrin with MMP-2 
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Figure 13: Distribution of α2 integrin subunit with respect to MMP-2. Not 
surprisingly, and as expected, the distribution of MMP-2 is clearly similar in the 
experiments and data sets collected to evaluate the distribution of this protease with respect 
to the α2 integrin. Of some note, as before, staining for MMP-2 appeared in concentric 
pattern in cells plated onto collagen and laminin, and somewhat less so on fibronectin 
(Figure 13). This result was very consistent and characteristic throughout these 
experiments. From the distribution of MMP-2 and the morphology of plated cells at 1 hour 
localize the protease within a region of transition. At this time point in the adhesion of cells 
the central region of the cell is rounded with the edges spreading out giving “fried-egg” 
morphology to the cell. The typical concentric distribution and concentration of MMP-2 
within the region of transition between the central and peripheral regions of the cell 
suggests that this protease may be functioning in the process of adhesion. Once again, 
MMP-2 was more widely and uniformly distributed over the basal surfaces of cells plated 
onto poly-l-lysine (Figure 13D, Panel 2).  
While the staining for the α2 integrin subunit was also similar to the pattern 
observed for the α1 subunit there were some minor differences. The bulk (e.g. not all) of 
staining for this integrin was roughly encircled by the outer concentric focal adhesions as 
defined by interference reflection microscopy. On collagen, this integrin subunit was more 
evenly distributed across the basal surfaces of the cells (Figure 13A, Collagen Panel 3) 
than the α1 subunit. The localization overlap image for α2 and MMP-2 indicates these 
antigens were co-incident within the central domains of the cells (Figure 13 Collagen Panel 
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5). There was not extensive staining (e.g. low “copy number”) but there appeared to be 
very little MMP-2 staining that was co-incident with this integrin chain.  
On laminin the α2 subunit appeared to be mainly concentrated in the central 
domains of the spreading cells (Figure 13B, Laminin Panel 3). This integrin was largely 
excluded from areas of close contact as judged by interference reflection microscopy 
(Figure 13B Panel 4). The overlap analysis indicated that there was a moderate association 
between the α2 integrin and MMP-2 protease (Figure 13B, Laminin Panel 5). The data 
image clearly indicates considerable MMP-2 staining that is co-incident with the α2 
integrin. 
On fibronectin, the staining patterns for MMP-2 and the α2 integrin were very 
similar to that observed for MMP-2 and the α1 integrin on this ECM substrate. One minor 
difference, the α2 integrin appeared to be somewhat more widely distributed and not so 
nearly confined to the central domains of the spreading cells (Figure 13C, Fibronectin 
Panel 3). Overlap analysis indicated a very low frequency of co-localization (Figure 13C 
Panel 5).  
On poly-l-lysine the α2 integrin was sparsely distributed and appeared to be 
aggregated into small clumps within the central domains of the cultured cells (Figure 13, 
Poly-l-lysine Panel 3). These structures appeared to be independent of close contacts as 
defined by interference reflection microscopy (Figure 13D, Panels 3 and 4). Overlap 
analysis indicated very little co-localization between MMP-2 and the α2 integrin occurs on 
this non-specific surface (Figure 13D, Panel 5). 
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FIGURE 13- Distribution of α2 integrin subunit with respect to MMP-2. 
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Figure 14:  Distribution of α3 integrin subunit with MMP-2. Staining for MMP-2 
on collagen, laminin, fibronectin and poly-l-lysine was again consistent with the other 
experiments conducted to define the distribution of this protease with the α1 and α2 
integrins (Figures 12 and 13).  Cells in this particular data set are representative of the cells 
that exhibit a less-well defined rounded cell shape (see Figure 14B and 14C). 
The α3 integrin was widely distributed across the basal surfaces of the cells on all 
of the surfaces assayed. The overall staining intensity for this integrin subunit was much 
higher than either the α1 or α2 integrin (This increased signal intensity can result from a 
difference in antibody affinities or from absolute differences in the amount of integrin. The 
IP experiments would suggest that there is more α3 integrin).  On collagen the α3 integrin 
was nearly evenly distributed over the entire basal surfaces of the cells (Figure 15 
Collagen, Panel 3). However, staining for the cell surface receptor did appear to be 
excluded from the very distal boarders of the cells. The overlap image indicates that co-
localization between MMP-2 and the α3 subunit occurs predominately in the peripheral 
domains of the spreading cells (Figure 14A, Panel 5).  
On laminin the α3 subunit appeared in a distribution that was essentially identical to 
that observed on collagen (Figure 14B, Laminin Panel 3 and 4). The overlap analysis 
images were also very similar to that observed in cell cultured on collagen. Co-localization 
was predominately along the edges of the central domains of the cells (Figure 14B, Panel 
5).  
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Cells cultured on fibronectin exhibited distribution of the α3 subunit on the basal 
cell surfaces that was very similar to that observed on collagen and laminin (Figure 14C, 
Fibronectin Panel 3 and 4). The overlap images indicated that co-localization also occurred 
in the central cell domains (Figure 14C, Panel 5). Qualitatively the overlap images 
suggested that there was more MMP-2 that was co-incident with the α3 subunit on this 
ECM surface (Figure 14C, Panel 5) than on collagen or laminin.  
On poly-l-lysine, MMP-2 and the α3 subunit were scattered over the basal surfaces 
of the cells (Figure 14D, Poly-l-lysine Panels 2-4). Overlap between these 2 antigens 
occurred mainly along the periphery, there appeared to be far less MMP-2 on the surface of 
these cells (Figure 14D, Panel 5). 
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FIGURE 14- Distribution of α3 integrin subunit with MMP-2 
 
136 
   
Figure 15: Distribution of α5 integrin subunit with MMP-2. On collagen and 
laminin the α5 integrin was distributed as punctate spots that were mainly concentrated in 
the central domains of the spreading cells. Again, the bulk of this staining appeared to be 
encircled by the focal contact structures (Figure 15A and B, Panels 3 and 4). Overlap 
analysis indicated the was co-localization of MMP-2 and α5 integrin in the more central 
domains of the spreading cells; however, there was considerable integrin chain that was 
independent of MMP-2 (Figure 15A and B, Panel 5).  
On fibronectin staining for MMP-2 was, as before, present in a less well defined 
concentric pattern (as compared to collagen and laminin) on the ventral surfaces (Figure 
15C Fibronectin Panel 2).  The α5 integrin was concentrated in triangular focal contacts 
that were scattered over the surfaces of the cells. Interference reflection microscopy 
confirmed that these structures corresponded to focal contact sites (Figure 15, Panel 4). In 
overlap images MMP-2 and α5 integrin were concentrated and co-localized in these 
domains (Figure 15C, Panel 5). 
On poly-l-lysine MMP-2 appeared in a poorly defined concentric pattern that 
encircled the central domains of the spreading cells (Figure 15D, Poly-l-lysine Panel 2). 
Staining for the α5 integrin appeared within the central “doughnut” pattern of the MMP-2 
labeling (Figure 15D, Panel 3). Qualitatively, there was less overall α5 integrin positive 
staining in these cells. Overlap analysis indicated that co-localization was predominately 
present around the outer portions of the α5 positive spots and on the inner ring of the 
concentric staining pattern that characterized MMP-2 staining (Figure 15D, Panel 5).  
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FIGURE 15 Distribution of α5 integrin subunit with MMP-2. 
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Representative Image Panels Used in Overlap Analysis: Integrin β1 chain/MMP-2 
The following series of confocal images depicts the distribution of integrin chains of the 
cardiac fibroblast with MMP-2. A Figure legend is not provided as this information is 
integrated within the results section preceding these images. Panel 1 represents the 
Interference Reflection, Panel 2 represents MMP-2 (red), Panel 3 represents β1 chain 
(green), Panel 4 is the overlay of these images, and Panel 5 is an overlap image with the β1 
integrin chain distribution shown in grey and the areas coincident with MMP-2 in green.  
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Figure 16. Distribution of β1 integrin with MMP-2.  In many ways the distribution 
of the β1 integrin can be expected to exhibit an average/aggregate distribution that 
resembles the distribution of individual α chains (because it is the binding partner to each 
of the α chains described in this study). On collagen (Figure 16A Collagen, Panel 3) and 
laminin (Figure 16B, Laminin Panel 3) β1 integrin appears in small aggregates of staining 
in the central domains of the spreading cells. On fibronectin, β1 appeared in a less well 
defined circular pattern on many cells (e.g. see Figure 16C, Fibronectin Panel 3). In the 
illustrated sample a roughly circular pattern of staining is evident. Within this domain there 
appears to be a broader, more continuous region of staining that corresponds with contact 
sites (Figure 16C, Panels 3 and 4). The clearly defined triangular focal adhesions that were 
delineated by α5 staining were not obviously present (see Figure 15C, Panel 5). 
Undoubtedly, these structures are present but not visible because the β1 partners with all of 
the other α chains (e.g. not able to see the trees {focal adhesions} because of the forest 
{extensive β1 staining in association with other α chains}). Moreover, similar shaped focal 
adhesions were detected in cells plated on fibronectin as depicted by interference reflection 
microscopy.   
In the overlap analysis for MMP-2 and β1 integrin the co-localization of these 
antigens occurred primarily within the central domains of the cultured cells. The extent of 
co-localization varied across the different substrates. For example on collagen, the overlap 
analysis suggested that there was far less co-localization and there was considerable MMP-
2 staining that appeared to be separate and distinct from the β1 integrin (Figure 16A, 
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Collagen Panel 5). On laminin, this analysis indicated that there was extensive co-
localization between MMP-2 and β1 integrin  within the central domains of the cells 
(Figure 16B Laminin, Panel 5). Very little β1 integrin staining appeared to be independent 
of MMP-2 on this particular surface. Qualitatively, cells plated onto fibronectin (Figure 
16C, Fibronectin Panel 5) exhibited overlap images that were similar to cells plated onto 
laminin. There were clear examples of overlap, and clear examples of β1 chain that was 
independent of MMP-2. On poly-l-lysine (Figure 16 Poly-l-lysine, Panel 5) the overlap 
images were intermediate to the staining patterns observed on laminin and fibronectin.  
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FIGURE 16- Distribution of β1 integrin with MMP-2 
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Representative Image Panels Used in Overlap Analysis: MT-1 MMP and MMP-2 
The following series of confocal images depict the distribution of MT1-MMP and MMP-2 
on the cardiac fibroblast. A Figure legend is not provided as this information is integrated 
within the results section preceding these images. Panel 1 represents the Interference 
Reflection, Panel 2 represents MMP-2 (red), Panel 3 represents MT1-MMP (green), Panel 
4 is the overlay of these images, and Panel 5 is an overlap image with the distribution of 
MT1-MMP shown in grey and the areas coincident with MMP-2 in green.  
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Figure 17: Distribution of MT1-MMP and MMP-2. These experiments were 
conducted to characterize the distribution of MMP-2 with respect to a known binding 
partner. The activation of proMMP-2 to the active isoform is mediated at the cell surface 
by MT1-MMP. As with all of the other conditions assayed in this study, staining for MMP-
2 appeared in a concentric circular pattern around the “central core” of the cells. This 
pattern was evident regardless of cell shape in cells cultured for 1 hour. Staining for MT1-
MMP was scattered over the ventral surfaces of the cells in a nearly uniform pattern 
(Figure 17A-D Panel 3).  There did not appear to be any preferential localization of this 
protease in any particular subcellular domain. This pattern was evident in cells plated onto 
collagen, laminin, and fibronectin.  
In the overlap analysis areas depicted in green (Panel 5) represent colocalization of 
MMP-2 on MT1-MMP whereas areas depicted in grey represent MT1-MMP independent 
of MMP-2. On collagen (Figure 17, Collagen Panel 5) and laminin (Figure 17, Laminin 
Panel 5) the overlap analysis indicated that perhaps half of the MT1-MMP and MMP-2 are 
associated with one another. Cells on these surfaces exhibited distinct spots of MT1-MMP 
that were co-incident with MMP-2, but nearly an equal number of MT1-MMP positive 
sites were independent of staining for this antigen. On fibronectin (Figure 17 Fibronectin 
Panel 5) and poly-l-lysine (Figure 17 Poly-l-lysine Panel 5) the relative amount of sites 
that were positive (co-incident) for both MT1-MMP and MMP-2 was visibly increased 
with respect to cells plated onto collagen and laminin. While MMP-2 appeared in the 
characteristic concentric staining pattern, the overlap analysis on collagen, laminin and 
fibronectin did not recapitulate this pattern. Co-localization analysis suggested that MT1-
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MMP and MMP-2 appeared to be present in association with one another in a nearly 
uniform pattern on the cultured cells (i.e. scattered over the basal surfaces). This is in 
contrast to cells plated onto poly-l-lysine. On this non-specific surface there was an 
obvious zone of co-localization between MT1-MMP and MMP-2. The overlap images 
reveal a concentric staining pattern similar to that observed to MMP-2 (Figure 17 Poly-l-
lysine Panel 5).  
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FIGURE 17- Distribution of MT1-MMP and MMP-2. 
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Overlap analysis: 
Scanning confocal microscopy indicates that MMP-2 is co-incident to varying 
degrees with specific integrin α chains; co-localization appears to vary as a function of the 
plating substrate. The visual analysis of these images is highly subjective, even if the 
methods used to collect the data are quantitative in nature.  Overlap analysis generates a 
numerical representation of the raw overlap between signals present in different channels 
in a microscopic data image. This process essentially distills the visual image into a far less 
subjective form. The term “raw” overlap is a qualifier that denotes that this analysis 
occurred without each channel being divided by the average intensity value of the 
representative channel. This type of manipulation essentially represents a smoothing of the 
data and sets a threshold at which signals from different channels will be accepted as data. 
No such filtering is used in raw overlap analysis. The resulting graphical representation of 
the overlap images represents an approximation of the coincidence of the two antigens 
without regard to differences in signal intensity that can exist between the two channels. 
This approach was used in this analysis to detect the relative differences in the overlap of 
MMP-2 with specific integrin chains, or with MT1-MMP and the degree to which this 
relationship is affected by ECM composition.  
 
Figure 18: Overlap analysis. The overlap coefficient for each of the specific 
integrin subunits with respect to MMP-2 varied as a function of ECM composition. For 
example, for cells plated onto collagen and laminin (Figure 18), on a scale of 0 (no 
overlap) to + 1.0 (complete overlap), the coefficient of overlap for α1 integrin and MMP-2 
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was approximately 0.27-0.29, on fibronectin the overlap value was 0.15 for this integrin 
subunit. On poly-l-lysine the overlap coefficient was approximately 0.31. Values for the α2 
integrin ranged from about 0.18 on collagen to approximately 0.35 on laminin and 
fibronectin. The α3 integrin and MMP-2 exhibited the highest coefficient of overlap on 
all of the surfaces evaluated. The overlap coefficient for these two antigens was also 
greater than the coefficient of overlap for MT1-MMP and MMP-2 on all surfaces. On 
collagen the overlap coefficient between α3 and MMP-2 was 0.4, and on laminin, 
fibronectin and poly-l-lysine it was approximately 0.5. Analysis of the α5 integrin and 
MMP-2 generated overlap coefficients of 0.26 on collagen, 0.35 on laminin, 0.3 on 
fibronectin and 0.37 on poly-l-lysine.  For the β1 integrin and MMP-2 the overlap 
coefficient was 0.3 on collagen, approximately 0.42 on laminin, and 0.3 on fibronectin and 
poly-l-lysine.  
As a comparison, the association of MMP-2 with MT1-MMP generated values of 
0.26 on collagen, 0.29 on laminin and approximately 0.38 on fibronectin and poly-l-lysine. 
(Horizontal dashed line Figure 18 represents overlap of MMP-2 and MT1-MMP). 
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FIGURE 18 
 
149 
   
 
Figure 18.  Overlap analysis of specific integrin subunits and MMP-2. The extent of 
overlap varied as a function of the ECM substrate used to plate the cells. The overlap 
coefficient was highest between α3 and MMP-2; this relationship existed on each of the 
substrates examined.  The dashed line in each panel represents the average overlap value 
generated from an analysis of MT1-MMP and MMP-2 for each ECM substrate. 
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Mander’s Coefficient  
Mander’s analysis takes overlap analysis one step further and determines the 
percentage of an antigen that is involved in the overlap with a second antigen. The output 
of this analysis determines the fractional population of one antigen that is co-localized with 
a second antigen. The analysis then reverses this process and determines the percentage of 
the second antigen that is co-localized with the first antigen. Values are expressed on a 
scale of 0 (no overlap) to +1.0 (total overlap). Data considered for Mander’s analysis was 
thresholded automatically within the JACoPlugin within Image J. This manipulation 
eliminates from the analysis data points that are on the low end of the intensity scale (grey 
pixel intensity from 0- 256) (potential noise). Data from the upper end of the intensity 
scale are not clipped in this filter.  This thresholding tightens the data by eliminating low 
intensity signal present in each channel that potentially could dilute the relationships of 
these antigens.  
 
Figure 19: Mander’s Coefficient. Once again the relative fraction of each antigen 
that was associated with the putative companion molecule varied as a function of the 
plating conditions. For all surfaces assayed, Mander’s coefficient was highest for the 
association of MMP-2 with the α3 subunit (Figure 19). In the converse analysis of this 
relationship the relative fraction of α3 integrin that was localized in association with MMP-
2 was substantially less. For example, on collagen, Mander’s coefficient for the association 
of MMP-2 with the α3 integrin was about 0.35. However, for the converse circumstance 
the association of the α3 integrin with MMP-2 generated a value of 0.14. This data 
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indicates that a considerable amount of the MMP-2 molecule is present in association with 
the α3 integrin. The low value generated for the association of α3 integrin with MMP-2 
indicates that there is a much higher copy number of this integrin subunit on the cell 
surface than MMP-2. (More α3  integrin is without MMP-2 than α3  integrin that is with 
MMP-2) Mander’s coefficient for MMP-2 with β1 integrin was similar on all surfaces and 
ranged from 0.2 to 0.3. Finally, Mander’s coefficient for MT1-MMP and MMP-2 ranged 
from about 0.1 on collagen to 0.2 on fibronectin, values that are substantially less (by 
nearly 2 fold) than that reported for the association of MMP-2 and the α3 integrin.  
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FIGURE  19 
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Figure 19. Mander’s coefficient of co-localization analysis for specific integrin subunits 
and MMP-2. For all substrates, Mander’s coefficient was highest for the association of 
MMP-2 with α3 integrin. However, this analysis indicates that the bulk of the α3 subunit 
exists independent of the MMP-2 molecule. The fractional co-localization for the other 
integrin subunits, including β1 integrin, and MMP-2 were more similar on all substrates. 
The converse analysis yielded similar results. Mander’s coefficients for the association of 
MMP-2 and MT1-MMP-2 were consistently less than the coefficients calculated for the 
association of MMP-2 with the α3 integrin subunit. 
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Summary 
Data presented in this document demonstrates the association of MMP-2 with the 
β1 integrin in an interaction that specifically involves the integrin alpha chain α3. 
Pharmacologically blocking MMP protease activity with SB-3CT decreases the strength of 
cells adherent on collagen and fibronectin. Both qualitative and quantitative confocal 
microscopy was implemented to define the in situ relationship of MMP-2 with the primary 
integrins of the neonatal cardiac fibroblast plated on to specific ECM components for 1 
hour. Similar analysis was conducted with MMP-2 and MT1-MMP, a known cell surface 
binding partner and activator of MMP-2  
Overlap analysis demonstrates the highest association of MMP-2 occurs with the α3 
integrin chain. This result is in agreement with biochemical data of the reciprocal 
interaction of this integrin alpha chain with MMP-2. Pull down assays did not demonstrate 
this relationship with the other alpha integrin chains addressed in these assays, namely the 
α1, α2, α5 integrin chains. These alpha chains, however, demonstrate some degree of 
overlap with MMP-2.  It is unclear as to why these alpha integrin chains demonstrate a 
level (albeit low) of overlap with MMP-2 with microscopy, but did not demonstrate a 
physical connection with this protease in our pull down assays. One possibility is related to 
the α3 integrin being promiscuous in both substrate specificity203 and in participating with 
heterogeneous integrins in forming adhesions 73. Perhaps the overlap of MMP-2 with α1, 
α2, α5 that is detected is actually MMP-2 bound to α3 integrin intermingled in close 
proximity with these integrin chains. 
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Overlap of MMP-2 with the β1 integrin chain reflects a lower level of association 
than was detected with the α3 chain. This result is expected as the β1 chain partners with a 
number of integrin alpha chains. The overlap present between the α1, α2, α5 integrin chain 
with MMP-2 was low in comparison to the overlap present between α3 and MMP-2 on all 
substrates. As a consequence of β1 integrin having multiple alpha chain binding partners 
the degree of overlap that is present between MMP-2 and β1 integrin reflects the average of 
the association of MMP-2 with all of the alpha chains that are present with β1   integrin. 
This averaging provides indirect evidence to the specificity of the interaction of MMP-2 
with the α3β1  integrin.  
 Evident from the images of cells plated for 1 hour was a typical distribution pattern 
of MMP-2 as a clearly discernable ring shape at the region of transition between the central 
rounded region and the flattened edges that are spreading outward.  This is of note as this 
location places this protease at the base of spreading adhesion structures. More elaborate 
techniques may delineate how this implication relates to the changes in adhesion 
maturation that occur with protease inhibition in cells plated on collagen and fibronectin. 
The substrate specific response likely represents a combination of factors both intrinsic and 
extrinsic to the cell; the integrin profile, the identity of the substrate, and the role of this 
protease.    
 In adhesion experiments, blocking MMP associated protease activity alters the 
strength of adhesion fibronectin and collagen. It is tempting to connect the separate results 
of adhesion and the distribution of MMP-2 with integrins on specific surfaces; however, 
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these connections would be largely speculative. One clear interpretation is the overlap of 
MMP-2 with the α3β1  integrin is present on cells following 1 hour of adhesion and this 
overlap is predominate and of a greater degree that the association of MMP-2 and MT1-
MMP.  Moreover, this interaction was defined to the cell surface interface by interference 
refection microscopy. This evidence supports our isolation of a complex of MMP-2: α3β1 
from the surface of cardiac fibroblast.  
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Chapter X.   
 
Discussion  
 
Biochemistry of the MMP-2 integrin complex. This study has demonstrated 2 
distinct results. First, MMP-2 is present in a complex that contains the α3β1 integrin and 
TIMP-2. Second, pharmacological inhibition of MMP activity disrupts the maturation of 
cell attachment sites in an ECM specific manner. Circumstantial evidence links these two 
observations and suggests that MMP-2 bound at the cell surface modulates the maturation 
of adhesion sites in the cultured cardiac neonatal fibroblast. Biochemical assays (IP, 
Western blot assays, cell culture experiments, and pharmacological inhibition assays) and 
scanning confocal microscopic examination (distribution of MMP-2 with respect to 
integrin receptors) of cultured cells indicates that MMP-2 present at the cell surface 
mediates this process. 
IP pull down experiments conducted on cell-suspensions reveal that MMP-2 is 
physically, and preferentially, associated with the α3β1 integrin complex. Conducting a pull 
down assay directed against either the α3 or β1 integrin chains recovered immunoreactive 
MMP-2 (as judged by Western blot analysis and zymographic analysis of material 
recovered by IP). Conversely, IP experiments conducted against MMP-2 recovered α3 and 
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β1 integrin. The complex recovered in these conventional IP pull down assays is stable 
enough to withstand the elution buffers used to recover the complex and subsequent SDS 
treatments during rinses, although running these samples on SDS gels under reducing 
conditions will break down the MMP-2:integrin complex. On one hand these data suggest 
the complex is very stable. However, an alternative explanation, and clearly one potential 
criticism of these experiments, comes from the standpoint that the extraction procedures 
used to put the antigens of interest into solution during the initial stages of the IP could 
lead to the secondary association of the MMP-2 with the α3β1 integrin. During extraction 
the association of MMP-2 with the different integrin subunits could occur through non-
physiological means as a consequence of the assay conditions. Under these circumstances 
the non-specific association of the MMP with the integrin complex could appear to be very 
stable-if the proteins of interest are literally entangled and denatured with one another. 
Several lines of evidence argue against this explanation.  
First, in selected experiments cells were processed with the cross-linker DTSSP in 
the living state prior to Western blot analysis. This particular cross-linker functions at the 
cell surface and will chemically cross-link proteins together that are within 12 Å (See 
Appendix 6). An analysis of cells that have been processed in this manner for the detection 
of MMP-2 reveals an immunoreactive protein running at a MW of 200-210 kDa (See 
Appendix 6). This experiment provides compelling evidence that MMP-2 is in, at least, 
close proximity to the integrin complex in the living cell. Similar experiments conducted to 
assay for the presence of MMP-9 failed to detect this closely related (both structurally and 
functionally) protease. These results, in conjunction with pull down assays directed against 
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MMP-2 that failed to detect interactions between MMP-2 and any other α chains, provides 
additional (albeit indirect) evidence that the MMP-2: α3β1 integrin interaction exhibits a 
considerable degree of specificity. 
 Second, scanning confocal microscopic observations of cultured cells were 
conducted under circumstances that make it possible to assess the extent to which different 
antigens are co-localized with one another within a spatial resolution of 0.1394µm in the x-
y dimension, 0.2358µm in the x-z with the 63x objective. These experiments demonstrated 
that the association of MMP-2 with the α3 integrin was the highest under all circumstances 
that were assayed. In fact, Mander’s coefficient of co-localization for MMP-2 and the α3 
chain was higher than Mander’s coefficient of co-localization for MMP-2 and the MT1-
MMP protease (a well known and well characterized binding partner for MMP-2).  
The results of these different types of experiments are consistent with a complex 
composed of MMP-2: α3β1 integrin. However, there is at least one discrepancy in the 
analysis of the present results that remains to be fully resolved. The MW of the complex 
detected in this study can not easily be reconciled with existing literature. Given the caveat 
that it can be dangerous to estimate the MW of a protein complex that has been separated 
on a SDS gel run under non-reducing conditions (the tertiary structure of a multi-molecular 
complex that has been run in a non-reduced state can result in the calculation of a highly 
anomalous MW), the 210 kDa complex is still exhibits a very unusual mass. Using a 
median estimate of mass and adding the reported MWs of β1 (115-130 kDa, non-reduced) 
204, 59, 61, α3 integrin (120-130 kDa non-reduced )204, MMP-2 (72 kDa for the pro-isoform 
and 64 kDa for the active isoform) TIMP-2 (20 kDa non-reduced) generates a complex that 
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would have a nominal total MW of approximately 340 kDa (β1 @ 123 + α3 @ 125 + MMP-
2 @ 70 kDa + TIMP-2 @ 20 kDa = 338 kDa). While changes in the Stokes radius can 
greatly alter the movement of proteins within the electric field of the gels this mass is 
considerably higher than the mass observed for the complex defined in this study.  
The MW of the various integrin subunits have been defined in different cell types 
(isolated from various stages of rat development) and rat hepatocytes by chemically 
labeling their surfaces by iodination. This approach places a radioactive marker on, just, 
the surface associated molecules 61, 113. The labeled material was then extracted and 
subjected to an IP against different integrin subunits. The incorporated radioactivity was 
used to detect the recovered antigens. IPs against the β1 chain have been conducted against 
rat cardiac fibroblasts 59, 205, cardiac myocytes 113 and hepatocytes 61 using this cell surface 
labeling technique. When the recovered material was separated by SDS under non-
reducing conditions the β1 integrin generated an estimated MW of approximately 115-130 
kDa, substantially lower than the mass of the complex described in this study 59, 61, 113 .  
In addition, when cell surface radio-labeled β1 chain is recovered under non-
reducing conditions all of the α chains that are associated with that β1 chain on the cell 
surface are also labeled. When a pull down directed against β1 is used to recover the α3 
chain it exhibits an apparent MW of approximately 120-130 kDa, again much smaller in 
mass than was detected in this study. The published gels and the written discussion in these 
studies do not disclose any evidence of a high MW band that could correspond to the 
complex detected by this study. In addition to these observations, there is yet one more 
complicating factor. In Western blot analysis conducted in this study of whole cell extracts 
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the estimated MWs of α3 and β1 more closely approximated the expected MWs of these 
antigens (see Figure 2). Together, these observations generate two questions: Why are the 
α and β chains that are recovered by IP in this study remaining as a very high MW 
complex? Second: Why does this complex exhibit a low MW compared to the reported 
MWs of the individual proteins detected in the complex. Unfortunately, there is no clear 
answer to these questions.  
If the samples processed in this study by IP responded as has been described in the 
literature it may have been possible to make more definitive conclusions about how the 
recovered complex might be structurally organized. For example, if this precondition had 
been met and the β1 represented the predominate binding site for MMP-2 in the complex; 
it would be expected that the α3 subunit would run at a substantially lower MW the SDS 
gels (closer to 120-130 kDa vs. 210-220 kDa). Recovering the complex with an IP against 
β1 or MMP-2 would bring down the α chain(s) that were present in the putative complex. 
Once the sample was run on the gels the α and β chains should dissociate and separate. 
Assuming the MMP was linked to the β chain, these two proteins would run together while 
the α chain would separate and run at its expected, and substantially, lower MW. The 
converse argument also holds true. If the α3 integrin represented the exclusive binding 
partner for MMP-2, the β1 integrin should have been dissociated from the “complex” and 
run at approximately (110-120 kDa vs. the observed 210-220 kDa).  
Still recognizing that it is an inexact science to predict an exact molecular weight of 
a protein complex that has been separated under non-reducing conditions, the existing 
literature and the present data can be used to argue that MMP-2 is linked to both integrin 
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subunits. Western blot analysis of the complex recovered in this study has indicated that 
TIMP-2 is present in association MMP-2 and the α3β1 integrin in the neonatal cardiac 
fibroblast. In these experiments, a pull down assay was conducted against β1 integrin and 
the recovered material was probed by Western blot for TIMP-1 and TIMP-2. This 
approach was used because an IP against MMP-2 would ordinarily be expected to bring 
down one or both of the TIMP peptides (the normal binding partners for MMP-2). An IP 
against the β1 should represent a fairly stringent approach in determining if the TIMP 
molecule(s) represent component elements of the complex. The TIMP-1 molecule was 
present in the whole cell lysates but was not clearly associated with the 210-220 kDa 
MMP-2:α3β1 complex. TIMP-2 was clearly present in the complex and a Western blot 
analysis of this type of an IP confirms that both α3 and MMP-2 are present in the recovered 
material and running at the 210-220 kDa mass (Figure 2 and Figure 3). 
There is at least one scenario that can be used to defend model that MMP-2 actually 
interacts with both the α3 and the β1 chains of the integrin complex. It is possible that when 
the recovered complex is separated by SDS gel electrophoresis that the 2 integrin chains 
separate from one another but the linkages that the anchor MMP-2 to β1 and MMP-2 to α3 
may be more stable, resulting in the appearance of the “common” 210-220 kDa complex 
that we have observed. One maybe composed of β1 MMP-2 and TIMP-2 (β1 @ 115-130 
kDa + MMP-2 @ 68-72 kDa = 183 kDa to 202 kDa).  One other complex could be 
composed of α3,  MMP-2, and TIMP-2 (α3 @  120-130 kDa + MMP-2 @ 68-72 kDa + 
TIMP-2 @ 20 kDa = 208 kDa to 222 kDa). Under these conditions a Western blot 
analysis would detect a complex composed of α3β1 integrin, MMP-2 and TIMP-2 running 
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at a “common” MW of 210-220 kDa. This result would occur because IP against α3 or β1 
integrin or MMP-2 will bring down the entire complex; the complex then partially breaks 
down in the gel run into the composite structures described. Analysis by Western blot of 
the individual components would then detect all of component elements running at a MW 
of 210-220 kDa.  
In order to unambiguously define the exact nature of the interactions that mediate 
the interaction between MMP-2 and the α3β1 integrin it will be necessary to specifically 
design and conduct experiments to explore the structural properties of this complex. 
Various proteases of the MMP family exhibit interactions with different integrins. 
Somewhat surprisingly the nature of the MMP integrin interaction varies considerably 
across cell type. For example, in human gingival fibroblasts MMP-2 is indirectly linked to 
β1 integrin through a collagen peptide fragment 187. In this system one domain of  the 
collagen peptide appears to be bound to the active site in the integrin, while the MMP, 
which recognizes and binds to native collagen 132 , is bound by the collagen fragment. The 
association of MMP-1 (collagenase) with the α2β1 integrin is primarily defined by 
structural motifs that are present in the α2 chain 184,185 . The binding events that anchor the 
C-terminal hemopexin domain of the MMP-2 molecule to the αvβ3 integrin remain ill 
defined 186. However, this interaction is specific to this integrin. In the gel shift assays 
described in this latter study mixing MMP-2 with the αvβ3 integrin results in an increase in 
MW. Conducting this same experiment with the α5β1 integrin and MMP-2 resulted in no 
apparent shift in MW in the samples in the gel analysis. Given these observations the 
MMP-2 in cardiac myocytes may be could be bound to the β1 through the hemopexin 
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domain 201 or the collagen binding domain 187 and to the α3 through TIMP-2 mediated 
events 200. A specific binding site for TIMP-2 on α3 has been detected 200. 
Experiments conducted to examine the association of TIMP-2 with the integrin 
complex provide some insights into how this interaction might be mediated. In this series 
of IPs were conducted against the α3 and β1 integrin. Material from these isolations were 
then run under non-reducing and reducing conditions and blotted for TIMP-2.  (Figure 3). 
Interestingly material that was pulled down with α3 and run under non-reducing conditions 
did not show reactivity to TIMP-2. This is not an artifact of the antibody used to detect 
TIMP-2 as this antibody recognized this antigen in non-reducing conditions in isolates of a 
β1 integrin pull down. Under reducing conditions, however, TIMP-2 is detected in the α3 
pull down. Blotting for MMP-2 in the isolates from the α3 pulldown confirm that the 
differences in the detection of TIMP-2 in the non-reduced and reduced conditions were not 
resultant from an ineffective pull down of the complex of MMP-2: α3β1:TIMP-2. One 
likely explanation for the differences in detection of TIMP-2 in α3 isolates is that in the 
non-reduced condition the binding of TIMP-2 to the α3 integrin chain conceals the epitope 
recognized by the antibody used in this study. The immunogen or target for this antibody 
directs this antibody to the N-terminal, loop-1 domain of TIMP-2. The structure of TIMP 
is maintained as a series of 5-6 loops by disulfide bonds. Presumably, in the non-reduced 
condition this epitope is concealed in the binding to the α3 integrin chain. With reduction 
TIMP-2 was detected. Defining the exact site of interaction is beyond the scope of these 
studies; however, the interaction of TIMP-2 with α3 likely mediated by the N-terminal 
domains of TIMP-2. Additionally TIMP-2 was detected from IP to the β1 chain under non-
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reducing and reducing conditions implying that the interaction sites of   TIMP-2 with α3 
and β1 are different200.  
In summary, experimental evidence suggests that MMP-2, α3β1 and TIMP-2 exist 
as a complex on the surface of the cardiac fibroblast. It remains unclear how this complex 
is organized and selecting one model over another to explain the present results is difficult 
at best. Alternative models to explain the composition of the 210-220 kDa complex that 
was identified in this study include:  
 
• A much higher mass complex that runs at an “anomalously low” MW of 
210-220 kDa as a consequence of the running conditions used to separate 
the proteins for analysis. In this model the tertiary structure of the intact 
complex causes it to run at a low MW in the SDS gels under non-reducing 
conditions. 
• A high MW complex in which the MMP-2 is linked to both the α and 
β chains. The 210-220 kDa complex is generated when the intact complex 
is broken down into 2 separate complexes composed of β1 @ 115-130 kDa 
+ MMP-2 @ 68-72 kDa and then α3 @  120-130 kDa + MMP-2 @ 68-72 
kDa + TIMP-2 @ 20 kDa. 
 
Of the two alternatives presented the first may be the most tenable for two reasons. First, 
the buffers used to isolate and recover the IP material for analysis appear to be relatively 
gentle, allowing the integrin chains to remain intact with one another. When conventional 
IPs were processed by boiling in SDS to recover the antigens the chains would occasional 
remain intact other times they would breakdown. This result appeared to be very variable 
and dependent upon the length of time (or temperature?) the samples were processed (very 
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small changes resulted in very inconsistent results which is one reason the Seize IP kits 
were used). Second, the test tube and gel shift assays conducted with MMP-2 and αvβ3 and 
α5β1 would appear to indicate that MMP-2 alone will not bind to the α5β1 (this 
circumstance may be changed if the TIMP-2 molecule alters the structure of the MMP-2 
molecule in such a way that MMP-2 would now bind the α5β1 integrin). 
 
Functional implications of the MMP-2 integrin complex.  The association of 
MMP-2 with the α3β1 integrin is particularly interesting when one considers the 
promiscuous nature of the substrate specificity of this integrin. Collagen, laminin and 
fibronectin are all surfaces engaged by the α3β1 integrin. The MMP-2 protease exhibits 
activity against each of these surfaces 18,130,131  
Adhesion assays conducted in this study provide evidence that the MMP-2:TIMP-
2:α3β1 complex plays a role in the maturation of cell adhesion sites in an ECM specific 
fashion. Pharmacological inhibition of MMP function with SB-3CT did not alter cell 
adhesion in conventional cell adhesion experiments (30 or 60 minute incubation intervals). 
This is perhaps not surprising; these early events of adhesion are relatively non-specific in 
nature and are largely driven by electrostatic interactions 106. When these same cultures 
were plated for 60 min and then challenged with a calibrated centrifugal force treatment 
with SB-3CT selectively reduced the adhesion of the neonatal cardiac fibroblast to 
collagen and fibronectin, but not laminin or poly-l-lysine. It seems unlikely that this 
substrate specific effect on adhesion represents a reflection of the intrinsic proteolytic 
properties of MMP-2. This protease can degrade a broad spectrum of ECM proteins, 
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including laminin 18. The proteolytic processing of collagen and fibronectin can uncover 
RGD binding sites that are not ordinarily accessible in these ECM proteins by the integrins 
of the cardiac fibroblast 206,207. Proteolytic processing of laminin exposes this very same 
type of binding site; however, the cardiac fibroblast typically exhibits low expression of 
the integrin that mediates adhesion to these (now uncovered) cryptic sites208,209. 
 It is not possible to entirely discount the role that the MT1-MMP:MMP-2 complex 
might play in the adhesion studies 136. Our co-localization experiments clearly demonstrate 
this complex is present, and presumably active, in cells that have been plated for 1 hour. 
However, at this time point the coefficient of colocalization for MMP-2 with the α3 
integrin is far larger than the coefficient of colocalization of this enzyme with β1 or its 
more classic binding partner, MT1-MMP. The low values generated by the co-localization 
analysis for the MT1-MMP and MMP-2 suggest that very little MMP-2 is associated with 
this binding partner during this early stage of culture. Nor can we detect active MMP-2 (or 
MMP-9) in the supernatant of the cultures at this time interval (Figure 2, Appendix 3). 
Given these results it seems likely that our inhibition experiments are impacting MMP-2 
activity on a very local scale 210. We have been unable to “rescue” cell adhesion in cultures 
treated with inhibitors by first pre-treating the ECM coated culture dishes with exogenous 
proteases. This result also suggests the impact of SB-3CT is a very local event specific to 
the cell surface. By implication and the shear volume (number) of MMP-2 molecules 
associated with the α3 integrin this seems like the most likely site at which protease 
inhibition effects the cells.   
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 In confocal localization experiments MMP-2 exhibited a low background of 
association with the other integrin α chains. If there this association is “real” it occurs at a 
very low level, if an IP is conducted from a known number of cells only the α3 and β1 
chains are detectable in the final isolate. The low “background” of association of MMP-2 
with the other α chains could be reflection of the relatively promiscuous nature of the α3β1 
integrin. This particular integrin complex can bind to a variety of ECM substrates and co-
operates with other integrins in the maturation and formation of adhesion sites 73. During 
adhesion the α3β1 integrin does not necessarily participate in the very earliest stages of cell 
attachment, rather it appears to play a more distal role in the process. The α3β1 integrin 
accumulates in developing adhesions and is an integral component of the formation of 
heterogeneous adhesion sites (sites composed of multiple integrin subtypes).  
The constraints placed on the co-localization analysis by the inherent limits of 
optical resolution of confocal microscopy (63X objective, x-y resolution 0.1394µm; x-z 
resolution 0.2358µm) makes it impossible to determine if the overlap represents an 
association of the α3β1: MMP-2 complex with other integrins, the association MMP-2 with 
a common β1 chain, or the true association of the MMP-2 molecule with other α subunits. 
Together the data suggests that MMP-2 is selectively associated with the α3β1 integrin, the 
integrin most closely associated with the maturation of adhesion sites. 
 Whenever a study involves the application of pharmacologic agents a common 
concern is that these agents will adversely impact cell viability. Any loss of cells from the 
adhesion assays as a result of death would be reported as a reduction in cell adhesion. 
Conversely, any loss of cells from a viability assay due to changes in cell adhesion will be 
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reported by the viability assay as a reduction in cell viability. These characteristics 
represent a major limitation in conducting and interpreting the data presented in this study.  
In attempts to mitigate and circumvent these technical limitations necessitates 
conducting the viability assays on full attached cells. This assumes that once the cells are 
attached that protease inhibition over a short interval of time will not greatly impact 
adhesion. Several observations form the basis for the argument that cell viability was not 
adversely affected over the 1 hour plating interval used during the adhesion assays in this 
study. Evidence supporting this conclusion is first provided by the conventional adhesion 
assays in which indicated equal initial adhesion in cells treated with inhibitors. The 
preliminary stages of the centrifugal adhesion assays support this result. A vital dye is 
added to the cultures immediately prior to centrifugation (essentially a conventional 
adhesion assay at this point). In these experiments all cultures exhibited similar numbers of 
cells. Perhaps the most convincing evidence that viability was not adversely affected by 
protease inhibition (or the vehicle carrier) during the 1 hour culture interval used in the 
adhesion assays is that the adhesion strength was selectively reduced on collagen and 
fibronectin, and not on laminin or poly-l-lysine. While this line of reasoning is not a 
“direct” line of evidence, it may be more accurate than the metabolite based assay in 
assessing viability. The reality is that metabolic assays are inherently limited in 
determining cell number.  It is possible for these types of assays to represent similarly a 
low number of cells with high activity with a high number of cells with low activity.    
  One result in the viability assays of note concerns the observation that changes in 
metabolic activity in response to SB-3CT were dependant on the density at which cells 
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were initially plated. Cells plated at high density for 24 hours have elevated rates of 
metabolism compared to cells plated for the same interval at low density (see Figure 3 and 
Figure 4 Appendix 7). In cultures plated at low density (2k) for 24 hours and then 
supplemented with inhibitor a depression in metabolic rates was evident within 2 hours of 
treatment.(Figure 10) A broad interpretation of these results would suggest that they are 
consistent in some ways with the presented model that MMP-2 mediated activity is 
necessary for focal adhesion maturation.  In cells that have reached adhesion equilibrium 
the inhibition of protease activity can be expected to impair the ability of the cells to 
routinely turn over existing adhesions and express nascent sites. At low density cells are 
much more mobile and in contact with the underlying substrate. In this type of culture the 
turnover and expression of nascent focal adhesions would be relatively robust. 
Interventions that effect adhesion may cause the displacement and loss of cells from this 
type of culture. In contrast at high density cells are more stationary and contact with one 
another. Under these conditions focal adhesion turnover and contact with the substratum 
may be relatively unimportant. Muscle cells express very prominent focal adhesions when 
maintained at low cell density and extremely rudimentary focal adhesions when cultured at 
very high density 211.  
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Figure 20 Schematic of Adhesion Maturation  
MMP-2 bound to of α3β1. 
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Inhibitor    
       
  α3      α5      β1 
MMP-2          
During  initial adhesion, the native ECM 
component fibronectin has available a number of sites for adhesion. For example, 
the binding site for the α5β1 is present in the on the surface of this glycoprotein.  
A 
 
MMP-2 bound to α3β1 integrin is positioned to 
cleave ECM constituents. Proteolysis of fibronectin 
exposes additional RGD binding sites that are unavailable 
in the native peptide. Additional binding sites increase the number 
of potential sites for integrin binding. Moreover, these sites can 
be bound by integrin such as α3β1 in addition to the α5β1  thereby increasing not only the 
number of binding sites but also the complement of integrin that bind to a unique ECM 
protein. Conventional adhesion assays at 30 minutes and 1hour support the maturation of 
adhesion during this time interval Proteolytic events may contribute to this maturation 
process. 
 
Treating cells with a specific protease inhibitor against 
MMP-2, blocks this proteolysis and as a consequence 
there is a decrease in the strength, maturation of 
adhesion. Theoretically, the increase in the number of binding sites 
would not occur. Under these circumstances the absolute or 
potential number of binding sites in the ECM is reduced and as a 
consequence there are fewer sites for attachment. Secondarily, the 
complement and number of receptors participating in adhesion are reduced. However, 
there are adequate binding sites on the native fibronectin substrate that support equal levels 
of initial adhesion and spreading as compared cells plated  Taken together these 
considerations suggest MMP-2 and potentially the complex of MMP-2 and α3β1 are 
involved in the maturation of adhesion in cells plated on fibronectin (and collagen but not 
on laminin or poly-l-lysine). 
C. 
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Physiological implications. The integrin MMP-2 complex identified in this study 
brings together both the receptors that mediate adhesion to the ECM, integrins, with the 
main class of enzymes responsible for the proteolysis of ECM components, the MMPs. 
Relevant to this discussion is the role of the cardiac fibroblast in development and disease. 
This cell type represents the major nexus responsible for the deposition, turnover, 
maintenance, and remodeling of the cardiac ECM. In the postnatal period rapid changes in 
hemodynamic load are associated with the turnover of existing matrix constituents and the 
elaboration of a robust cardiac ECM. A complex composed of MMP-2 and the α3β1 
integrin may represent a self-contained mechano-sensitive site that can detect changes in 
load while mediating aspects of the proteolytic processing of the local microenvironment 
to facilitate cell migration and the shedding of integrins 212   
 Early in the progression of cardiac hypertrophy the myocardium adapts and 
increases performance to meet peripheral demand. However, the onset of changes in the 
composition (myocardial compliance) of the ECM parallels the transition to 
decompensation and failure of the myocardium174, 175.  As in cardiac development, the 
deposition of nascent matrix components requires the remodeling or degradation of the 
preexisting ECM. Similarly, changes in the hemodynamic load initiate the elaboration and 
accumulation of these components.  MMP-2 is expressed in concert, temporally and 
spatially during the developmental period171, 172. Likewise, in the adult changes in 
hemodynamic stress trigger a similar sequence of events and are a prelude to remodeling of 
the ventricular wall127.  The developmental mechanisms and relationships between 
mechanical stretch, the expression of proteases, and elaboration of ECM components are 
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carried over and relevant to the adult. In the adult heart changes in the compliance 
(composition) of the ventricular wall and systolic dysfunction can be induced by the over-
expression of MMP-2 177; whereas, deleterious remodeling can be attenuated by 
pharmacologically interventions that decrease the levels of this protease178, 179.  
 Treatment paradigms for hypertension, a complex disease entity of multiple 
etiologies, are focused on reducing the mechanical load on the heart. This treatment 
strategy delays the progression toward and the transition of compensated heart disease to 
decompensated  heart disease. If this complex represents a mechanosensitive site for the 
detection of mechanical load on the cardiac interstitium and at the same time is a site for 
effecting both changes in fibroblast cell adhesion and matrix turnover, interventions 
targeting this complex could augment current treatment paradigms. These strategies may 
decrease the migration of cardiac fibroblast and attenuate maladaptive changes in the 
cardiac interstitium.  However, the extent that these in vitro observations carry over into 
the in vivo situation is unclear. The complex of MMP-2 and α3β1 integrin represents a site 
on the surface of the cultured cardiac fibroblast that combines mechano-sensitive and 
proteolytic elements that may mediate substrate specific maturation of adhesion. 
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APPENDIX 1 
 
Introduction. The principle limitation of conventional IPs is the possible 
contamination of the recovered material with the antibodies used to precipitate the antigen 
of interest. Conventional IP relies on the capture of the primary antibody/ antigen complex 
on to the surface of beads functionalized with protein A or protein G or a combination of 
proteins A/G depending on the species of origin for the primary antibody. For example, in 
a pull down assay for β1 integrin the starting cell lysate is incubated with a known 
concentration of primary antibody. Once captured, the complexes are rinsed several times 
and the antigen is eluted using conditions that disrupt the binding of the primary antibody 
to the antigen. This may be achieved by changing the ionic strength of rinse buffers, a 
change in the pH of the buffers, dissociation induced by boiling of the sample, and/or by a 
combination of these conditions.  Antigen recovery also can be achieved by exposing the 
recovered material to reducing conditions (very harsh by comparison to the other 
methods).  
Ideally, the antibody is retained on the beads and only the antigen is released; 
however, this result is highly dependent upon the starting antibody. More typically the 
antigen and antibody complex and the antibody bead complex are broken down, liberating 
the primary antibody from the carrier beads. Under these conditions the primary antibody 
will “travel” with the antigen in the subsequent analysis. If the recovered material is 
processed for Western blot analysis this contaminating primary antibody may be 
recognized by the secondary antibodies used to probe the blot. The use of the Seize IP kit 
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largely eliminates these cross-reactivity concerns because the primary antibodies used in 
the initial recovery are chemically linked to a solid phase support. 
 
Methods 
Immunodetection in the infrared range using Odyssey Scanner (LiCor) was utilized 
to confirm the source of contaminating signal that was variably present in the evaluation  
of samples recovered by routine, conventional IP (See Methods section for Routine IP and 
IP of plated CF). Following chemiluminescent detection, PVDF membranes were stripped, 
blocked (Li-Cor, 927-40000) and probed at 1:1000 with Mouse anti-MMP-2 antibody. For 
infrared imaging, the blot was counterstained at a rate of 1:10,000 with Goat anti-Mouse 
700 nM IR Conjugate (Rockland, 610-430-002) and with Goat anti-Rabbit 800 nM IR 
(LiCor, 926-32211) conjugate.  Blot was pre-scanned for adjustment of signal to 
background in the 700 nM and 800 nM channels. Final scan of blot captured at a resolution 
of 84.7µm with an intensity setting of “4” in both channels.   
 
Results 
Appendix 1 Figure 1 
Routine IP.  A suspension of cardiac fibroblast  were divided into two groups; lysed 
with RIPA buffer that was either supplemented or not supplemented with Complete 
protease inhibitor cocktail (Roche, 11 697 498 001) and processed for routine IP against β1 
integrin. MMP-2 was detected at a number of molecular weights in the samples recovered 
by IP to β1 integrin (Lane 3 and Lane 4), in the raw unprocessed cell lysate (Lane 5), and in 
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lanes used to separate a recombinant MMP-2 protein standard (Lane 6). This antigen was 
not detected in the null IP (Lane 1) or in the β1 antibody lane (primary antibody diluted in 
Laemmli buffer and run directly on the blot) (Lane2).  The application of broad spectrum 
protease inhibitors did not disrupt the association of MMP-2 and β1 integrin in this assay 
(compare lane 3 with lane 4). In this particular isolation no cross-reactivity of the primary 
Rabbit IP antibody was detected when the Western blots were probed for the detection of 
the Mouse MMP-2 primary antibody (using Horse anti-Mouse).  
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Appendix 1 Figure 2 
In a second representative series of experiments Western blots were generated from 
a routine IP against β1 integrin from lysates generated from suspended cells, or cells plated 
out for 1 hour on collagen, laminin, fibronectin, and poly-l-lysine (Panel A, Lanes 3-7, 
respectively). Recovered material was processed for Western blot analysis for the detection 
of MMP-2. Secondary Horse anti-Mouse antibody was applied and the blot was developed. 
MMP-2 was detected in whole cell lysate (Lane 1). In the null IP (Lane 2) bands were 
detected that match the molecular weight expected for intact immunoglobulin (150kDa), 
heavy chain (50kDa), and light chain (25kDa). The presence of these bands indicates that 
the precipitating antibody is being carried forward in the analysis. This contaminate 
interferes with the unambiguous identification of MMP-2 co-precipitated with a β1 
immunoprecipitation from lysate of suspended and plated cells (Panel A, Lanes 3-7).  
The original PVDF was stripped, re-blocked, and re-probed with Mouse anti-
MMP-2 antibody (Panels B-D). For infrared imaging, the blot was counterstained with 
Goat anti-Mouse 700 nM IR conjugate (Rockland) and with Goat anti-Rabbit 800 nM IR 
(LiCor) conjugate. In this assay immunoreactivity was present in the Null IP, indicating 
that primary anti-β1 (Rabbit) antibodies used to conduct the original IP cross reacts with 
either the anti-MMP-2 (MaB, unlikely) primary, the secondary Horse anti-Mouse HRP 
antibody used to probe for the MMP-2 antibody, or both (Panel A, Lane 2). Staining the 
resulting blot using an IR tagged antibody demonstrates the spurious signal originates from 
the Rabbit anti-β1 integrin antibodies used to conduct the IP (Panel D, Lane 2). Cross 
reactivity from the carryover of anti-β1 integrin antibody is likely a product of different lots 
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of secondary antibodies used to probe the Western blots. This cross-reactivity occurred in 
some experiments and not others, necessitating the use of the Seize IP approach 
documented in the main section of this study. 
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Appendix 1, Figure 2 
 
 
Utilization of IR dyes to demonstrate carryover of primary antibody in traditional IP. 
 
The panels represent a single traditional IP experiment against β1  integrin (Anti-Rabbit) 
and processed for detection of MMP-2 (Anti-Mouse) using conventional 
chemiluminescence (A) and infrared detection as an overlay (B) or in separate detection 
channels; 700nM anti-Mouse(C) and 800nM anti- Rabbit. The IR system separates the 
contribution of the primary detection of MMP-2 (C) from the background contribution of 
Anti-β1  (D), which constrains interpretation of traditional development (A). The initial 
design for this experiment was to address the question of is there changes in the amount of 
MMP-2 in association with β1  integrin when CF are plated on specific surfaces. Lane 1, 
Cell lysate(Input); Lane 2, Null IP(no lysate); Lane 3, CF processed directly from culture 
plate; Lanes 4-7, CF plated for 1hr onto Collagen, Laminin, Fibronectin, and Poly-L-
Lysine, respectively; Lane 8, MMP-2 Standard.    
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APPENDIX 2 
 
Introduction. The IP experiments in this study were conducted with cells that have 
been maintained in culture flasks for varying lengths of time, trypsinized, rinsed several 
times and then allowed to recover for 15 minutes in suspension culture. In selected 
experiments cells were trypsinized, allowed to recover for 15 minutes and then plated for 1 
hour on various substrates prior to processing. Under either condition clear evidence of 
MMP-9 was not detectable in cell pellet fractions (as judged by zymography and Western 
blot analysis).  However, in conditioned media recovered from cultures of CF that had 
been plated for 1 hour or for more extended periods of time this protease was readily 
detected by gelatin zymography. Unlike MMP-2, it appears that MMP-9 is detectable only 
in the conditioned media compartment at the 1 hour time interval. 
 
Methods 
Culture plates (Corning, 6 well) were coated with 10 µg/ml fibronectin or poly-l-
lysine overnight at 4˚C. Plates were rinsed 3X with PBS and blocked with 1% BSA at 
room temperature for 1 hour. CF were tryspsinized and counted as described, 50 K cells 
were delivered in 2 ml of ITS supplemented DMEM per well for each of the time points to 
be assessed and incubated from 1 hour to 48 hours. Media samples were collected from the 
individual cultures at the appropriate time, mixed 1:1 with Laemmeli Buffer and frozen at -
70˚C.  
205 
   
With the expectation that  the absolute concentration of gelatinases would be low in 
2 ml of conditioned media from 50K cells, and to avoid the sometimes negative effects 
from concentration steps (such as Trichloroacetic acid precipitation), the large format 
Protean II XI gel electrophoresis system was used to conduct this specific zymography. 
The 20 cm x 20 cm x 0.15 cm format gel with a 20 well comb accommodates a large 
loading volume (max 187 µl). In this assay 150 µl of sample from each culture condition 
was assayed. Positive control of Gelatinase activity was established with Zymography 
Standard (Millipore CC023). From stock, a 1:100 dilution in Laemmeli buffer was made 
(Labelled “A”); from this dilution four serial dilutions were made at 1:10 (Labelled B-E). 
In each lane 20 µl of each standard sample A-E was loaded.  Non-conditioned media was 
prepared identical to experimental groups and run as a negative control.  Electrophoresis 
and subsequent processing for gelatin zymography were conducted as described.  
    
Results 
CF plated onto fibronectin and poly-l-lysine exhibit gelatinolytic activity of MMP-
2 and MMP-9 in the conditioned media fractions as early as 1 hour following plating and 
this activity was detected out to at least 48 hours post plating. We can assume that the 
continued presence of the pro-MMP-9 results from continued deposition as the pro-form 
would otherwise be depleted by the activation cascade of this protease. On the other hand, 
levels of pro-MMP-2 seem to accumulate without obvious processing of this enzyme to the 
active form in the media fractions. MMP-9 activity in conditioned media at 1 hour is not 
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accompanied by any detectable activity in the cell pellet fractions at this time point (See 
Appendix 3).  
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Appendix 2, Figure 1 
 
 
Gelatin Zymography. Accumulation of Gelatinases in media conditioned by Cardiac 
Fibroblast plated onto fibronectin or poly-l-lysine for 1, 4, 6, 12, 24, and 48 hours, Lanes 
1-7 respectively. Dilutions  of gelatinase standard (Lanes A-C ) run as positive control 
indicate the sensitivity of zymography for small amounts of gelatinase and identify  along 
with apparent molecular weight the proteases in conditioned media as proMMP-9 and 
proMMP-2.  
 
 
 
 
 
208 
   
APPENDIX 3 
 
Introduction. SB-3CT is a highly specific inhibitor of MMP mediated protease activity 
213. It has known inhibitory effects on the gelatinases, MMP-2 and MMP-9.  This reagent 
binds to the active site in the enzyme and functions as a competitive inhibitor 214. To 
demonstrate the efficacy of this agent for this use, cultures were mixed with 10 µM SB-
3CT and plated for 1 hour. Cell pellet fractions were separated by SDS gel electrophoresis 
and processed for zymography.   
 
Methods 
Culture plates were coated with 0.07µg/mm2 fibronectin, cells were cultured as 
naïve, vehicle treated (Buffer R) (50 mM HEPES (pH 7.5), 150 mM NaCl, 5 mM CaCl2, 
0.01% Brij-35 and 50%DMSO) or 10µM SB-3CT treated. “Buffer R” is the diluent for an 
intermediate dilution of stock SB-3CT conducted prior to final dilutions in aqueous media. 
Cells were suspended in ITS media, or ITS media supplemented with vehicle or SB-3CT 
and incubated 15 minutes prior to plating. Groups plated in triplicate of 40 K cells/well in a 
final volume of 2 ml of media. Following a 1 hour incubation media was aspirated 
carefully and cultures rinsed 3X with cold PBS; excess PBS was wicked by inverting 
culture plates and placing them on top of lint free towels. Plates were placed on ice and 50 
µl RIPA was applied per well. Lysates were collected with cell scrapers. Samples were 
centrifuged at 10,000 X G at 4˚C for 15 minutes. Supernatant was assayed by Bradford 
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Protein assay mixed with Laemmeli buffer at a concentration of 10 µg/30 µl total volume, 
heated for 3 minutes at 60˚C, and processed for gelatin zymography.  
In a separate parallel experiment cells were treated with GM-6001 at 5µM, with  a 
matched concentration of DMSO as vehicle control. Following 1 hour of plating, 
conditioned media was collected, and centrifuged for 15 minutes at 10,000 X G at 4˚C. 
Cultures were rinsed 3X with cold PBS as described and cell pellets were collected as 
described.  Conditioned Media fractions were run based on equal protein values of 15 µg 
per sample in a total of 30 µl volume. 
 
 
Results 
 
SB-3CT treatment decreased MMP-2 associated activity as determined by Gelatin 
zymography (Figure 1, A). As judged by densitometric analysis, the trace (Optical Density 
X mm2) values of samples treated with SB-3CT were approximately 50% of vehicle 
treated controls (Figure 2, B).  Data shows the feasibility of this agent in blocking MMP-2 
activity in cell pellet fractions.  Treatment of cultures with GM6001 promoted an increase 
in pro-MMP-2 that was not detected in the untreated or vehicle control cultures. As this 
inhibitor blocks MT1-MMP mediated activity the increase in pro-MMP-2 detected in this 
experiment is likely a reflection of decreased processing of pro-MMP-2 on the surface of 
the cell to active MMP-2 (Figure 2, A). GM6001 did not appear to impact the activity of 
MMP-2 in the conditioned media fraction. We note the activity of MMP-9 in conditioned 
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media as “presumptive” as the positive control in this zymogram is a MMP-2 standard. 
However, the zymograms in this appendix show clear activity of MMP-2 without the 
activity of MMP-9 in cell pellet fractions.  
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Appendix 3, Figure 1 
 
 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.
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Appendix 3,Figure 2 
 
 
 A.
 
 
 
 
 
 
 
 
 
 
 
 
 B.
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APPENDIX 4 
 
Introduction. The running conditions used to prepare an IP for zymographic 
analysis are similar, but not completely identical to the conditions used to prepare this 
material for conventional Western Blot analysis. In early experimentation 
immunoreactivity against MMP-2 was present in samples recovered by IP directed at β1 
integrin. However, zymographic activity was not detectable in these early samples. Several 
explanations could account for this result. However, one concern of note was that the 
MMP-2 enzyme was not stable in the putative complex with β1 integrin when samples 
were processed for zymography. Alternatively, the enzyme might be stable in the complex 
but not present in a form that can be activated in the zymographic gels. Integrin associated 
proteases have been reported to be difficult to activate under some circumstances 187. To 
verify that IPs against β1 integrin that have been processed for zymography retain MMP-2 
selected samples were processed by IP against β1 integrin, processed for zymography and 
then processed directly from the zymographic gels for Western blot analysis. In parallel 
with zymographic processing, samples were directly assessed for MMP-2 by Western blot 
analysis.  These experiments demonstrate that MMP-2 immunoreactivity is present in the 
material processed for zymography and at a MW that appears to be consistent with the 
MW of the complex identified in the main body of this study. The underlying reasons that 
no protease activity was detectable in the IP recovered samples remain unclear. These 
results ultimately led to processing the material recovered by IP against β1 integrin in the 
presence of SB-3CT. Under these circumstances protease activity was detectable when the 
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samples were processed for zymography. Possible reasons for why MMP-2 activity might 
be preserved in these experiments include: 
 
- In the purification of the complex by IP the resultant elution is of sufficiently 
high enrichment for the auto-activation and catalysis of MMP-2 to occur and 
the inhibitor prevents the processing of a fraction of this population.  
 
- As described by 187 (who identified collagen mediated binding of MMP-2 to β1 
integrin) cell surface bound MMP-2 may be resistant activation.  
 
- In some instances, there is a cooperative interaction between TIMP-2 and MMP 
inhibitors in MT1-MMP mediated activation of MMP-2 196. SB-3CT could be 
acting to selectively activate MMP-2 in the immunoprecipitated complex.  
 
- Alternatively, elution from routine IP was conducted by heating the antigen off 
the surface of the Protein A/G beads. Thermal denaturation could result in lack 
of enzymatic activity by while the antigenicity of the peptide is maintained. In 
comparison, the elution of complexes from the Seize IP is conducted with low 
pH buffering and a preservation of enzymatic activity only in the SB-3CT.   
 
 One consideration that has not been discussed concerns the limits of detection for 
the techniques used in these assays. Zymography standard at a stock concentration of 
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0.1mg/ml was diluted 1:100, then as a series of dilutions at 1:10 to test the approximate 
limit of detection for zymography. Gelatinase standard was detectable at a 1:10,000 
dilution when 20 ul of the diluted samples was developed for 18 hours (Appendix 2). The 
starting concentration of standard is supplied as a mixed population of enzyme species. 
With this caveat, the total amount of protein detectable by zymography was in the range of 
2 ρg.  Limits of ECL Plus detection are demonstrated to be as little as 20 ρg of protein in 
slot blotting applications 215 (Manis 2007). With similar limits of detection, these 
techniques should be complimentary in the identification of MMP-2.  
The most likely scenario to explain discrepancy discussed regarding the detection 
of MMP-2 has origin in the differences in the methods of routine and Seize IP.  The 
latency of MMP is controlled through an interaction of the pro-peptide sequence with the 
Zn+2 of the catalytic domain. This coordination bond or “cysteine switch” stabilizes the 
pro-peptide and suppresses MMP-2 activation. When samples recovered by conventional 
IP are processed for Western blotting or zymography they were routinely boiled. Heating 
this type of can denature proteins and thereby prevent MMP-2 activation. In material 
recovered by the Seize IP methodology, the samples are eluted from the beads by a change 
in pH. Under these circumstances, lowering the pH can promote the activation of MMP-2. 
With the MMP-2 in high concentration in an IP recovered sample, the pH induced 
activation could result in the initiation of auto-catalytic activation and self cleavage of 
MMP-2. Under these conditions, the presence of an MMP-2 inhibitor such as SB-3CT 
could act to preserve a fraction of MMP-2 or block the activation and subsequent 
degradation of the isolate. This later explanation seems likely.  
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Methods 
Immunoprecipitation and gelatin zymography. Gelatin zymography was conducted 
on samples recovered by IP against β1 Integrin under conventional methods. Material 
recovered by IP was first separated by conventional SDS gel electrophoresis on a 10% slab 
gel and transferred to PVDF for Western blot analysis against β1 and/or MMP-2 (AB1952, 
Chemicon; IM51, Calbiochem, respectively.) Representative fractions of IPs were then 
subjected to gelatin zymography.  
Zymography. Equal volumes of whole cell lysate or protein fractions purified by IP 
from a suspension of  2 x 106 cells  were mixed with Laemmli buffer and separated on a 
SDS 10% polyacrylamide gel supplemented with 1.0% gelatin. Gelatinase standards 
(Chemicon; 20 µl of stock solutions that had been diluted 1:200) were used as positive 
controls to identify MMP-9 and MMP-2 enzymatic activity. In experiments that focused on 
MMP-2, proMMP-2 (Calbiochem, PF037) was used as the positive control (20 µl of a 
1:200 dilution of the stock solution). Following electrophoretic separation at 120V 
(constant voltage), gels were incubated in renaturation buffer (BioRad) for 1 hour and then 
transferred into development buffer (Bio-Rad) for 18 hours at 37ºC. Gels were fixed (20% 
Methanol, 10% Glacial Acetic Acid, 70% distilled de-ionized H2O) and stained with 
Coomassie Blue, G-250 (Bio-Rad). De-stained gels were imaged (Gel Doc 2000, BioRad) 
and analyzed by densitometry (Quantity One, BioRad) to characterize gelatinolytic 
activity.  
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Following development and documentation, the gelatin zymograms were 
transferred to PVDF for Western Blot analysis against MMP-2. The preparation of these 
samples was done in the absence of exogenous protease inhibitors (to allow protease 
activity associated with IP material to function and degrade the gelatin present in the 
zymograms). Lanes were loaded with a whole cell lysate prepared from a cell suspension, 
an IP to β1 (AB1952, Chemicon), or recombinant human MMP-2 pro-enzyme standard 
(PF037, Calbiochem). The anti-MMP-2 antibody used in these experiments recognizes the 
72 kDa latent and 66 kDa active species of MMP-2.   
In separate experiments cardiac fibroblasts (2 x 106 cells ) were prepared as a 
suspension culture, pelleted, and lysed directly with RIPA buffer in the absence of protease 
inhibitors for  conventional immunoprecipitation directed against β1 integrin.   Raw cell 
lysate and the enriched IP samples were prepared for processing by 10% SDS-PAGE (Gel 
1) and for processing by 10%SDS- PAGE, 0.01% Gelatin Zymogram (Gel 2). Following 
electrophoresis, Gel 1 was processed for Western blotting against MMP-2. Gel 2 was 
processed for Zymography. Images were captured of the developed and stained zymogram. 
An additional interval of destaining was conducted by incubating the zymogram in Towbin 
buffer prior to overnight transfer (125mA) to PVDF membrane. The samples transferred 
from the zymograms were then processed for immunodetection of MMP-2 by conventional 
methods.   
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Results 
Western blotting of cell lysate and IP of β1 integrin confirm the presence of MMP-2 
reactivity as compared to recombinant MMP-2 standard (Gel 1: A) in samples that were 
processed in parallel as an input for gelatin zymography (Gel 2: B). Similar patterns of 
immunoreactive MMP-2 are detected in (A) and (C) for whole cell lysate, IP to β1 integrin 
and for MMP-2 positive control. However, the gelatinolytic activity detected (B) does not 
follow same this pattern. In whole cell lysate, there are a number of gelatinolytic bands that 
are not confirmed as MMP-2 by Western blot although the anti-MMP-2 mAB recognizes 
both the 72 kDa latent and 66 kDa active species of MMP-2. The lack of Zymographic 
activity from the IP, at the MW expected for MMP-2, is contrasted by the immunoreactive 
bands detected by Western blot (C). 
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Appendix 4, Figure 1  
  
Zymography and Western Blotting.  Conventional immunoprecipitation to β1 integrin was 
assessed in parallel for MMP-2 by Western blot (A) and by Gelatin Zymography (B).  At 
the conclusion of zymographic processing, the zymogram was transferred and blotted for 
MMP-2 (C). This experiment was conducted to verify that MMP-2 was actually retained in 
the complex recovered by IP and then processed for zymography. Lack of definitive 
zymographic activity in the IP sample is in contrast to the immunodetection of MMP-2.  
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APPENDIX 5 
 
Introduction. MMP-2 is typically bound to TIMP-2; MMP-9 is typically bound to TIMP-
1. However, TIMP-1 and TIMP-2 can both bind the active form of either enzyme (Ward 
1991), making both peptides potential candidates as component elements of the α3β1 
integrin MMP-2 complex. Of the two molecules, TIMP-2 probably represents the more 
likely binding partner, a specific binding interaction between TIMP-2 and the α3β1 integrin 
has been identified 200.  
 
Methods 
Following the Seize IP protocol, MMP-2 or β1 was recovered. Next, each sample 
was supplemented with β-mecaptoethanol (2.5ul:100ul sample) and heated at 95˚C for 5 
min. Western blotting to TIMP-1 (AB800, Chemicon) was conducted on reduced samples 
according to the  manufacturer’s literature that states that the antibody does not  bind well 
to the non-reduced protein.  
 
Results 
In whole cell lysate immunoreactivity against TIMP-1 was detected; however, in 
the enriched fractions isolated by Seize IP directed against MMP-2 and β1 no such activity 
was detected for TIMP-1.   
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Appendix 5, Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
Western Blotting to TIMP-1 did not show reactivity in elution steps from IP to MMP-2 
(Lanes 1-3) or from IP to β1 integrin (Lanes 4-6). The presence of this small molecular 
weight inhibitor was detected in whole cell lysate.  
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APPENDIX 6 
 
Introduction. To determine if MMP-2 becomes secondarily associated with the α3β1 
integrin complex when a cell lysate is prepared, live cardiac fibroblasts were pre-treated 
with the cross-linking agent DTSSP (21578, Pierce). This reagent will cross-link peptides 
that are within 12 angstroms of one another on the cell surface. Processing cross-linked 
cells makes it possible to determine the spatial relationships that might exist within the 
radius of the reagent used to prepare the samples for IP analysis or Western blot analysis.  
 
Methods 
Cell surface associated proteins were crosslinked to stabilize protein-protein 
interactions using DTSSP (21578, Pierce). This reagent has an effective cross linking 
distance of 12 Å and solubility properties limits this crosslinker to the cell surface.   In 
these experiments cardiac fibroblasts were plated out onto poly-l-lysine coated 6 well 
dishes in ITS media supplemented with 5ul:20ml Gelatinase standard (CC073, Millipore) 
or plain ITS media.  Following one hour of plating, cultures were rinsed 3X with PBS, 
cultures were then supplemented to a final concentration of crosslinker at 1 mM in PBS 
and allowed to incubate for 30 minutes at room temperature. The reaction was quenched 
with the addition of sufficient Tris (stock solution 1 M, pH 7.5) to bring the final Tris 
concentration to 15 mM for a 15 minute incubation interval. At this point cultures were 
placed on ice, treated with RIPA buffer, and scraped to collect the cell pellet fraction. 
Samples were centrifuged to pellet debris and the supernatant was transferred to clean 
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sample tubes and mixed with Laemmeli buffer in preparation for SDS-PAGE. Parallel 
cultures without the use of crosslinker were processed for SDS-PAGE. Samples were 
separated for Western blotting against MMP-2 and β1 integrin on separate blots.   
 
Results 
Application of exogenous gelatinase did not appear to alter the staining patterns 
present in the crosslinked (Panels A & C) or native (Panels B & D) cell pellet fractions 
(these blots were run on 7.5 % PAGE instead of the 10% Gels that are typically used in 
this study, as a result the position of a bands are shifted downward on the gel). Similar 
molecular weight bands at 200-210kDa blots stained against MMP-2 in both the 
crosslinked and naïve cell pellet suggest that the interaction of MMP-2 and β1 integrin 
occurs on the surface of cardiac fibroblast. Further, the application of exogenous gelatinase 
(Panel A & B) did not qualitatively increase the amount of staining for MMP-2 as 
compared to staining present generated from naïve cells (Panels C & D). The molecular 
weight band of 200-210kDa in “unpurified” cell pellets placed in the context of IP data 
demonstrating a complex of α3β1: MMP-2 at this same molecular weight suggests 1) 
MMP-2 and β1  may be associated on the cell surface 2) that this association is not 
dependant on crosslinking of the cell surface, and 3) application of exogenous gelatinase 
did not meaningfully increase the amount of MMP-2 in cell pellets.  
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Appendix 6, Figure 1 
 
 
 
 
Figure 1. Crosslinking of cell surface. Cells plated on poly-l-lysine were cultured in the 
presence and absence of exogenous gelatinase. At the conclusion replicate cultures were 
surface crosslinked (Panel A & Panel C) or maintained naïve (Panel B & Panel D). Cell 
pellet lysates were separated by PAGE and blotted for MMP-2 and for β1  integrin.    
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APPENDIX 7 
 
 
Introduction. Any loss of cells due to death will artificially reduce the total number of 
cells observed in an adhesion assay. As a result of this potential condition cell viability was 
tested under a variety of culture conditions.  
 
Methods 
Assays were conducted to verify that cell viability remains constant under the 
conditions used to define cell adhesion. Many of these assays were conducted on cells that 
had been plated and allowed to adhere for a defined interval of time prior to the cultures 
being supplemented with drug or vehicle. This approach made it possible that each 
experimental condition had the same number of cells at the onset of the assay (this 
assumption can not be made if cells are treated in suspension with various drugs and then 
plated-if the drug alters adhesion or if the drug reduces viability the total number of cells 
will be reduced but the reason will be unknown).  
 These assays were designed to parallel the cell number used for plating in adhesion 
assays (2 K and 40 K/ per well/ 96 well plate). Viability was assessed by two metabolic 
based measures; the WST-1 assay and with Calcein AM. The WST-1 assay is typically 
used as an assay to measure cell proliferation; in this study it was used to determine the 
potential toxicity of the inhibitors (GM-6001 and SB-3CT) used in conventional and 
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centrifugal adhesion assays. This colorimetric assay relies on the conversion by 
mitochondrial dehydrogenases of the WST-1 tetrazolium salt to formazan. The 
accumulated formazan is then measured at an absorbance of  ~450 nm. Calcein AM is 
metabolically dependant as well; however, it is the metabolic cleavage of this dye that 
converts Calcein AM to Calcein, the fluorescently active species of the dye. This 
conversion decreases the membrane permeability of the dye thereby “trapping” the dye in 
the cell and providing a “direct” measure of cell number. Accumulated Calcein was 
measured at 480ex/520em. These assays function to validate the adhesion data and suggest 
a cell number/density dependant response to treatment with MMP inhibitors. As the scope 
of adhesion assays narrowed, viability testing became more focused and was tailored to 
encompass conditions used to evaluate the impact of protease inhibition on cell adhesion.  
Viability was assessed on collagen, laminin, and fibronectin under the following sets of 
conditions;  
  
Inhibitor Assay Cells 
Per well 
Dose/ Vehicle Timing of 
dose 
Incubation 
time 
GM-6001 WST-1 40 K 0, 10, 25µM After 30min 4 hr 
SB-3CT WST-1 40 K 0,1,5,10,25µM At plating 4 hr 
SB-3CT WST-1 40 K 0,1,5,10,25µM At plating 24 hr 
SB-3CT WST-1 2 K 0,1,5,10,25µM At plating 24 hrs 
SB-3CT Calcein AM 2 K 0,1,5,10,25µM At plating 24 hrs 
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SB-3CT WST-2 2 K 0,1,5,10,25µM At 24, 26, 
28 hr post 
plating 
6 hr,4 hr,2 hr
 
Data from viability assays on SB-3CT was expressed as the percent of activity 
detected in the untreated, substrate matched control. Data from each plating substrate was 
screened by one-way ANOVA (P=<0.001), pairwise multiple comparisons were done  
using the Holm-Sidak method with an overall significance level of 0.05.  
 
 
Results 
General Inhibitor: GM 6001. The WST-1 assay was used in these experiments to 
detect overt changes in cell viability attributable to the presence of the GM6001 protease 
inhibitor. In this assay 40 K cardiac fibroblasts were plated in triplicate on collagen, 
laminin, fibronectin, poly-l-lysine or BSA coated surfaces. All experimentation was 
conducted with ITS media. Cells were plated for a 30 minute interval, then, the appropriate 
doses of inhibitor were delivered to the cultures so that the final concentration of inhibitor 
was 0 µM, 10 µM, and 25 µM. These doses were selected based on the manufacturer’s 
recommended typical cell culture dose. After an additional 30 minutes (total of 1 hour 
post-plating), 10 µl of the WST-1 reagent was added to the cultures. The assay was 
allowed to develop for a total of 4 hours. Cell number was interpolated from a five point 
standard curve.  
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Substrates coated with collagen or fibronectin supported an equal metabolic rate 
across all administered doses of the inhibitor (Figure 1). As judged by the WST-1 assay, 
total cell number remained constant across all conditions tested on these 2 substrates. 
Cultures plated onto laminin coated surfaces showed a decrease in metabolic activity at the 
25 µM dose with respect to the 10 µM dose and non-treated controls. Similarly, cultures 
plated onto Poly-l-lysine exhibited a decrease in metabolic activity at this same 
concentration of inhibitor. On BSA, total cell number, as reported by the WST-1 assay, 
was decreased in cultures treated with the 10 µM dose and the 25 µM dose with respect to 
non-treated cells. In summary, 10 µM GM6001 appears to be well tolerated by CF when 
the cells are plated onto collagen, laminin, fibronectin, poly-l-lysine and BSA at this time 
interval. N=1 of triplicates.  
Specific Inhibitor: SB-3CT. The impact of the specific inhibitor SB-3CT on cell 
viability was also tested over a range of concentrations and culture conditions using the 
WST-1 assay.  Initial experiments focused on the viability of cardiac fibroblast when 
plated in the presence of 1 µM, 5 µM, 10 µM, and 25 µM SB-3CT, or vehicle (Buffer R 
25µM) for a 4 hour time interval on Collagen, Laminin, or Fibronectin coated culture 
surfaces. At this time point 10 µl of WST-1 reagent was added to the cultures and allowed 
to develop for two hours. The metabolic activity of cardiac fibroblast plated under these 
conditions was largely unaffected by the presence of varying doses of SB-3CT (Figure 2).  
SB-3CT exhibits evidence of a density dependent effect on cell viability. At high 
cell density (40 K) the relative number of cells was similar on all surfaces and at all doses 
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of inhibitor assayed (1 µM, 5 µM, 10 µM, and 25 µM) at the 6 hour time point (Figure 2). 
In control experiments, cultures treated with or without vehicle (Buffer R, 25 µM) 
exhibited a metabolic profile that was similar to that of cultures treated with the various 
concentrations of the inhibitor.  
After 24 hours, a cell density dependent effect of inhibitor became manifest. Cell 
viability in cultures treated with 0, 1, and 5 µM inhibitor was similar in low density 
(Appendix 7, Figure 4) and high density(Figure 3 cultures (2K vs. 40K), although there 
was a subjective evidence of increased metabolic activity with increasing dose of inhibitor. 
This pattern diverged at the 10 µM dose of inhibitor. At this dose, viability in low density 
cultures (2K) was markedly depressed with respect to control cultures (non-treated and 
vehicle matched) plated at the same density. In contrast to these results, the total metabolic 
activity present in cultures plated at high cell density (40 K) remained unchanged (and 
subjectively higher) when treated with inhibitor. A similar, albeit more pronounced trend 
was apparent in cultures treated with the 25 µM concentration.  Total metabolic activity 
was depressed in cultures plated at low cell density (2 K) with respect to non-treated and 
vehicle matched controls. At high cell density (40 K) total metabolic activity was increased 
in cultures treated with this dose of inhibitor with respect to non-treated and vehicle 
control. The vehicle controls (DMSO matched to 25 µM dose) in these experiments 
exhibited a nominal effect on cultures plated at low cell density and little to no effect in 
cultures plated at high cell density.  N=1 for 40k cells, N=2 for 2k cells at the 24 time 
point. 
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Calcein AM: Live cell analysis. A potential limitation of a metabolic based assay in 
assessing cell number is that changes in metabolic activity can be mistakenly interpreted as 
an increase or a decrease in the actual number of cells. To verify the results of the WST-1 
metabolic assay Calcein AM was used to characterize cell viability/number in cultures 
plated at low cell density (2 K). This reagent is only taken up and retained in live cells. In 
these experiments CF were plated in the presence or absence of 1 µM, 5 µM, 10 µM, 25 
µM SB3-CT or vehicle (Buffer R, matched concentration) prepared in ITS media for 24 
hours on collagen, laminin, or fibronectin (Appendix 7, Figure 5a-c, respectively).  Cell 
number was then determined by Calcein fluorescence derived from a standard curve of cell 
plated in parallel with the experimental cultures. At low doses of inhibitor (1 µM and 5 
µM) the increase in metabolic activity detected by the WST-1 was not accompanied by any 
detectable change in cell number as measured by the Calcein Live cell assay. However, 
without exception, treatment with SB-3CT at the 10 µM dose, and higher, resulted in a 
75% decrease in viable cells as compared to both the untreated and vehicle controls at the 
24 hour time point.  
In summary, the treatment of cardiac fibroblasts with the gelatinase specific 
inhibitor (SB-3CT) has effects that are dose and cell density dependant. At low density, 
and low dose (5 µM) cell number is not affected; yet, there is a slight increase in the 
metabolic activity detected in these cells. It can be postulated that the increased metabolic 
activity may be attributed to increased migration, or turnover of adhesions; yet, the reason 
is unknown.  
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Time component of viability. The specific MMP inhibitor SB-3CT induces dose 
dependant changes in cell viability. A time course study was conducted to more fully 
characterize the effects of this reagent. In preliminary studies, cells cultured in the presence 
of SB-3CT for 24 hours exhibited increased metabolic activity at low dose (5 µM) and 
decreased viability at high dose (10 µM). In these experiments cells were plated at low 
density (2K) in culture wells coated with collagen, laminin or fibronectin for a total of 30 
hours in ITS media (Figure 6a-c). At 2 hours, 4 hours, and 6 hours prior to assessing 
metabolic activity, media was aspirated and replaced with media supplemented with 0, 1, 
5, or 10 µM SB-3CT or vehicle (DMSO) control. The approach was used to avoid artifacts 
that might be induced by changes in adhesion that may occur when cells are plated in the 
presence of inhibitor.   
The maximum dose over time tolerated by the cultures without a change in viability 
is 5 µM for a duration of 2 hours.  At time points greater than 2 hours, there is a subjective 
decrease in the metabolic activity in these cultures as compared to non-treated and vehicle 
matched controls. At 10 µM SB-3CT, there was a detectable decrease in  metabolic 
activity cell viability within 2 hours. With increasing time of exposure (4 hours and 6 
hours) there was a more pronounced decrease in metabolic activity in cultures treated with 
10 µM SB-3CT with respect to non-treated and vehicle controls. The decrease in metabolic 
activity as a function of dose and time of exposure was similar on all surfaces tested. 
(Figure 10).  
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Conclusions 
 
While data indicate that there is a decrease in the metabolic activity of cardiac fibroblast  
following 2 hours of exposure to 10uM SB-3CT these results do not necessarily translate 
as a decrease in the viability of cells in the 1 hour interval used in adhesion assays or 
challenge the validity of adhesion results.   This statement is based  on equivalent  data of 
initial cell adhesion in SB-3CT treated cultures as compared to control  at 1 hour using a 
vital dye in conducting centrifugal adhesion assays . The following guidelines should be 
adhered to in the application of SB-3CT; short term experiments (1 hour in duration) a 
maximum dose of 10uM is tolerated, for longer durations (24 hours in duration) doses of 
1uM and 5uM are appropriate. In the application of GM-6001 the maximal tolerated dose 
was 10uM for duration of 4 hours of culture.  
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Appendix 7, Figure 1 
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Appendix 7, Figure 2 
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Appendix 7, Figure #3 
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Appendix 7, Figure #4 
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Appendix 7, Figure 5 
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